Texas |
6036 |
46-2135597 | ||
(State or other jurisdiction of incorporation or organization) |
(Primary Standard Industrial Classification Code Number) |
(IRS Employer Identification Number) |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller Reporting Company | |||||
Emerging growth company |
Exchange Act Rule 13e-4(i) (Cross-Border Issuer Tender Offer) ☐ |
||
Exchange Act Rule 14d-1(d) (Cross-Border Third-Party Tender Offer) ☐ |
ii | ||||
iii | ||||
1 | ||||
10 | ||||
53 | ||||
54 | ||||
65 | ||||
82 | ||||
84 | ||||
85 | ||||
85 | ||||
Annex Index |
||||
A-1 |
||||
B-1 |
• | the impact of COVID-19 on our business, including the impact of the actions taken by governmental authorities to try and contain the virus or address the impact of the virus on the United States economy (including, without limitation, the Coronavirus Aid, Relief, and Economic Security Act), and the resulting effect of all of such items on our operations, liquidity and capital position, and on the financial condition of our borrowers and other customers; |
• | geographic concentration in the Greater Houston market, Dallas-Fort Worth market, and Austin-San Antonio market; |
• | interest rate risk and fluctuations in interest rates; |
• | our ability to maintain important deposit relationships; |
• | our ability to grow or maintain our deposit base; |
• | our ability to implement our expansion strategy; |
• | changes in key management personnel; |
• | credit risk associated with our business; |
• | the adequacy of our allowance for loan losses; |
• | the amount of nonperforming and classified assets that we hold; |
• | market conditions and economic trends generally and in the banking industry; |
• | our borrowers’ ability to repay loans; |
• | changes in value of the collateral securing our loans; |
• | credit risks associated with our real estate and construction lending; |
• | changes in the economy affecting real estate values and liquidity; |
• | the accuracy of the valuation techniques we use in evaluating collateral; |
• | systems failures, fraudulent activity, interruptions or data breaches involving our information technology and communications systems of third parties; |
• | the risk of fraud related to our asset-based lending and commercial finance products; |
• | our ability to raise additional capital in the future; |
• | competition from financial services companies and other companies that offer banking services; |
• | natural disasters and other catastrophes; |
• | changes in the laws, rules, regulations, interpretations or policies relating to financial institution, accounting, tax, trade, monetary and fiscal matters; |
• | monetary policies and regulations of the Board of Governors of the Federal Reserve System (the “Federal Reserve”); |
• | the development of an active, liquid market for our common stock; |
• | fluctuations in the market price of our common stock; |
• | additional debt or future issuances of new debt securities or preferred stock; and |
• | and other factors discussed elsewhere in this prospectus, in particular the “Risk Factors” section of this Prospectus beginning on page 10, as well as in the Company’s periodic reports filed with the SEC |
Old Notes |
$82,250,000 in aggregate principal amount of 5.500% Fixed-to-Floating |
New Notes |
Up to $82,250,000 in aggregate principal amount of 5.500% Fixed-to-Floating |
registration rights under the registration rights agreement that we entered into with the initial purchasers of the Old Notes or otherwise; and because the holders of the New Notes are not entitled to registration rights, holders of the New Notes will not have the right to additional interest under the circumstances described in the registration rights agreement relating to our fulfillment of our registration obligations. |
Exchange Offer |
We are offering to exchange the New Notes for a like principal amount of Old Notes. Subject to the terms of the exchange offer, following the expiration or termination of the exchange offer, we will exchange the Old Notes that have been validly tendered and not validly withdrawn prior to such expiration or termination for an equal principal amount of the New Notes. |
Expiration Date |
The exchange offer will expire at 5:00 p.m., New York City time, on , 2022, unless we decide to extend it. |
Withdrawal Rights |
Except as otherwise provided in this prospectus, you may validly withdraw your tender of Old Notes at any time prior to 5:00 p.m., New York City time, on the expiration date. For a withdrawal of tendered Old Notes to be effective, the exchange agent must receive, on or prior to 5:00 p.m., New York City time, on the expiration date, a computer generated notice of withdrawal, transmitted by The Depository Trust Company, or DTC, on your behalf in accordance with the appropriate procedures of DTC’s “Automated Tender Offer Program,” or ATOP. See “The Exchange Offer—Withdrawal of Tenders.” |
Conditions to Exchange Offer |
The exchange offer is subject to customary conditions, which we may waive. See “The Exchange Offer—Conditions.” |
Procedures for Tendering Old Notes |
For the Old Notes that were issued in book-entry form, which are currently represented by global notes held for the account of DTC, as depositary, DTC or DTC’s nominee is treated as the registered holder of such Old Notes and will be the only entity that can tender such Old Notes for New Notes. |
In order to participate in the exchange offer, you must follow the procedures established by DTC for tendering Old Notes held in book-entry form. These ATOP procedures require that, prior to the expiration date of the exchange offer, (i) DTC receive (a) your instructions to exchange your Old Notes and (b) your agreement to be bound by the terms of the accompanying letter of transmittal, and (ii) the exchange agent receive a computer generated message known as an “agent’s message” that is transmitted through ATOP. |
Please note that by using the ATOP procedures to tender and exchange Old Notes, you will be bound by the terms of the accompanying letter of transmittal, and you will be deemed to have |
made the acknowledgments and representations it contains. See “The Exchange Offer—Eligibility; Transferability” and “The Exchange Offer-Representations.” |
For Old Notes that were issued in physical form, tender of such Old Notes is to be made by properly completing and signing the letter of transmittal and delivering the same, together with the physical note or physical notes, if applicable, representing the Old Notes being tendered and any required signature guarantees and any other documents required by the letter of transmittal, to UMB Bank, N.A. the exchange agent, at the address listed under “The Exchange Offer—Exchange Agent” on or prior to 5:00 p.m., New York City Time, on the expiration date. |
Certain Material United States Federal Income Tax Considerations |
The exchange of Old Notes for New Notes in the exchange offer will not constitute a taxable event for United States federal income tax purposes. For additional information, see “Certain Material United States Federal Income Tax Considerations.” You should consult your own tax advisor as to the tax consequences of exchanging your Old Notes for New Notes. |
Registration Rights |
Under the terms of the registration rights agreement that we entered into with the initial purchasers of the Old Notes at the time we issued the Old Notes, we agreed to register the New Notes and undertake the exchange offer. We are making this exchange offer solely to satisfy our obligations under the registration rights agreement. After the exchange offer is completed, we will have no further obligations, except under certain limited circumstances, to provide for any exchange or undertake any further registration with respect to the Old Notes. |
Transferability |
Based on existing interpretations of the Securities Act by the staff of the SEC set forth in several no-action letters issued to other parties, we believe that you, or any other person receiving New Notes, may offer for resale, resell or otherwise transfer the New Notes without complying with the registration and prospectus delivery requirements of the Securities Act, provided that: |
• | you are, or the person receiving the New Notes is, acquiring the New Notes in the ordinary course of business; |
• | you do not, nor does any such person, have an arrangement or understanding with any person to participate in any distribution (within the meaning of the Securities Act) of the New Notes; |
• | you are not, nor is any such person, an “affiliate” of ours within the meaning of Rule 405 under the Securities Act; |
• | you are not, nor is any such person, a broker-dealer registered under the Exchange Act, and you are not engaged in and do not intend to engage in, nor is any such person engaged in or intending to engage in, any distribution (within the meaning of the Securities Act) of the New Notes; and |
• | you are not acting on behalf of any person who could not truthfully make these statements. |
Our belief that transfers of New Notes would be permitted without complying with the registration and prospectus delivery requirements of the Securities Act under the conditions described above is based on interpretations by the staff of the SEC given to other, unrelated issuers in similar exchange offers. The staff of the SEC has not considered the exchange offer in the context of a no-action letter, and we cannot assure you that the staff of the SEC would make a similar interpretation with respect to the exchange offer. If our belief is not accurate and you transfer a New Note without delivering a prospectus meeting the requirements of the Securities Act or without an exemption from such requirements, you may incur liability under the Securities Act. We do not and will not assume, or indemnify you against, such liability. See “Risk Factors—Risks Related to the Exchange Offer.” |
Any broker-dealer that holds Old Notes acquired for its own account as a result of market-making activities or other trading activities and that receives New Notes for its own account pursuant to the exchange offer may be a statutory underwriter and must acknowledge that it will deliver a prospectus meeting the requirements of the Securities Act in connection with any resale of such New Notes. See “Plan of Distribution.” |
Consequences of Failing to Exchange Old Notes |
Any Old Notes that are not exchanged in the exchange offer will continue to be governed by the applicable indenture relating to the Old Notes and the terms of the Old Notes. Old Notes that are not exchanged will remain “restricted securities” within the meaning of Rule 144(a)(3) under the Securities Act and will be subject to the restrictions on transfer described in the Old Notes, and you will generally not be able to offer, sell, pledge or otherwise transfer the Old Notes, except to us or to any of our subsidiaries, under a registration statement that has been declared effective under the Securities Act or under an exemption from the requirements of the Securities Act. Upon the completion of the exchange offer, we will have no further obligations, except under limited circumstances, to provide for any exchange or undertake any further registration with respect to the Old Notes. If you do not participate in the exchange offer, the liquidity of your Old Notes could be adversely affected. See “Risk Factors—Risks Related to the Exchange Offer” and “The Exchange Offer—Consequences of Failure to Exchange.” |
Use of Proceeds |
We will not receive any cash proceeds from the exchange of Old Notes for New Notes as a result of the exchange offer. |
Cancellation of Exchanged Old Notes |
Old Notes that are surrendered in exchange for New Notes will be retired and cancelled and will not be reissued. Accordingly, the issuance of the New Notes under the exchange offer will not result in any increase in our outstanding indebtedness. |
Exchange Agent |
UMB Bank, N.A. is serving as the exchange agent for the exchange offer. See “The Exchange Offer-Exchange Agent” for the address, telephone number and email address of the exchange agent. |
Issuer |
Third Coast Bancshares, Inc. |
Securities Offered |
5.500% Fixed-to-Floating |
Aggregate Principal Amount |
Up to $82,250,000. |
Maturity Date |
April 1, 2032, unless previously redeemed. |
Form and Denomination |
The New Notes will be issued only in registered form without interest coupons and in minimum denominations of $100,000. and any integral multiple of $1,000 in excess thereof. The New Notes will be evidenced by a global note deposited with the trustee for the New Notes, as custodian for DTC, and transfers of beneficial interests will be facilitated only through records maintained by DTC and its participants. |
Interest Rate and Interest Rate Payment Dates During Fixed Rate Period |
From, and including, March 31, 2022, to, but excluding, April 1, 2027, unless redeemed prior to such date, the New Notes will bear interest at a rate of 5.500% per annum, payable semi-annually in arrears on April 1 and October 1 of each year through April 1, 2027. The first interest payment will be made on October 1, 2022. |
Interest Rate and Interest Rate Payment Dates During Floating Rate Period |
From and including April 1, 2027, to but excluding the maturity date (such period, the “floating rate period”) or early redemption date, the New Notes will bear interest at a rate, which is reset quarterly, equal to the then current Three Month Term SOFR (as defined in “Definitions Relating to the Determination of the Floating Interest Rate” in this prospectus) (or other applicable Benchmark, as defined in “Definitions Relating to the Determination of the Floating interest Rate” in this prospectus) (provided, however, that in the event Three-Month Term SOFR is less than zero, Three-Month Term SOFR shall be deemed to be zero) plus 315 basis points. If Three-Month Term SOFR cannot be determined on a given date, a different index shall be determined and used in accordance with the terms of the Indenture. |
If the calculation agent determines on or prior to the relevant Reference Time that a Benchmark Transition Event and its related Benchmark Replacement Date (each as defined under “Description of the Subordinated Notes—Definitions Relating to the Determination of the Floating Interest Rate”) have occurred with respect to Three-Month Term SOFR (or other applicable Benchmark), then the provisions under “Description of the Subordinated Notes—Effect of Benchmark Transition Event,” which are referred to herein as the “benchmark transition provisions,” will thereafter apply to all determinations of the interest rate on the notes for each interest period during the floating rate period. In accordance with the benchmark transition provisions, after a Benchmark Transition Event and its related Benchmark Replacement Date have occurred, the interest rate on the notes for each interest period during the floating rate period will be an annual rate equal to the Benchmark Replacement (as defined under “Description of the Subordinated Notes—Definitions Relating to the Determination of the Floating Interest Rate”) plus 315 basis points. |
Day Count Convention |
30-day month/360-day year to but excluding April 1, 2027, and, thereafter, a 360-day year and the number of days actually elapsed. |
Record Dates |
Each interest payment will be made to the holders of record who held the New Notes at the close of business on the fifteenth calendar day prior to the applicable interest payment date. |
Subordination; Ranking |
The New Notes will be our general unsecured, subordinated obligations and: |
• | will rank subordinate and junior in right of payment to all of our existing and future “senior indebtedness” (as defined below); |
• | will rank equally in right of payment and upon the Company’s liquidation with the Company’s existing and all future indebtedness the terms of which provide that such indebtedness ranks equally with promissory notes, bonds, debentures and other evidences of indebtedness of types that include the Subordinated Notes; |
• | will rank senior in right of payment and upon the Company’s liquidation to any indebtedness the terms of which provide that such indebtedness ranks junior to promissory notes, bonds, debentures and other evidences of indebtedness of types that include the Subordinated Notes; and |
• | will be effectively subordinated to all of the existing and future indebtedness, deposits and other liabilities of the Company’s current and future subsidiaries, including without limitation, its bank subsidiary’s liabilities to depositors in connection with the deposits in the bank, the subordinated debt issued by its bank subsidiary, as well as liabilities to general creditors and liabilities arising during the ordinary course or otherwise. |
See “Description of the Notes—Subordination.” |
Optional Redemption |
We may, at our option, redeem the New Notes (i) in whole or in part beginning with the interest payment date of April 1, 2027, and on any interest payment date thereafter, or (ii) in whole, but not in part, upon the occurrence of a “Tier 2 Capital Event,” a “Tax Event,” or “Investment Company Event” (each as defined below in “Description of the Notes—Redemption”). |
Any redemption of the New Notes will be at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the date of redemption. Any redemption of the New Notes will be subject to receipt of the approval of the Board of Governors of the Federal Reserve System to the extent such approval is then required under applicable laws or regulations, including capital adequacy rules or regulations. Any partial redemptions will be processed through The Depository Trust Company, in accordance with its rules and procedures, as a Pro Rata Pass-Through Distribution of Principal. The New Notes are not subject to redemption at the option of the noteholders thereof. |
The New Notes will not be entitled to the benefit of any sinking fund. |
No Limitations on Indebtedness |
The indenture governing the New Notes and the terms of the New Notes do not contain any covenants limiting or restrictions on the incurrence of indebtedness or other obligations by us or by a subsidiary of ours, including the Bank. |
Limited Indenture Covenants |
The indenture governing the New Notes contains no financial covenants requiring us to achieve or maintain any minimum financial results relating to our financial position or results of operations or meet or exceed any financial ratios as a general matter or in order to incur additional indebtedness or obligations or to maintain any reserves. |
Moreover, neither the indenture nor the New Notes contain any covenants prohibiting us from, or limiting our right to, grant liens on our assets to secure our indebtedness or other obligations that are senior in right of payment to the New Notes, repurchase our stock or other securities, including any of the New Notes, or pay dividends or make other distributions to our shareholders (except, in the case of dividends or other distributions on junior securities, upon an event of default). |
Listing; No Public Market |
The New Notes are a new issue of securities with no established trading market and we do not expect any public market to develop in the future for the New Notes. We do not intend to list the New Notes on any national securities exchange or quotation system. |
Risk Factors |
See “Risk Factors” beginning on page 10 of this prospectus, as well as in our reports filed with the SEC, and other information included in this prospectus for a discussion of factors you should consider carefully before deciding to participate in the exchange offer. |
Trustee |
UMB Bank, N.A., or successor if replaced in accordance with the applicable provisions of the indenture. |
• | We are subject to interest rate risk and fluctuations in interest rates may adversely affect our earnings. |
• | The withdrawal of deposits by our largest depositors could force us to fund our business through more expensive and less stable sources. |
• | We may not be able to grow or maintain our deposit base, which could adversely impact our funding costs. |
• | We may not be able to implement our expansion strategy, which may adversely affect our ability to maintain our historical earnings trends. |
• | We may not be able to manage the risks associated with our anticipated growth through de novo |
• | The unexpected loss of our executive management team and other key employees could adversely affect us. |
• | We may not be able to adequately measure and limit our credit risk, which could lead to unexpected losses. |
• | Our allowance for loan losses may prove to be insufficient to absorb potential losses in our loan portfolio. |
• | The amount of nonperforming and classified assets may increase significantly, resulting in losses, costs and expenses. |
• | Our largest loan relationships currently make up a material percentage of our total loan portfolio. |
• | We participate in the small business loan program under the CARES Act, which may expose us to credit losses. |
• | New lines of business or new products and services may subject us to additional risks. |
• | Without effective internal control over financial reporting, we may not be able to report our financial results accurately and timely. |
• | Faulty data or modeling approaches on which our management’s decision-making relies could negatively impact our decision-making ability or possibly subject us to regulatory scrutiny in the future. |
• | We have pledged all of the stock of the Bank as collateral for a loan and if the lender forecloses, you could lose your investment. |
• | A lack of liquidity could impair our ability to fund operations and could have a material adverse effect on our business, financial condition and results of operations. |
• | We may need to raise additional capital in the future, and such capital may not be available when needed or at all. |
• | The borrowing needs of our clients may increase, especially in a challenging economic environment, which could result in increased borrowing against our contractual obligations to extend credit. |
• | We face strong competition from financial services companies and other companies that offer banking services. |
• | Negative public opinion regarding our company or failure to maintain our reputation in the communities we serve could adversely affect our business and prevent us from growing our business. |
• | We may not be able to overcome the integration and other risks associated with acquisitions, which could have a material adverse effect on our ability to implement our business strategy. |
• | If the judgments, assumptions or estimates used in our critical accounting policies are inaccurate our financial statements and related disclosures could be affected. |
• | Adverse economic conditions in our primary geographic markets could negatively impact our operations and customers. |
• | Our primary markets are susceptible to natural disasters and other catastrophes that could negatively impact the economies of our markets, our operations or our customers. |
• | We could recognize losses on investment securities held in our securities portfolio, particularly if interest rates increase or economic and market conditions deteriorate. |
• | System failures, interruptions or data breaches involving third party information technology and telecommunication systems we rely on could adversely affect our operations and financial condition. |
• | The occurrence of fraudulent activity, breaches of our information security, and cybersecurity attacks could adversely affect our business and operations, as well as cause legal or reputational harm. |
• | We may face difficulties with respect to the effective availability and implementation of continually necessary technological changes. |
• | We operate in a highly regulated environment and the laws and regulations that govern us, or changes in them, or our failure to comply with them, could adversely affect us. |
• | Our failure to comply with any supervisory actions to which we are or become subject as a result of any federal banking agency examination could adversely affect us. |
• | The market price of our common stock may be subject to substantial fluctuations. |
• | The market price of our common stock could decline significantly due to actual or anticipated issuances or sales of our common stock. |
• | We may incur additional debt or issue new debt securities, which would be senior to our common stock. |
• | We may issue shares of preferred stock in the future, which could make it difficult for another company to acquire us or could otherwise adversely affect holders of our common stock. |
• | We are dependent upon the Bank for cash flow, and the Bank’s ability to make cash distributions is restricted. |
• | Our corporate organizational documents contain certain provisions that could have an anti-takeover effect. |
• | Our bylaws could limit a shareholder’s ability to obtain a favorable judicial forum for disputes with us. |
• | An investment in our common stock is not an insured deposit and is subject to risk of loss. |
• | If you do not validly tender your Old Notes, you will continue to hold unregistered Old Notes, and your ability to transfer Old Notes will be limited. |
• | Changes in SOFR could adversely affect the amount of interest that accrues on the SOFR-linked notes and the trading prices for the SOFR-linked notes. |
• | Our obligations under the notes are unsecured and subordinated to any senior indebtedness of the Company. |
• | credit losses resulting from financial stress being experienced by our borrowers as a result of the pandemic and related governmental actions (including risks related to the PPP under the CARES Act and related credit risks resulting from PPP lending due to forbearance or failure of customers to qualify for loan forgiveness); |
• | increased bankruptcies being experienced by the carrier, freight broker and shipper clients serviced by our commercial finance operations; |
• | declines in collateral values; |
• | declines in oil and gas prices and disruptions in the oil and gas industry; |
• | third-party disruptions, including outages at network providers and other suppliers; |
• | increased cyber and payment fraud risk, as cybercriminals attempt to profit from the disruption, given increased online and remote activity; and |
• | operational failures due to changes in our normal business practices necessitated by the pandemic and related governmental actions. |
• | intense competition from other banking organizations and other acquirers for potential target companies; |
• | market pricing for desirable acquisitions resulting in returns that are less attractive than we have traditionally sought to achieve; |
• | incurring time and expense associated with identifying and evaluating potential acquisitions and negotiating potential transactions, resulting in our attention being diverted from the operation of our existing business; |
• | using inaccurate estimates and judgments to evaluate credit, operations, management and market risks with respect to the target institution or assets; |
• | failure to achieve expected revenues, earnings or synergies from an acquisition; |
• | potential exposure to unknown or contingent liabilities of banks and businesses we acquire, including compliance and regulatory issues; |
• | the time and expense required to integrate the operations and personnel of the combined businesses; |
• | experiencing higher operating expenses relative to operating income from the new operations and the failure to achieve expected cost savings; |
• | losing key employees and customers; |
• | reputational issues if the target’s management does not align with our culture and values; |
• | significant problems relating to the conversion of the financial and customer data of the target; |
• | integration of acquired customers into our financial and customer product systems; |
• | risks of impairment to goodwill and other acquired assets; or |
• | regulatory timeframes for review of applications, which may limit the number and frequency of transactions we may be able to consummate. |
• | increases in loan delinquencies; |
• | increases in nonperforming asses and foreclosures; |
• | decreases in demand for our products and services, which could adversely affect our liquidity position; and |
• | decreases in the value of the collateral securing our loans, especially real estate, which could reduce customers’ borrowing power and repayment ability. |
• | obtain unauthorized access to confidential information belonging to us or our clients and customers; |
• | manipulate or destroy data; |
• | disrupt, sabotage or degrade service on a financial institution’s systems; and |
• | steal money. |
• | the proliferation of new technologies, and the use of the Internet and telecommunications technologies to conduct financial transactions; |
• | these threats arise from numerous sources, not all of which are in our control, including among others human error, fraud or malice on the part of employees or third parties, accidental technological failure, electrical or telecommunication outages, failures of computer servers or other damage to our property or assets, natural disasters or severe weather conditions, health emergencies or pandemics, or outbreaks of hostilities or terrorist acts; |
• | the techniques used in cyber-attacks change frequently and may not be recognized until launched or until well after the breach has occurred; |
• | the increased sophistication and activities of organized crime groups, hackers, terrorist organizations, hostile foreign governments, disgruntled employees or vendors, activists and other external parties, including those involved in corporate espionage; |
• | the vulnerability of systems to third parties seeking to gain access to such systems either directly or using equipment or security passwords belonging to employees, customers, third-party service providers or other users of our systems; and |
• | our frequent transmission of sensitive information to, and storage of such information by, third parties, including our vendors and regulators, and possible weaknesses that go undetected in our data systems notwithstanding the testing we conduct of those systems. |
• | actual or anticipated fluctuations in our operating results, financial condition or asset quality; |
• | changes in economic or business conditions; |
• | the effects of, and changes in, trade, monetary and fiscal policies, including the interest rate policies of the Federal Reserve; |
• | publication of research reports about us, our competitors, or the financial services industry generally, or changes in, or failure to meet, securities analysts’ estimates of our financial and operating performance, or lack of research reports by industry analysts or ceasing of coverage; |
• | operating and stock price performance of companies that investors deemed comparable to us; |
• | additional or anticipated sales of our common stock or other securities by us or our existing shareholders; |
• | additions or departures of key personnel; |
• | perceptions in the marketplace regarding our competitors or us, including the perception that investment in Texas is unattractive or less attractive during periods of low oil prices; |
• | significant acquisitions or business combinations, strategic partnerships, joint ventures or capital commitments by or involving our competitors or us; |
• | other economic, competitive, governmental, regulatory and technological factors affecting our operations, pricing, products and services; and |
• | other news, announcements or disclosures (whether by us or others) related to us, our competitors, our primary markets or the financial services industry. |
• | empower our board of directors, without shareholder approval, to issue our preferred stock, the terms of which, including voting power, are to be set by our board of directors; |
• | include a classified board of directors, with directors of each class serving a three-year term; |
• | eliminate cumulative voting in elections of directors; |
• | provide our board of directors with the exclusive right to alter, amend or repeal our first amended and restated bylaws or to adopt new bylaws; |
• | require the request of holders of at least 50% of the issued and outstanding shares of our capital stock entitled to vote at a meeting to call a special shareholders’ meeting; |
• | require any shareholder derivative suit or shareholder claim against an officer or director of breach of fiduciary duty or violation of the Texas Business Organizations Code, or the TBOC, certificate of formation, or bylaws to be brought in Harris County in the State of Texas, subject to certain exceptions as described below; |
• | require shareholders that wish to bring business before annual or special meetings of shareholders, or to nominate candidates for election as directors at annual or special meetings of shareholders, to provide timely advanced notice of their intent in writing; and |
• | enable our board of directors to increase, at any annual, regular or special meetings of directors, the number of persons serving as directors and to fill up to two vacancies created as a result of the increase by a majority vote of the directors between two successive annual shareholder meetings. |
• | making it more difficult for us to satisfy our obligations with respect to our debt, including the notes; |
• | requiring us to dedicate a substantial portion of our cash flow from operations to payments on our debt, thereby reducing funds available for other purposes; |
• | increasing our vulnerability to adverse economic and industry conditions, which could place us at a disadvantage relative to our competitors that have less debt; |
• | limiting our flexibility in planning for, or reacting to, changes in our business and the industries in which we operate; and |
• | limiting our ability to borrow additional funds, or to dispose of assets to raise funds, if needed, for working capital, capital expenditures, acquisitions and other corporate purposes. |
• | the New Notes have been registered with the SEC under the Securities Act and, as a result, will not bear any legend restricting their transfer; |
• | the New Notes bear different a CUSIP number from the Old Notes; |
• | the New Notes generally will not be subject to transfer restrictions; |
• | holders of the New Notes are not entitled to registration rights under the registration rights agreement or otherwise; and |
• | because the New Notes will not be entitled to registration rights, holders of the New Notes will not have the right to additional interest under the circumstances described in the registration rights agreement relating to our fulfillment of our registration obligations. |
• | file a registration statement with the SEC on or prior to the 60th day after March 31, 2022 with respect to a registered offer to exchange the Registrable Securities (as defined below) for the New Notes; |
• | cause that registration statement to be declared effective by the SEC no later than 120 days after March 31, 2022; |
• | cause that registration statement to remain effective until the closing of the exchange offer; |
• | commence the exchange offer promptly after the effectiveness of the registration statement and keep the exchange offer open for not less than 20 business days, or longer if required by applicable law, after the date on which notice of the exchange offer is given to the holders of the Old Notes; and |
• | consummate the exchange offer no later than 45 days after the effective date of that registration statement. |
• | you are not, nor is any such person, an “affiliate” of ours within the meaning of Rule 405 under the Securities Act; |
• | you are, or the person receiving the New Notes is, acquiring the New Notes in the ordinary course of business; |
• | you do not, nor does any such person, have an arrangement or understanding with any person to participate in any distribution (within the meaning of the Securities Act) of the New Notes; |
• | you are not, nor is any such person, a broker-dealer registered under the Exchange Act, and you are not engaged in and do not intend to engage in, nor is any such person engaged in or intending to engage in, any distribution (within the meaning of the Securities Act) of the New Notes; and |
• | you are not acting on behalf of any person who could not truthfully make these statements. |
• | will not be able to rely on the interpretations of the staff of the SEC set forth in the no-action letters described above; |
• | will not be able to tender Old Notes in the exchange offer; and |
• | must comply with the registration and prospectus delivery requirements of the Securities Act in connection with any sale or transfer of the New Notes, unless the sale or transfer is made pursuant to an exemption from those requirements. |
• | such Old Notes are tendered to us other than in accordance with the terms and conditions of the exchange offer; |
• | we determine that the exchange offer, or the making of any exchange by a holder, violates any applicable law or any applicable interpretation by the staff of the SEC; or |
• | any action or proceeding is instituted or threatened in any court or by or before any governmental agency with respect to the exchange offer which, in our judgment, would reasonably be expected to impair our ability to proceed with the exchange offer. |
• | a properly transmitted “ agent’s message |
• | a timely confirmation of a book-entry tender of the Old Notes into the exchange agent’s account at DTC through ATOP pursuant to the procedure for book-entry transfer described below to be received by the exchange agent prior to 5:00 p.m. New York City time on the expiration date. |
• | name of the beneficial owner tendering such Old Notes; |
• | account number of the beneficial owner tendering such Old Notes; |
• | principal amount of Old Notes tendered by such beneficial owner; and |
• | a confirmation that the beneficial owner of the Old Notes has agreed to be bound by the terms of the accompanying letter of transmittal. |
• | the physical Old Note; |
• | a properly completed and duly executed letter of transmittal; and |
• | all other documents required by the letter of transmittal. |
• | any New Notes that you receive will be acquired in the ordinary course of business; |
• | you are not participating in the exchange offer with a view to distribute any New Notes nor do you have any arrangement or understanding with any person to participate in the distribution (within the meaning of the Securities Act) of the New Notes in violation of the provisions of the Securities Act; |
• | you are not an “affiliate” (within the meaning of Rule 405 under the Securities Act); |
• | if you are a broker-dealer that will receive New Notes for your own account in exchange for Old Notes, you acquired those New Notes as a result of market-making or other trading activities, and you will satisfy any applicable prospectus delivery requirements in connection with any resale of such New Notes; and |
• | you are not acting on behalf of any person or entity who could not truthfully make the foregoing representations and warranties. |
• | specify the name of the tendering holder of Old Notes to be withdrawn; |
• | specify the principal amount of the Old Notes delivered for exchange; |
• | if you hold book-entry Old Notes, specify the name and number of the account at DTC to be credited with the withdrawn Old Notes; include a statement that such holder is withdrawing its election to have such Old Notes exchanged; and |
• | if you hold book-entry Old Notes, otherwise comply with the procedures of DTC. |
• | New Notes and/or substitute Old Notes not exchanged are to be delivered to, or registered or issued in the name of, any person other than the registered holder of the Old Notes so exchanged; |
• | tendered Old Notes are registered in the name of any person other than the person signing the letter of transmittal; or |
• | a transfer tax is imposed for any reason other than the exchange of Old Notes under the exchange offer. |
• | to us or to any of our subsidiaries; |
• | under a registration statement that has been declared effective under the Securities Act; |
• | for so long as the Old Notes are eligible for resale pursuant to Rule 144A under the Securities Act, to a person the holder of the Old Notes and any person acting on its behalf reasonably believes is a “qualified institutional buyer” as defined in Rule 144A under the Securities Act, that purchases for its own account or for the account of another qualified institutional buyer, in each case, to whom notice is given that the transfer is being made in reliance on Rule 144A under the Securities Act; or |
• | under any other available exemption from the registration requirements of the Securities Act (in which case we and the trustee will have the right to require the delivery of an opinion of counsel (at the holder’s sole cost), certifications and/or other information satisfactory to us and the trustee); in each case, subject to compliance with any applicable foreign, federal, state or other securities laws. |
• | the registration statement is not filed with the SEC on or prior to the 60th day after March 31, 2022; |
• | the registration statement is not declared effective by the SEC on or before 120 days after March 31, 2022; or |
• | the exchange offer is not consummated within 45 days following the effective date of the registration statement; |
• | if required, a shelf registration statement is not filed with the SEC on or prior to (A) the 180 th day following March 31, 2022 or (B) the 60th day after the obligation to file a shelf registration statement with the SEC arises, whichever is later; |
• | if required, a shelf registration statement is not effective on or prior to (A) the 225th day following March 31, 2022 or (B) the 105th day after an obligation to file with the SEC a shelf registration statement arises, whichever is later; |
• | a shelf registration statement is effective with the SEC but such shelf registration statement ceases to be effective or such shelf registration statement or the prospectus included therein ceases to be usable in connection with resales of the Old Notes due to any act or omission of the Company and (A) the aggregate number of days in any consecutive 365-day period for which the shelf registration statement or such prospectus shall not be effective or usable exceeds 120 days, (B) the shelf registration statement or such prospectus shall not be effective or usable for more than two periods (regardless of duration) in any consecutive 365-day period, or (C) the shelf registration statement or such prospectus shall not be effective or usable for a period of more than 60 consecutive days; or |
• | the registration statement is effective with the SEC but, if the registration statement is being used in connection with the resale of the New Notes , the registration statement ceases to be effective or the registration statement or the prospectus included therein ceases to be usable in connection with resales of New Notes due to any act or omission of the Company during the 120-day period following the last date on which exchanges are accepted and (A) the aggregate number of days in any consecutive 365-day period for which the registration statement or such prospectus shall not be effective or usable exceeds 120 days, (B) the registration statement or such prospectus shall not be effective or usable for more than two periods (regardless of duration) in any consecutive 365-day period, or (C) the registration statement or the prospectus shall not be effective or usable for a period of more than 60 consecutive days; |
• | the issuance of New Notes has been registered with the SEC under the Securities Act and, as a result, will not bear any legend restricting their transfer; |
• | the New Notes bear a different CUSIP number from the Old Notes; |
• | the New Notes are generally not subject to transfer restrictions; |
• | holders of the New Notes are not entitled to registration rights under the registration rights agreement that we entered into with the initial purchasers of the Old Notes or otherwise; and |
• | because holders of New Notes are not entitled to registration rights, holders of the New Notes will not have the right to additional interest under the circumstances described in the registration rights agreement relating to our fulfillment of our registration obligations. |
• | the Benchmark Replacement will replace the then-current Benchmark (each of such terms as defined below) for all purposes relating to the notes during the floating rate period in respect of such determination on such date and all determinations on all subsequent dates; |
• | in connection with the implementation of a Benchmark Replacement, the Calculation Agent will have the right to make Benchmark Replacement Conforming Changes from time to time; |
• | any determination, decision or election that may be made by the Calculation Agent under the terms of the notes, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action or selection (A) will be conclusive and binding on the holders of the notes and the trustee absent manifest error, (B) if made by the Company as Calculation Agent, will be made in the Company’s sole |
discretion, (C) if made by a Calculation Agent other than the Company, will be made after consultation with the Company, and the Calculation Agent will not make any such determination, decision or election to which the Company reasonably objects and (D) notwithstanding anything to the contrary herein, shall become effective without consent from the holders of the notes, the trustee or any other party; |
• | after a Benchmark Transition Event and its related Benchmark Replacement Date have occurred, interest payable on the notes for the Floating Rate Period will be an annual rate equal to the sum of the applicable Benchmark Replacement plus 315 basis points. |
(a) | Compounded SOFR; |
(b) | the sum of: (i) the alternate rate that has been selected or recommended by the Relevant Governmental Body as the replacement for the then-current Benchmark for the applicable Corresponding Tenor and (ii) the Benchmark Replacement Adjustment; |
(c) | the sum of: (i) the ISDA Fallback Rate and (ii) the Benchmark Replacement Adjustment; or |
(d) | the sum of: (i) the alternate rate that has been selected by the Calculation Agent as the replacement for the then-current Benchmark for the applicable Corresponding Tenor giving due consideration to any industry-accepted rate as a replacement for the then-current Benchmark for U.S. Dollar denominated floating rate securities at such time and (ii) the Benchmark Replacement Adjustment. |
(a) | the spread adjustment, or method for calculating or determining such spread adjustment (which may be a positive or negative value or zero), that has been selected or recommended by the Relevant Governmental Body for the applicable Unadjusted Benchmark Replacement; |
(b) | if the applicable Unadjusted Benchmark Replacement is equivalent to the ISDA Fallback Rate, then the ISDA Fallback Adjustment; or |
(c) | the spread adjustment (which may be a positive or negative value or zero) that has been selected by the Calculation Agent giving due consideration to any industry-accepted spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of the then-current Benchmark with the applicable Unadjusted Benchmark Replacement for U.S. Dollar denominated floating rate securities at such time. |
(a) | in the case of clause (a) of the definition of “Benchmark Transition Event,” the relevant Reference Time in respect of any determination; |
(b) | in the case of clause (b) or (c) of the definition of “Benchmark Transition Event,” the later of (i) the date of the public statement or publication of information referenced therein and (ii) the date on which the administrator of the Benchmark permanently or indefinitely ceases to provide the Benchmark; or |
(c) | in the case of clause (d) of the definition of “Benchmark Transition Event,” the date of the public statement or publication of information referenced therein. |
(a) | if the Benchmark is Three-Month Term SOFR, (i) the Relevant Governmental Body has not selected or recommended a forward-looking term rate for a tenor of three months based on SOFR, (ii) the development of a forward-looking term rate for a tenor of three months based on SOFR that has been recommended or selected by the Relevant Governmental Body is not complete or (iii) the Calculation Agent determines that the use of a forward-looking rate for a tenor of three months based on SOFR is not administratively feasible; |
(b) | a public statement or publication of information by or on behalf of the administrator of the Benchmark announcing that such administrator has ceased or will cease to provide the Benchmark, permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide the Benchmark; |
(c) | a public statement or publication of information by the regulatory supervisor for the administrator of the Benchmark, the central bank for the currency of the Benchmark, an insolvency official with jurisdiction over the administrator for the Benchmark, a resolution authority with jurisdiction over the administrator for the Benchmark or a court or an entity with similar insolvency or resolution authority over the administrator for the Benchmark, which states that the administrator of the Benchmark has ceased or will cease to provide the Benchmark permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide the Benchmark; or |
(d) | a public statement or publication of information by the regulatory supervisor for the administrator of the Benchmark announcing that the Benchmark is no longer representative. |
(e) | the rate, or methodology for this rate, and conventions for this rate selected or recommended by the Relevant Governmental Body for determining Compounded SOFR; provided that: |
(f) | if, and to the extent that, the Calculation Agent determines that Compounded SOFR cannot be determined in accordance with clause (a) above, then the rate, or methodology for this rate, and conventions for this rate that have been selected by the Calculation Agent giving due consideration to any industry-accepted market practice for U.S. Dollar denominated floating rate securities at such time. |
• | the principal (and premium, if any) of and interest in respect of our indebtedness for borrowed money, whether or not evidenced by securities, notes, debentures, bonds or other similar instruments issued by us, including obligations incurred in connection with the acquisition of property, assets or businesses; |
• | all of our capital lease obligations; |
• | all of our obligations issued or assumed as the deferred purchase price of property, all of our conditional sale obligations and all of our obligations under any conditional sale or title retention agreement, but excluding trade accounts payable in the ordinary course of business; |
• | all of our obligations arising from off-balance sheet guarantees and direct credit substitutes, including obligations in respect of any letters of credit, bankers’ acceptance, security purchase facilities and similar credit transactions; |
• | all of our obligations associated with derivative products, including obligations in respect of interest rate swap, cap or other agreements, interest rate future or options contracts, currency swap agreements, currency future or option contracts and other similar agreements; |
• | all obligations of the type referred to in the bullets above of other persons for the payment of which we are responsible or liable as obligor, guarantor or otherwise; |
• | all obligations of the types referred to in the bullets above of other persons secured by a lien on any of our property or assets whether or not such obligation is assumed by us; and |
• | any deferrals, renewals or extensions of any obligations of the type described in the bullets above. |
• | the notes; |
• | trade accounts payable arising in the ordinary course of business; |
• | any indebtedness that by its terms is subordinated to, or ranks on an equal basis with, the notes; or |
• | without limiting the generality of the foregoing, any subordinated debentures or junior subordinated debentures, of our underlying trust preferred securities issued by our subsidiary trusts (including our subsidiary trusts acquired on or after March 31, 2022) that are outstanding as of March 31, 2022 or that are issued after March 31, 2022 by any such subsidiary trust of ours, which subordinated debentures or junior subordinated debentures shall in all cases be junior to the notes. |
• | we are subject to any termination, winding-up, liquidation or reorganization, whether in bankruptcy, insolvency, reorganization or receivership proceedings or upon an assignment for the benefit of our creditors or any other marshalling of our assets and liabilities or otherwise; or |
• | a default in the payment of principal of, or premium, if any, or interest on any senior indebtedness, beyond any applicable grace period, or if any event of default with respect to any Senior Indebtedness will have occurred and be continuing, or would occur as a result of the payment of principal of or interest on the notes or in respect of any retirement, purchase or other acquisition of the notes, permitting the holders of such Senior Indebtedness (or a trustee on behalf of the holders thereof) to accelerate the maturity thereof, unless and until such default or event of default has been cured or waived or has ceased to exist. |
• | a “Tier 2 Capital Event,” means the receipt by the Company of a legal opinion from counsel experienced in such matters to the effect that, as a result of any change, event, occurrence, circumstance or effect occurring on or March 31, 2022, the notes do not constitute, or within 90 days of the date of such legal opinion will not constitute, “Tier 2 Capital” (or its then equivalent if the Company were subject to such capital requirement); |
• | a “Tax Event,” means the receipt by the Company of a legal opinion from counsel experienced in such matters to the effect that, as a result of a change or a prospective change in law on or after March 31, 2022, there is more than an insubstantial risk that interest paid by the Company on the Subordinated Notes is not, or, within 90 days of the date of such legal opinion, will not be, deductible by the Company, in whole or in part, for United States federal income tax purposes.; or |
• | an “Investment Company Event,” which means any event whereby we become required to register as an investment company pursuant to the Investment Company Act of 1940, as amended. |
• | DTC notifies us that it is unwilling or unable to continue acting as the depositary for the global notes, or DTC has ceased to be a clearing agency registered under the Exchange Act, and in either case we do not appoint a successor depositary within 90 days; |
• | we determine that the notes are no longer to be represented by the global notes and so notify the trustee in writing; or |
• | an event of default with respect to the notes has occurred and is continuing and DTC has requested the issuance of definitive subordinated notes. |
• | you cannot receive notes registered in your name if they are represented by the global notes; |
• | you cannot receive certificated (physical) notes in exchange for your beneficial interest in the global notes; |
• | you will not be considered to be the owner or holder of the global notes or any note it represents for any purpose; and |
• | all payments on the global notes will be made to DTC or its nominee. |
• | the entry of a decree or order for relief in respect of the Company by a court having jurisdiction in the premises in an involuntary case or proceeding under any applicable bankruptcy, insolvency, or reorganization law, now or hereafter in effect of the United States or any political subdivision thereof, and such decree or order will have continued unstayed and in effect for a period of 60 consecutive days; |
• | the commencement by the Company of a voluntary case under any applicable bankruptcy, insolvency or reorganization law, now or hereafter in effect of the United States or any political subdivision thereof, or the consent by the Company to the entry of a decree or order for relief in an involuntary case or proceeding under any such law; |
• | the failure of the Company to pay any installment of interest on any of the Subordinated Notes as and when the same will become due and payable, and the continuation of such failure for a period of 30 days; |
• | the failure of the Company to pay all or any part of the principal of any of the Subordinated Notes as and when the same will become due and payable under this Indenture; |
• | the failure of the Company to perform any other covenant or agreement on the part of the Company contained in the Subordinated Notes or in this Indenture, and the continuation of such failure for a period of 60 days after the date on which notice specifying such failure, stating that such notice is a “Notice of Default” hereunder and demanding that the Company remedy the same, will have been given, in the manner set forth in the Indenture, to the Company by the Trustee, or to the Company and the Trustee by the Holders of at least 25% in aggregate principal amount of the Subordinated Notes at the time Outstanding; or |
• | the default by the Company under any bond, debenture, note or other evidence of indebtedness for money borrowed by the Company having an aggregate principal amount outstanding of at least $30,000,000, whether such indebtedness now exists or is created or incurred in the future, which default (i) constitutes a failure to pay any portion of the principal of such indebtedness when due and payable after the expiration of any applicable grace period or (ii) results in such indebtedness becoming |
due or being declared due and payable prior to the date on which it otherwise would have become due and payable without, in the case of clause (i), such indebtedness having been discharged or, in the case of clause (ii), without such indebtedness having been discharged or such acceleration having been rescinded or annulled. |
• | to evidence the succession of another person to us, and the assumption by any such successor of our covenants contained in the indenture and in the notes; |
• | to add to our covenants for the benefit of holders of the notes or to surrender any right or power conferred upon us with respect to the notes issued under the indenture; |
• | to permit or facilitate the issuance of notes in uncertificated or global form, provided any such action will not adversely affect the interests of the holders; |
• | to evidence and provide for the acceptance of appointment under the indenture by a successor trustee with respect to the notes and to add to or change any of the provisions of the indenture, as necessary, to provide for or facilitate the administration of the trusts thereunder by more than one trustee, in accordance with the requirements set forth in the indenture; |
• | to cure any ambiguity or to correct or supplement any provision in the indenture that may be defective or that may be inconsistent with any other provision therein; |
• | to make any other provisions with respect to matters or questions arising under the indenture that will not adversely affect the interests of the holders of then outstanding notes; |
• | to add any additional events of default; |
• | to supplement any of the provisions of the indenture to such extent necessary to permit or facilitate the legal defeasance, covenant defeasance and/or satisfaction and discharge of the notes in accordance with the indenture, provided that any such action will not adversely affect the interests of any holder of notes; |
• | to provide for the issuance of the New Notes pursuant to the exchange offer; |
• | to conform any provision in the indenture to the requirements of the Trust Indenture Act; or |
• | to make any change that does not adversely affect the legal rights under the indenture of any holder of then outstanding notes. |
• | reduce the rate of or change the time for payment of interest, including defaulted interest, on any notes; |
• | reduce the principal of or change the stated maturity of any notes or change the date on which any notes may be subject to redemption or reduce the redemption price therefor; |
• | make any note payable in money other than United States dollars; |
• | make any change in provisions of the indenture protecting the right of each holder of the notes to receive payment of principal of and interest on such notes on or after the due date thereof or setting forth the contractual right to bring suit to enforce such payment; |
• | reduce the percentage in principal amount of the notes, the consent of whom is required for any such supplemental indenture, or the consent of whom required to waive certain defaults and covenants under the indenture; or |
• | modify any of the provisions of the section of the indenture governing supplemental indentures with the consent of holders, or those provisions relating to waiver of past defaults or waiver of certain covenants, except to increase any such percentage required for such actions or to provide that certain other provisions of the indenture cannot be modified or waived without the consent of the holder of each outstanding note affected thereby. |
• | either: (a) all notes that have been authenticated and delivered (with certain specified exceptions) have been delivered to the trustee for cancellation, or (b) all notes that have not been delivered to the trustee for cancellation (i) have become due and payable, (ii) will become due and payable at their stated maturity within one year, or (iii) if redeemable at our option, are to be called for redemption within one year under arrangements reasonably satisfactory to the trustee for the giving of notice of redemption by the trustee, and we have deposited or caused to be deposited with the trustee funds in an amount sufficient to pay and discharge the entire indebtedness on such outstanding notes, including the applicable principal and interest on such notes; |
• | we have paid or caused to be paid all other sums then payable under the indenture with respect to the outstanding notes or the indenture; and |
• | we have delivered to the trustee an officers’ certificate and an opinion of counsel, each stating that all conditions precedent under the indenture relating to the satisfaction and discharge of the indenture have been satisfied. |
• | the rights of the holders of such outstanding notes to receive payments in respect of the principal of and interest on such notes when payments are due; |
• | our and the trustee’s obligations with respect to such notes concerning registration of notes, mutilated, destroyed, lost and stolen notes, maintenance of an office or agency for payment and money for payments on the notes to be held in trust; |
• | the rights, powers, trusts, duties and immunities of the trustee under the indenture; and |
• | the defeasance provisions of the indenture. |
• | we must irrevocably deposit or caused to be deposited with the trustee as trust funds in trust for the purpose of making the following payments, specifically pledged as security for, and dedicated solely to, the benefit of the holders of outstanding notes, (i) an amount in dollars, (ii) government obligations that through the scheduled payment of principal and interest in respect thereof in accordance with their terms will provide, not later than one day before the due date of any payment of principal of and interest, if any, on such notes, money or (iii) a combination thereof, in any case, in an amount sufficient, without consideration of any reinvestment of such principal and interest, in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the trustee, to pay and discharge, and which will be applied by the trustee to pay and discharge, the principal of and interest, if any, on such outstanding notes on the stated maturity of such principal or installment of principal or interest or the applicable redemption date, as the case may be; |
• | such legal defeasance or covenant defeasance must not result in a breach or violation of, or constitute a default under, the indenture or any other material agreement or instrument to which we or any of our subsidiaries are a party or by which we or any of them are bound; |
• | no event of default or event which, with notice or lapse of time or both, would become an event of default with respect to such notes can have occurred and be continuing on the date of such deposit, and, solely in the case of legal defeasance, no event of default or event which, with notice or lapse of time or both, would become an event of default under the indenture will have occurred and be continuing at any time during the period ending on and including the 91st day after the date of such deposit (this condition to legal defeasance will not be deemed satisfied until the expiration of such period); |
• | in the case of legal defeasance, we must deliver to the trustee an opinion of counsel stating that (i) we have received from, or there has been published by, the Internal Revenue Service a ruling or (ii) since the date of the indenture, there has been a change in applicable federal income tax law, in either case to the effect that, and based thereon such opinion of independent counsel will confirm that, the holders of such outstanding notes will not recognize income, gain or loss for federal income tax purposes as a result of such legal defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such legal defeasance had not occurred; |
• | in the case of covenant defeasance, we must deliver to the trustee an opinion of counsel to the effect that the holders of such outstanding notes will not recognize income, gain or loss for federal income tax purposes as a result of such covenant defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such covenant defeasance had not occurred; |
• | we must deliver to the trustee an officers’ certificate and an opinion of counsel, each stating that all conditions precedent to the legal defeasance or covenant defeasance, as the case may be, under the indenture have been satisfied; |
• | if the moneys or government obligations, or combination thereof, as the case may be, deposited are sufficient to pay the principal of and interest, if any, on such notes, provided that such notes are redeemed on a particular redemption date, we must have given the trustee irrevocable instructions to redeem such notes on such date and to provide notice of such redemption to holders of such notes as provided in or under the indenture; and |
• | the trustee must have received such other documents, assurances and opinions of counsel as the trustee may reasonably require. |
• | Business of the Company; |
• | Supervision and Regulation; |
• | Human Capital; |
• | Properties; |
• | Legal Proceedings; |
• | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities; |
• | Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Year Ended December 31, 2021; |
• | Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Period Ended March 31, 2022; |
• | Corporate Governance; |
• | Board of Directors; |
• | Executive Officers; |
• | Executive Compensation; |
• | Director Compensation; |
• | Certain Relationships and Related Person Transactions; |
• | Beneficial Ownership of the Company’s Common Stock; and |
• | Director Independence. |
Minimum Ratio for Capital Adequacy Purposes |
Additional Capital Conservation Buffer |
Minimum Ratio with Capital Conservation Buffer |
||||||||||
Total risk-based capital ratio (total capital to risk-weighted assets) |
8.00 | % | 2.50 | % | 10.50 | % | ||||||
Tier 1 risk-based capital ratio (tier 1 capital to risk-weighted assets) |
6.00 | % | 2.50 | % | 8.50 | % | ||||||
CET 1 risk-based capital ratio (CET 1 capital to risk-weighted assets) |
4.50 | % | 2.50 | % | 7.00 | % | ||||||
Tier 1 leverage ratio (tier 1 capital to average assets) |
4.00 | % | — | 4.00 | % |
• | assigning exposures secured by single-family residential properties to either a 50% risk weight for first-lien mortgages that meet prudent underwriting standards or a 100% risk weight category for all other mortgages; |
• | providing for a 20% credit conversion factor for the unused portion of a commitment with an original maturity of one year or less that is not unconditionally cancellable (increased from 0% under the previous risk-based capital rules); |
• | assigning a 150% risk weight to all exposures that are nonaccrual or 90 days or more past due (increased from 100% under the previous risk-based capital rules), except for those secured by single-family residential properties, which will be assigned a 100% risk weight, consistent with the previous risk-based capital rules; |
• | applying a 150% risk weight instead of a 100% risk weight for certain HVCRE acquisition, development, and construction loans; and |
• | applying a 250% risk weight to the portion of mortgage servicing rights and deferred tax assets arising from temporary differences that could not be realized through net operating loss carrybacks that are not deducted from CET1 capital (increased from 100% under the previous risk-based capital rules). |
• | a leverage ratio of greater than 9%; |
• | total consolidated assets of less than $10 billion; |
• | total off-balance sheet exposures (excluding derivatives other than sold credit derivatives and unconditionally cancelable commitments) of 25% or less of total consolidated assets; and |
• | total trading assets and trading liabilities of 5% or less of total consolidated assets. |
• | internal policies, procedures and controls designed to implement and maintain the bank’s compliance with all of the requirements of the USA PATRIOT Act, the BSA and related laws and regulations; |
• | systems and procedures for monitoring and reporting suspicious transactions and activities; |
• | a designated compliance officer; |
• | employee training; |
• | an independent audit function to test the AML program; |
• | procedures to verify the identity of each customer upon the opening of accounts; and |
• | heightened due diligence policies, procedures and controls applicable to certain foreign accounts and relationships. |
Location |
Address |
Owned/Leased | ||
Humble | 20202 Highway 59 North, Humble, Texas 77338 | Owned | ||
Galleria | 1800 West Loop South, Suite 100, Houston, Texas 77027 | Leased | ||
Conroe | 1336 League Line Road, Suite 100, Conroe, Texas 77304 | Leased | ||
Pearland | 1850 Pearland Parkway, Pearland, Texas, 77581 | Owned | ||
Beaumont | 229 Dowlen Road, Suite C, Beaumont, Texas 77706 | Leased | ||
Lake Jackson | 85 Oak Drive, Lake Jackson, Texas 77566 | Owned | ||
Mid County | 2901 Turtle Creek Drive, Suite 115, Port Arthur, Texas 77642 | Leased | ||
Nixon | 200 North Nixon Avenue, Nixon, Texas 78140 | Owned | ||
La Vernia | 13809 West Highway 87, La Vernia, Texas 78121 | Owned | ||
Plano | 1201 W. 15th Street, Suite 100, Plano, Texas 75075 | Leased | ||
Dallas | 8235 Douglas Avenue, Suite 100, Dallas, Texas 75225 | Leased | ||
Detroit | 12038 US Highway 82 West, Detroit, Texas 75436 | Owned | ||
Austin (LPO) | 5508 Highway 290 West, Austin, Texas 78375 | Leased |
For the Year Ended December 31, |
For the Year Ended December 31, |
|||||||||||||||||||||||||||||||
(Dollars in thousands) |
2021 |
2020 |
Increase (Decrease) |
2020 |
2019 |
Increase (Decrease) |
||||||||||||||||||||||||||
Interest income |
$ | 100,615 | $ | 82,241 | $ | 18,374 | 22.3 | % | $ | 82,241 | $ | 49,925 | $ | 32,316 | 64.7 | % | ||||||||||||||||
Interest expense |
10,062 | 14,360 | (4,298 | ) | (29.9 | )% | 14,360 | 15,974 | (1,614 | ) | (10.1 | )% | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net interest income |
90,553 | 67,881 | 22,672 | 33.4 | % | 67,881 | 33,951 | 33,930 | 99.9 | % | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Provision for loan losses |
9,923 | 7,550 | 2,373 | 31.4 | % | 7,550 | 1,625 | 5,925 | 364.6 | % | ||||||||||||||||||||||
Noninterest income |
4,878 | 2,682 | 2,196 | 81.9 | % | 2,682 | 1,217 | 1,465 | 120.4 | % | ||||||||||||||||||||||
Noninterest expense |
71,025 | 47,403 | 23,622 | 49.8 | % | 47,403 | 30,310 | 17,093 | 56.4 | % | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Income before income taxes |
14,483 | 15,610 | (1,127 | ) | (7.2 | )% | 15,610 | 3,233 | 12,377 | 382.8 | % | |||||||||||||||||||||
Income tax expense |
3,059 | 3,495 | (436 | ) | (12.5 | )% | 3,495 | 852 | 2,643 | 310.2 | % | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net income |
$ | 11,424 | $ | 12,115 | $ | (691 | ) | (5.7 | )% | $ | 12,115 | $ | 2,381 | $ | 9,734 | 408.8 | % | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, |
||||||||||||||||||||||||||||||||||||
2021 |
2020 |
2019 |
||||||||||||||||||||||||||||||||||
(Dollars in thousands) |
Average Outstanding Balance |
Interest Earned/ Paid (3) |
Average Yield/ Rate |
Average Outstanding Balance |
Interest Earned/ Paid (3) |
Average Yield/ Rate |
Average Outstanding Balance |
Interest Earned/ Paid (3) |
Average Yield/ Rate |
|||||||||||||||||||||||||||
Assets |
||||||||||||||||||||||||||||||||||||
Interest-earnings assets: |
||||||||||||||||||||||||||||||||||||
Investment securities |
$ | 31,251 | $ | 1,043 | 3.34 | % | $ | 14,709 | $ | 297 | 2.02 | % | $ | 2,422 | $ | 24 | 0.99 | % | ||||||||||||||||||
Loans, gross |
1,646,591 | 98,886 | 6.01 | % | 1,433,412 | 80,791 | 5.64 | % | 739,525 | 47,570 | 6.43 | % | ||||||||||||||||||||||||
Federal funds sold and other interest- earning assets |
267,983 | 686 | 0.26 | % | 152,066 | 1,153 | 0.76 | % | 90,356 | 2,331 | 2.58 | % | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total interest-earning assets |
1,945,825 | 100,615 | 5.17 | % | 1,600,187 | 82,241 | 5.14 | % | 832,303 | 49,925 | 6.00 | % | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Less allowance for loan losses |
(14,198 | ) | (10,506 | ) | (7,360 | ) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Total interest-earning assets, net of allowance |
1,931,627 | 1,589,681 | 824,943 | |||||||||||||||||||||||||||||||||
Noninterest-earning assets |
132,825 | 80,686 | 44,220 | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Total assets |
$ | 2,064,452 | $ | 1,670,367 | $ | 869,163 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
For the Year Ended December 31, |
||||||||||||||||||||||||||||||||||||
2021 |
2020 |
2019 |
||||||||||||||||||||||||||||||||||
(Dollars in thousands) |
Average Outstanding Balance |
Interest Earned/ Paid (3) |
Average Yield/ Rate |
Average Outstanding Balance |
Interest Earned/ Paid (3) |
Average Yield/ Rate |
Average Outstanding Balance |
Interest Earned/ Paid (3) |
Average Yield/ Rate |
|||||||||||||||||||||||||||
Liabilities and Shareholders’ Equity |
||||||||||||||||||||||||||||||||||||
Interest-bearing liabilities: |
||||||||||||||||||||||||||||||||||||
Interest-bearing deposits |
$ | 1,421,757 | $ | 8,526 | 0.60 | % | $ | 1,150,723 | $ | 12,302 | 1.07 | % | $ | 625,040 | $ | 13,787 | 2.21 | % | ||||||||||||||||||
Notes payable |
22,329 | 1,091 | 4.89 | % | 39,793 | 1,615 | 4.06 | % | 24,335 | 1,436 | 5.90 | % | ||||||||||||||||||||||||
FHLB advances |
56,442 | 445 | 0.79 | % | 50,000 | 443 | 0.89 | % | 36,995 | 751 | 2.03 | % | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total interest-bearing liabilities |
1,500,528 | 10,062 | 0.67 | % | 1,240,516 | 14,360 | 1.16 | % | 686,370 | 15,974 | 2.33 | % | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Noninterest-bearing deposits |
383,747 | 310,357 | 122,961 | |||||||||||||||||||||||||||||||||
Other liabilities |
9,547 | 6,661 | 3,442 | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Total liabilities |
1,893,822 | 1,557,534 | 812,773 | |||||||||||||||||||||||||||||||||
Shareholders’ equity, including ESOP owned shares |
170,630 | 112,833 | 56,390 | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Total liabilities and shareholders’ equity |
$ | 2,064,452 | $ | 1,670,367 | $ | 869,163 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Net interest income |
$ | 90,553 | $ | 67,881 | $ | 33,951 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Net interest spread (1) |
4.50 | % | 3.98 | % | 3.67 | % | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Net interest margin (2) |
4.65 | % | 4.24 | % | 4.08 | % | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
(1) | Net interest spread is the average yield on interest-earning assets minus the average rate on interest-bearing liabilities. |
(2) | Net interest margin is equal to net interest income divided by average interest-earning assets. |
(3) | Interest earned/paid includes accretion of deferred loan fees, premiums and discounts. Interest income on loans includes loan fees and discount accretion of $32.8 million, $18.5 million, and $6.4 million for the year ended December 31, 2021, 2020, and 2019, respectively. |
For the Year Ended December 31, 2021 compared to 2020 |
For the Year Ended December 31, 2020 compared to 2019 |
|||||||||||||||||||||||
Increase (Decrease) Due to Changes In |
Total Increase (Decrease) |
Increase (Decrease) Due to Changes In |
Total Increase (Decrease) |
|||||||||||||||||||||
(Dollars in thousands) |
Volume |
Rate |
Volume |
Rate |
||||||||||||||||||||
Interest-earning assets: |
||||||||||||||||||||||||
Investment securities |
$ | 334 | $ | 412 | $ | 746 | $ | 122 | $ | 151 | $ | 273 | ||||||||||||
Loans, gross |
12,015 | 6,080 | 18,095 | 44,598 | (11,377 | ) | 33,221 | |||||||||||||||||
Federal funds sold and other interest-earning assets |
879 | (1,346 | ) | (467 | ) | 1,592 | (2,770 | ) | (1,178 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total increase in interest income |
$ | 13,228 | $ | 5,146 | $ | 18,374 | $ | 46,312 | $ | (13,996 | ) | $ | 32,316 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Interest-bearing liabilities: |
||||||||||||||||||||||||
Interest-bearing deposits |
$ | 2,898 | $ | (6,674 | ) | $ | (3,776 | ) | $ | 11,644 | $ | (13,129 | ) | $ | (1,485 | ) | ||||||||
Notes payable |
(709 | ) | 185 | (524 | ) | 912 | (733 | ) | 179 | |||||||||||||||
FHLB advances |
57 | (55 | ) | 2 | 264 | (572 | ) | (308 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total increase (decrease) in interest expense |
$ | 2,246 | $ | (6,544 | ) | $ | (4,298 | ) | $ | 12,820 | $ | (14,434 | ) | $ | (1,614 | ) | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Increase in net interest income |
$ | 10,982 | $ | 11,690 | $ | 22,672 | $ | 33,492 | $ | 438 | $ | 33,930 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, |
For the Year Ended December 31, |
|||||||||||||||||||||||||||||||
(Dollars in thousands) |
2021 |
2020 |
Increase (Decrease) |
2020 |
2019 |
Increase (Decrease) |
||||||||||||||||||||||||||
Noninterest Income: |
||||||||||||||||||||||||||||||||
Service charges and fees |
$ | 2,367 | $ | 1,709 | $ | 658 | 38.5 | % | $ | 1,709 | $ | 547 | $ | 1,162 | 212.4 | % | ||||||||||||||||
Gain on sale of SBA loans |
586 | 266 | 320 | 120.3 | % | 266 | — | 266 | 100.0 | % | ||||||||||||||||||||||
Earnings on bank-owned life insurance |
567 | 354 | 213 | 60.2 | % | 354 | 258 | 96 | 37.2 | % | ||||||||||||||||||||||
Other |
1,358 | 353 | 1,005 | 284.7 | % | 353 | 412 | (59 | ) | (14.3 | )% | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total noninterest income |
$ | 4,878 | $ | 2,682 | $ | 2,196 | 81.9 | % | $ | 2,682 | $ | 1,217 | $ | 1,465 | 120.4 | % | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, |
For the Year Ended December 31, |
|||||||||||||||||||||||||||||||
(Dollars in thousands) |
2021 |
2020 |
Increase (Decrease) |
2020 |
2019 |
Increase (Decrease) |
||||||||||||||||||||||||||
Noninterest Expense: |
||||||||||||||||||||||||||||||||
Salaries and employee benefits |
$ | 48,642 | $ | 29,262 | $ | 19,380 | 66.2 | % | $ | 29,262 | $ | 19,983 | $ | 9,279 | 46.4 | % | ||||||||||||||||
Net occupancy and equipment expenses |
5,367 | 4,127 | 1,240 | 30.0 | % | 4,127 | 2,612 | 1,515 | 58.0 | % | ||||||||||||||||||||||
Other: |
||||||||||||||||||||||||||||||||
Legal and professional fees |
5,293 | 3,962 | 1,331 | 33.6 | % | 3,962 | 2,415 | 1,547 | 64.1 | % | ||||||||||||||||||||||
Data processing and network expenses |
3,060 | 3,184 | (124 | ) | (3.9 | )% | 3,184 | 1,738 | 1,446 | 83.2 | % | |||||||||||||||||||||
Regulatory assessments |
1,101 | 1,303 | (202 | ) | (15.5 | )% | 1,303 | 434 | 869 | 200.2 | % | |||||||||||||||||||||
Advertising and marketing expenses |
1,889 | 1,326 | 563 | 42.5 | % | 1,326 | 699 | 627 | 89.7 | % | ||||||||||||||||||||||
Loan operations and other real estate owned expenses |
1,963 | 1,369 | 594 | 43.4 | % | 1,369 | 819 | 550 | 67.2 | % | ||||||||||||||||||||||
Loss on sale of other real estate owned |
344 | — | 344 | 100.0 | % | — | 38 | (38 | ) | 100.0 | % | |||||||||||||||||||||
Other expenses |
3,366 | 2,870 | 496 | 17.3 | % | 2,870 | 1,572 | 1,298 | 82.6 | % | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total noninterest expense |
$ | 71,025 | $ | 47,403 | $ | 23,622 | 49.8 | % | $ | 47,403 | $ | 30,310 | $ | 17,093 | 56.4 | % | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||
(Dollars in thousands) |
2021 |
2020 |
2019 |
|||||||||
Income tax expense |
$ | 3,059 | $ | 3,495 | $ | 852 | ||||||
Effective tax rate |
21.1 | % | 22.4 | % | 26.4 | % |
As of December 31, |
||||||||||||||||||||||||||||||||||||||||
2021 |
2020 |
2019 |
2018 |
2017 |
||||||||||||||||||||||||||||||||||||
(Dollars in thousands) |
Amount |
Percent |
Amount |
Percent |
Amount |
Percent |
Amount |
Percent |
Amount |
Percent |
||||||||||||||||||||||||||||||
Real estate: |
||||||||||||||||||||||||||||||||||||||||
Commercial real estate: |
| |||||||||||||||||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | 383,941 | 18.6 | % | $ | 353,273 | 22.7 | % | $ | 219,920 | 27.2 | % | $ | 190,954 | 27.7 | % | $ | 169,947 | 28.3 | % | ||||||||||||||||||||
Non-farm non-residential non-owner occupied |
445,308 | 21.5 | % | 277,804 | 17.9 | % | 191,036 | 23.6 | % | 155,850 | 22.7 | % | 116,169 | 19.4 | % | |||||||||||||||||||||||||
Residential |
213,264 | 10.3 | % | 140,622 | 9.0 | % | 87,064 | 10.7 | % | 60,048 | 8.7 | % | 47,125 | 7.9 | % | |||||||||||||||||||||||||
Construction, development and other |
320,335 | 15.5 | % | 98,207 | 6.3 | % | 60,445 | 7.5 | % | 57,026 | 8.3 | % | 57,874 | 9.6 | % | |||||||||||||||||||||||||
Farmland |
9,934 | 0.5 | % | 4,653 | 0.3 | % | 7,359 | 0.9 | % | 8,955 | 1.3 | % | 5,952 | 1.0 | % | |||||||||||||||||||||||||
Commercial and industrial |
611,348 | 29.5 | % | 645,928 | 41.5 | % | 214,935 | 26.6 | % | 191,487 | 27.8 | % | 178,663 | 29.8 | % | |||||||||||||||||||||||||
Consumer |
4,001 | 0.2 | % | 4,157 | 0.3 | % | 3,781 | 0.5 | % | 4,184 | 0.6 | % | 5,473 | 0.9 | % | |||||||||||||||||||||||||
Other |
80,593 | 3.9 | % | 31,448 | 2.0 | % | 24,066 | 3.0 | % | 19,855 | 2.9 | % | 18,825 | 3.1 | % | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Total loans |
$ | 2,068,724 | 100.0 | % | $ | 1,556,092 | 100.0 | % | $ | 808,606 | 100.0 | % | $ | 688,359 | 100.0 | % | $ | 600,028 | 100.0 | % | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2021 |
||||||||||||||||||||
(Dollars in thousands) |
One Year or Less |
One Through Five Years |
Five Years Through Fifteen Years |
After Fifteen Years |
Total |
|||||||||||||||
Real estate: |
||||||||||||||||||||
Commercial real estate: |
| |||||||||||||||||||
Non-farm non-residential owner occupied |
$ | 24,056 | $ | 104,877 | $ | 164,147 | $ | 90,861 | $ | 383,941 | ||||||||||
Non-farm non-residential non-owner occupied |
36,719 | 234,347 | 137,368 | 36,874 | 445,308 | |||||||||||||||
Residential |
26,662 | 77,088 | 60,334 | 49,180 | 213,264 | |||||||||||||||
Construction, development and other |
83,846 | 207,120 | 20,526 | 8,843 | 320,335 | |||||||||||||||
Farmland |
2,483 | 4,399 | 1,715 | 1,337 | 9,934 | |||||||||||||||
Commercial and industrial |
243,510 | 291,570 | 70,445 | 5,823 | 611,348 | |||||||||||||||
Consumer |
1,260 | 2,126 | 615 | — | 4,001 | |||||||||||||||
Other |
44,713 | 35,832 | 48 | — | 80,593 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total loans |
$ | 463,249 | $ | 957,359 | $ | 455,198 | $ | 192,918 | $ | 2,068,724 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Amounts with fixed rates |
$ | 181,575 | $ | 492,259 | $ | 54,915 | $ | 35,698 | $ | 764,447 | ||||||||||
Amounts with floating rates |
$ | 281,674 | $ | 465,100 | $ | 400,283 | $ | 157,220 | $ | 1,304,277 |
As of December 31, |
||||||||||||||||||||
(Dollars in thousands) |
2021 |
2020 |
2019 |
2018 |
2017 |
|||||||||||||||
Nonaccrual loans (1) |
$ | 10,030 | $ | 7,257 | $ | 4,078 | $ | 5,044 | $ | 4,549 | ||||||||||
Loans > 90 days and still accruing |
278 | 752 | 194 | — | 694 | |||||||||||||||
Restructured loan—accruing |
5,295 | 4,395 | 328 | 419 | 460 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total nonperforming loans |
$ | 15,603 | $ | 12,404 | $ | 4,600 | $ | 5,463 | $ | 5,703 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Other real estate owned and repossessed assets |
1,676 | 3,367 | 1,767 | 2,052 | 727 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total nonperforming assets |
$ | 17,279 | $ | 15,771 | $ | 6,367 | $ | 7,515 | $ | 6,430 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratio of nonaccrual loans to total loans |
0.48 | % | 0.47 | % | 0.50 | % | 0.73 | % | 0.76 | % | ||||||||||
Ratio of nonperforming loans to total loans |
0.75 | % | 0.80 | % | 0.57 | % | 0.79 | % | 0.95 | % | ||||||||||
Ratio of nonperforming loans to total assets |
0.62 | % | 0.66 | % | 0.50 | % | 0.65 | % | 0.85 | % | ||||||||||
Ratio of nonperforming assets to total assets |
0.69 | % | 0.84 | % | 0.69 | % | 0.89 | % | 0.96 | % | ||||||||||
Ratio of nonperforming loans to total loans plus OREO |
0.75 | % | 0.80 | % | 0.57 | % | 0.79 | % | 0.95 | % | ||||||||||
Ratio of nonaccrual loans to total loans |
0.47 | % | 0.50 | % | 0.73 | % | 0.76 | % | ||||||||||||
Ratio of allowance for loan losses to nonaccrual loans |
192.37 | % | 165.07 | % | 199.19 | % | 137.33 | % | 120.03 | % |
(1) | Restructured loans-nonaccrual are included in nonaccrual loans. |
As of December 31, |
||||||||||||||||||||
(Dollars in thousands) |
2021 |
2020 |
2019 |
2018 |
2017 |
|||||||||||||||
Nonaccrual loans by category: |
||||||||||||||||||||
Real estate: |
||||||||||||||||||||
Commercial real estate |
||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | 1,008 | $ | 1,944 | $ | 57 | $ | — | $ | — | ||||||||||
Non-farm non-residential non-owner occupied |
346 | 385 | — | 1,310 | — | |||||||||||||||
Residential |
127 | 85 | 630 | — | 1,557 | |||||||||||||||
Construction, development and other |
244 | 264 | — | 53 | — | |||||||||||||||
Commercial and industrial |
8,297 | 4,155 | 3,342 | 3,681 | 2,992 | |||||||||||||||
Consumer |
— | — | 15 | — | — | |||||||||||||||
Other |
— | — | 34 | — | — | |||||||||||||||
Purchased credit impaired |
8 | 424 | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total nonaccrual loans |
$ | 10,030 | $ | 7,257 | $ | 4,078 | $ | 5,044 | $ | 4,549 | ||||||||||
|
|
|
|
|
|
|
|
|
|
As of December 31, 2021 |
||||||||||||||||||||||||
(Dollars in thousands) |
Pass |
Special Mention |
Substandard |
Purchased Credit Impaired |
Doubtful |
Total |
||||||||||||||||||
Real estate: |
||||||||||||||||||||||||
Commercial real estate: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | 370,062 | $ | 6,953 | $ | 6,926 | $ | — | $ | — | $ | 383,941 | ||||||||||||
Non-farm non-residential non-owner occupied |
428,972 | 8,338 | 7,276 | 722 | — | 445,308 | ||||||||||||||||||
Residential |
212,109 | — | 1,069 | 86 | — | 213,264 | ||||||||||||||||||
Construction, development and other |
315,979 | — | 244 | 4,112 | — | 320,335 | ||||||||||||||||||
Farmland |
9,934 | — | — | — | — | 9,934 | ||||||||||||||||||
Commercial and industrial |
605,322 | 1,146 | 4,816 | 64 | — | 611,348 | ||||||||||||||||||
Consumer |
3,979 | 22 | — | — | — | 4,001 | ||||||||||||||||||
Other |
80,593 | — | — | — | — | 80,593 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Gross loans |
$ | 2,026,950 | $ | 16,459 | $ | 20,331 | $ | 4,984 | $ | — | $ | 2,068,724 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2020 |
||||||||||||||||||||||||
(Dollars in thousands) |
Pass |
Special Mention |
Substandard |
Purchased Credit Impaired |
Doubtful |
Total |
||||||||||||||||||
Real estate: |
||||||||||||||||||||||||
Commercial real estate: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | 335,442 | $ | 12,189 | $ | 5,642 | $ | — | $ | — | $ | 353,273 | ||||||||||||
Non-farm non-residential non-owner occupied |
255,468 | 12,706 | 5,730 | 3,900 | — | 277,804 | ||||||||||||||||||
Residential |
139,743 | — | 861 | 18 | — | 140,622 | ||||||||||||||||||
Construction, development and other |
93,817 | — | 267 | 4,123 | — | 98,207 | ||||||||||||||||||
Farmland |
4,653 | — | — | — | — | 4,653 | ||||||||||||||||||
Commercial and industrial |
629,093 | 6,144 | 9,847 | 270 | 574 | 645,928 | ||||||||||||||||||
Consumer |
4,157 | — | — | — | — | 4,157 | ||||||||||||||||||
Other |
31,448 | — | — | — | — | 31,448 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Gross loans |
$ | 1,493,821 | $ | 31,039 | $ | 22,347 | $ | 8,311 | $ | 574 | $ | 1,556,092 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
For Year Ended December 31, |
||||||||||||||||||||
(Dollars in thousands) |
2021 |
2020 |
2019 |
2018 |
2017 |
|||||||||||||||
Allowance for loan loss at beginning of period |
$ | 11,979 | $ | 8,123 | $ | 6,927 | $ | 5,460 | $ | 4,597 | ||||||||||
Provision for loan loss |
9,923 | 7,550 | 1,625 | 1,500 | 1,613 | |||||||||||||||
Charge-offs: |
||||||||||||||||||||
Commercial real estate: |
||||||||||||||||||||
Non-farm non-residential non-owner occupied |
— | (2,336 | ) | — | — | — | ||||||||||||||
Commercial and industrial |
(2,914 | ) | (1,389 | ) | (506 | ) | (108 | ) | (750 | ) | ||||||||||
Consumer |
— | (7 | ) | (2 | ) | (14 | ) | — | ||||||||||||
Other |
(20 | ) | — | — | — | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total charge-offs |
(2,934 | ) | (3,732 | ) | (508 | ) | (122 | ) | (750 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Recoveries: |
||||||||||||||||||||
Commercial real estate: |
||||||||||||||||||||
Non-farm non-residential owner occupied |
— | — | 50 | — | — | |||||||||||||||
Commercial and industrial |
323 | 33 | 29 | 89 | — | |||||||||||||||
Consumer |
1 | 5 | — | — | — | |||||||||||||||
Other |
3 | — | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total recoveries |
327 | 38 | 79 | 89 | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net (charge-offs) recoveries |
(2,607 | ) | (3,694 | ) | (429 | ) | (33 | ) | (750 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Allowance for loan losses at end of period |
$ | 19,295 | $ | 11,979 | $ | 8,123 | $ | 6,927 | $ | 5,460 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratio of allowance for loan loss to total loans |
0.93 | % | 0.77 | % | 1.00 | % | 1.01 | % | 0.91 | % | ||||||||||
Ratio of net (charge-offs) recoveries to average loans |
(0.16 | )% | (0.26 | )% | (0.06 | )% | (0.01 | )% | (0.14 | )% |
As of December 31, |
||||||||||||||||||||||||||||||||||||||||
2021 |
2020 |
2019 |
2018 |
2017 |
||||||||||||||||||||||||||||||||||||
(Dollars in thousands) |
Allowance for Loan Loss Amount |
% Loans in Each Category |
Allowance for Loan Loss Amount |
% Loans in Each Category |
Allowance for Loan Loss Amount |
% Loans in Each Category |
Allowance for Loan Loss Amount |
% Loans in Each Category |
Allowance for Loan Loss Amount |
% Loans in Each Category |
||||||||||||||||||||||||||||||
Real estate: |
||||||||||||||||||||||||||||||||||||||||
Commercial real estate: |
||||||||||||||||||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | 3,456 | 18.6 | % | $ | 2,608 | 22.7 | % | $ | 2,158 | 27.2 | % | $ | 1,559 | 27.7 | % | $ | 1,119 | 28.3 | % | ||||||||||||||||||||
Non-farm non-residential non-owner occupied |
5,935 | 21.5 | % | 3,107 | 17.9 | % | 1,627 | 23.6 | % | 1,669 | 22.7 | % | 1,094 | 19.4 | % | |||||||||||||||||||||||||
Residential |
957 | 10.3 | % | 1,218 | 9.0 | % | 373 | 10.7 | % | 219 | 8.7 | % | 137 | 7.9 | % | |||||||||||||||||||||||||
Construction, development and other |
2,064 | 15.5 | % | 932 | 6.3 | % | 330 | 7.5 | % | 306 | 8.3 | % | 260 | 9.6 | % | |||||||||||||||||||||||||
Farmland |
45 | 0.5 | % | 32 | 0.3 | % | 29 | 0.9 | % | 28 | 1.3 | % | 14 | 1.0 | % | |||||||||||||||||||||||||
Commercial and industrial |
6,500 | 29.5 | % | 3,858 | 41.5 | % | 3,504 | 26.6 | % | 3,063 | 27.8 | % | 2,731 | 29.8 | % | |||||||||||||||||||||||||
Consumer |
6 | 0.2 | % | 35 | 0.3 | % | 16 | 0.5 | % | 14 | 0.6 | % | 12 | 0.9 | % | |||||||||||||||||||||||||
Other |
332 | 3.9 | % | 189 | 2.0 | % | 86 | 3.0 | % | 69 | 2.9 | % | 93 | 3.1 | % | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
$ | 19,295 | 100.0 | % | $ | 11,979 | 100.0 | % | $ | 8,123 | 100.0 | % | $ | 6,927 | 100.0 | % | $ | 5,460 | 100.0 | % | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, |
||||||||||||||||||||||||
2021 |
2020 |
2019 |
||||||||||||||||||||||
(Dollars in thousands) |
Amortized Cost |
Estimated Fair Value |
Amortized Cost |
Estimated Fair Value |
Amortized Cost |
Estimated Fair Value |
||||||||||||||||||
Investment securities available for sale: |
||||||||||||||||||||||||
State and municipal securities |
$ | 1,087 | $ | 1,094 | $ | 1,881 | $ | 1,894 | $ | — | $ | — | ||||||||||||
Mortgage-backed securities |
791 | 811 | 1,005 | 1,028 | 535 | 536 | ||||||||||||||||||
Corporate bonds |
23,556 | 24,527 | 22,571 | 22,673 | — | — | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$ | 25,434 | $ | 26,432 | $ | 25,457 | $ | 25,595 | $ | 535 | $ | 536 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2021 |
||||||||
(Dollars in thousands) |
Amortized Cost |
Estimated Fair Value |
||||||
Due in one year or less |
$ | 661 | $ | 662 | ||||
Due from one year to five years |
426 | 432 | ||||||
Due from five years to ten years |
23,556 | 24,527 | ||||||
|
|
|
|
|||||
24,643 | 25,621 | |||||||
Mortgage-backed securities |
791 | 811 | ||||||
|
|
|
|
|||||
Total available for sale |
$ | 25,434 | $ | 26,432 | ||||
|
|
|
|
As of December 31, |
||||||||||||||||||||||||
2021 |
2020 |
2019 |
||||||||||||||||||||||
(Dollars in thousands) |
Amount |
Percent |
Amount |
Percent |
Amount |
Percent |
||||||||||||||||||
Noninterest-bearing demand deposits |
$ | 531,401 | 24.8 | % | $ | 327,361 | 20.0 | % | $ | 128,297 | 15.9 | % | ||||||||||||
Interest-bearing deposits |
1,298,546 | 60.6 | % | 909,992 | 55.7 | % | 388,430 | 48.1 | % | |||||||||||||||
Savings |
33,539 | 1.6 | % | 22,261 | 1.4 | % | 5,178 | 0.6 | % | |||||||||||||||
Time deposits |
277,713 | 13.0 | % | 374,217 | 22.9 | % | 285,353 | 35.4 | % | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total deposits |
$ | 2,141,199 | 100.0 | % | $ | 1,633,831 | 100.0 | % | $ | 807,258 | 100.0 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, |
||||||||||||
(Dollars in thousands) |
2021 |
2020 |
2019 |
|||||||||
Three months or less |
$ | 41,920 | $ | 49,874 | $ | 34,863 | ||||||
Over three months through six months |
20,200 | 24,566 | 8,518 | |||||||||
Over six months through twelve months |
44,770 | 65,431 | 74,802 | |||||||||
Over twelve months |
4,576 | 9,704 | 21,484 | |||||||||
|
|
|
|
|
|
|||||||
Total |
$ | 111,466 | $ | 149,575 | $ | 139,667 | ||||||
|
|
|
|
|
|
Year Ended December 31, |
||||||||||||||||||||||||
2021 |
2020 |
2019 |
||||||||||||||||||||||
(Dollars in thousands) |
Average Balance |
Average Rate |
Average Balance |
Average Rate |
Average Balance |
Average Rate |
||||||||||||||||||
Noninterest-bearing deposits |
$ | 383,747 | — | $ | 310,357 | — | $ | 122,961 | — | |||||||||||||||
Interest-bearing demand deposits |
$ | 1,064,737 | 0.62 | % | $ | 734,638 | 0.82 | % | $ | 353,066 | 2.07 | % | ||||||||||||
Savings |
27,776 | 0.29 | % | 19,877 | 0.21 | % | 4,114 | 0.53 | % | |||||||||||||||
Time deposits |
329,244 | 0.57 | % | 396,208 | 1.57 | % | 267,860 | 2.41 | % | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Total interest-bearing deposits |
$ | 1,421,757 | 0.60 | % | $ | 1,150,723 | 1.07 | % | $ | 625,040 | 2.21 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total deposits |
$ | 1,805,504 | 0.47 | % | $ | 1,461,080 | 0.84 | % | $ | 748,001 | 1.84 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, |
||||||||
(Dollars in thousands) |
2021 |
2020 |
||||||
FHLB borrowings |
$ | 50,000 | 70,000 | |||||
Line of Credit—Senior Debt |
1,000 | — | ||||||
Note Payable—Senior Debt |
— | 20,875 | ||||||
Note Payable—Subordinated Debt |
— | 13,000 | ||||||
|
|
|
|
|||||
Total borrowings |
$ | 51,000 | $ | 103,875 | ||||
|
|
|
|
For the Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Sources of Funds: |
||||||||||||
Deposits: |
||||||||||||
Noninterest-bearing |
18.6 | % | 18.6 | % | 14.1 | % | ||||||
Interest-bearing |
68.9 | % | 68.9 | % | 71.9 | % | ||||||
FHLB advances |
2.7 | % | 3.0 | % | 4.3 | % | ||||||
Notes payable |
1.1 | % | 2.4 | % | 2.8 | % | ||||||
Other liabilities |
0.4 | % | 0.4 | % | 0.4 | % | ||||||
Shareholders’ equity, including ESOP-owned shares |
8.3 | % | 6.7 | % | 6.5 | % | ||||||
|
|
|
|
|
|
|||||||
Total |
100.0 | % | 100.0 | % | 100.0 | % | ||||||
|
|
|
|
|
|
|||||||
Uses of Funds: |
||||||||||||
Loans, net |
79.1 | % | 85.1 | % | 84.2 | % | ||||||
Securities (available for sale and held to maturity) |
1.4 | % | 1.0 | % | 0.3 | % | ||||||
Federal funds sold and other interest-earning assets |
13.0 | % | 9.1 | % | 10.4 | % | ||||||
Other noninterest-earning assets |
6.5 | % | 4.8 | % | 5.1 | % | ||||||
|
|
|
|
|
|
|||||||
Total |
100.0 | % | 100.0 | % | 100.0 | % | ||||||
|
|
|
|
|
|
|||||||
Average noninterest-bearing deposits to average deposits |
21.3 | % | 21.3 | % | 16.4 | % | ||||||
Average total loans to average deposits |
91.2 | % | 98.1 | % | 98.9 | % |
Actual December 31, |
||||||||||||||||||||||||
2021 |
2020 |
2019 |
Minimum Capital Requirement |
Minimum Capital Requirement with Capital Buffer |
Minimum To Be Well Capitalized |
|||||||||||||||||||
Third Coast Bank, SSB |
||||||||||||||||||||||||
Tier 1 leverage capital (to average assets) |
12.3 | % | 7.2 | % | 8.9 | % | 4.0 | % | 4.0 | % | 5.0 | % | ||||||||||||
Common equity tier 1 capital (to risk weighted assets) |
12.6 | % | 11.5 | % | 10.8 | % | 4.5 | % | 7.0 | % | 6.5 | % | ||||||||||||
Tier 1 capital (to risk weighted assets) |
12.6 | % | 11.5 | % | 10.8 | % | 6.0 | % | 8.5 | % | 8.0 | % | ||||||||||||
Total capital (to risk weighted assets) |
13.5 | % | 12.5 | % | 11.9 | % | 8.0 | % | 10.5 | % | 10.0 | % |
As of December 31, |
||||||||||||||||||||||||
2021 |
2020 |
2019 |
||||||||||||||||||||||
Change in Interest Rates (Basis Points) |
Percent Change in Net Interest Income |
Percent Change in Fair Value of Equity |
Percent Change in Net Interest Income |
Percent Change in Fair Value of Equity |
Percent Change in Net Interest Income |
Percent Change in Fair Value of Equity |
||||||||||||||||||
+ 300 |
8.22 | % | 16.74 | % | (1.68 | )% | 20.30 | % | 4.03 | % | 10.06 | % | ||||||||||||
+ 200 |
4.80 | % | 11.29 | % | (1.91 | )% | 13.36 | % | 1.66 | % | 6.11 | % | ||||||||||||
+ 100 |
1.83 | % | 5.74 | % | (1.48 | )% | 6.82 | % | (0.17 | )% | 2.48 | % | ||||||||||||
Base |
— | — | — | — | — | — | ||||||||||||||||||
–100 |
2.34 | % | (2.36 | )% | 5.20 | % | (2.77 | )% | (0.41 | )% | (2.79 | )% |
For the Three Months Ended March 31, |
||||||||||||||||
(Dollars in thousands) |
2022 |
2021 |
Increase (Decrease) |
|||||||||||||
Interest income |
$ | 27,184 | $ | 25,625 | $ | 1,559 | 6.1 | % | ||||||||
Interest expense |
1,974 | 2,907 | (933 | ) | (32.1 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Net interest income |
25,210 | 22,718 | 2,492 | 11.0 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Provision for loan losses |
4,000 | 1,500 | 2,500 | 166.7 | % | |||||||||||
Noninterest income |
1,666 | 750 | 916 | 122.1 | % | |||||||||||
Noninterest expense |
20,181 | 15,518 | 4,663 | 30.0 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Income before income taxes |
2,695 | 6,450 | (3,755 | ) | (58.2 | )% | ||||||||||
Income tax expense |
608 | 1,354 | (746 | ) | (55.1 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Net income |
$ | 2,087 | $ | 5,096 | $ | (3,009 | ) | (59.0 | )% | |||||||
|
|
|
|
|
|
For the Three Months Ended March 31, |
||||||||||||||||||||||||
2022 |
2021 |
|||||||||||||||||||||||
(Dollars in thousands) |
Average Outstanding Balance |
Interest Earned/ Paid (3) |
Average Yield/ Rate |
Average Outstanding Balance |
Interest Earned/ Paid (3) |
Average Yield/ Rate |
||||||||||||||||||
Assets |
||||||||||||||||||||||||
Interest-earnings assets: |
||||||||||||||||||||||||
Investment securities |
$ | 28,170 | $ | 276 | 3.97 | % | $ | 25,181 | $ | 252 | 4.06 | % | ||||||||||||
Loans, gross |
2,208,462 | 26,682 | 4.90 | % | 1,604,107 | 25,198 | 6.37 | % | ||||||||||||||||
Federal funds sold and other interest earning assets |
260,275 | 226 | 0.35 | % | 225,850 | 175 | 0.31 | % | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total interest-earning assets |
2,496,907 | 27,184 | 4.42 | % | 1,855,138 | 25,625 | 5.60 | % | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
Less allowance for loan losses |
(20,395 | ) | (12,626 | ) | ||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
Total interest-earning assets, net of allowance |
2,476,512 | 1,842,512 | ||||||||||||||||||||||
Noninterest-earning assets |
150,871 | 101,177 | ||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
Total assets |
$ | 2,627,383 | $ | 1,943,689 | ||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
Liabilities and Shareholders’ Equity |
||||||||||||||||||||||||
Interest-bearing liabilities: |
||||||||||||||||||||||||
Interest-bearing deposits |
$ | 1,640,273 | $ | 1,844 | 0.46 | % | $ | 1,356,885 | $ | 2,377 | 0.71 | % | ||||||||||||
Notes payable |
1,891 | 23 | 4.93 | % | 33,783 | 423 | 5.08 | % | ||||||||||||||||
FHLB advances |
50,000 | 107 | 0.87 | % | 53,911 | 107 | 0.80 | % | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total interest-bearing liabilities |
1,692,164 | 1,974 | 0.47 | % | 1,444,579 | 2,907 | 0.82 | % | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Noninterest-bearing deposits |
620,900 | 368,413 | ||||||||||||||||||||||
Other liabilities |
12,782 | 7,726 | ||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
Total liabilities |
2,325,846 | 1,820,718 | ||||||||||||||||||||||
Shareholders’ equity, including ESOP- owned shares |
301,537 | 122,971 | ||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
Total liabilities and shareholders’ equity |
$ | 2,627,383 | $ | 1,943,689 | ||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
Net interest income |
$ | 25,210 | $ | 22,718 | ||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||
Net interest spread (1) |
3.95 | % | 4.78 | % | ||||||||||||||||||||
Net interest margin (2) |
4.09 | % | 4.97 | % |
(1) | Net interest spread is the average yield on interest-earning assets minus the average rate on interest-bearing liabilities. |
(2) | Net interest margin is equal to net interest income divided by average interest-earning assets. |
(3) | Interest earned/paid includes accretion of deferred loan fees, premiums and discounts. Interest income on loans includes loan fees and discount accretion of $3.2 million and $8.5 million for the three months ended March 31, 2022 and 2021, respectively. |
For the Three Months March 31, 2022 compared to 2021 |
||||||||||||
Increase (Decrease) Due to Changes In |
Total Increase (Decrease) |
|||||||||||
(Dollars in thousands) |
Volume |
Rate |
||||||||||
Interest-earning assets: |
||||||||||||
Investment securities |
$ | 30 | $ | (6 | ) | $ | 24 | |||||
Loans, gross |
9,490 | (8,006 | ) | 1,484 | ||||||||
Federal funds sold and other interest-earning assets |
24 | 27 | 51 | |||||||||
|
|
|
|
|
|
|||||||
Total increase in interest income |
$ | 9,544 | $ | (7,985 | ) | $ | 1,559 | |||||
|
|
|
|
|
|
|||||||
Interest-bearing liabilities: |
||||||||||||
Interest-bearing deposits |
$ | 495 | $ | (1,028 | ) | $ | (533 | ) | ||||
Notes payable |
(399 | ) | (1 | ) | (400 | ) | ||||||
FHLB advances |
(8 | ) | 8 | — | ||||||||
|
|
|
|
|
|
|||||||
Total increase (decrease) in interest expense |
$ | 88 | $ | (1,021 | ) | $ | (933 | ) | ||||
|
|
|
|
|
|
|||||||
Increase (decrease) in net interest income |
$ | 9,456 | $ | (6,964 | ) | $ | 2,492 | |||||
|
|
|
|
|
|
For the Three Months Ended March 31, |
||||||||||||||||
(Dollars in thousands) |
2022 |
2021 |
Increase (Decrease) |
|||||||||||||
Noninterest Income: |
||||||||||||||||
Service charges and fees |
$ | 619 | $ | 472 | $ | 147 | 31.1 | % | ||||||||
Earnings on bank-owned life insurance |
143 | 128 | 15 | 11.7 | % | |||||||||||
Other |
904 | 150 | 754 | 502.7 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total noninterest income |
$ | 1,666 | $ | 750 | $ | 916 | 122.1 | % | ||||||||
|
|
|
|
|
|
|
|
For the Three Months Ended March 31, |
||||||||||||||||
(Dollars in thousands) |
2022 |
2021 |
Increase (Decrease) |
|||||||||||||
Noninterest Expense: |
||||||||||||||||
Salaries and employee benefits |
$ | 13,324 | $ | 9,963 | $ | 3,361 | 33.7 | % | ||||||||
Net occupancy and equipment expenses |
1,873 | 1,196 | 677 | 56.6 | % | |||||||||||
Other: |
||||||||||||||||
Legal and professional fees |
1,746 | 1,115 | 631 | 56.6 | % | |||||||||||
Data processing and network expenses |
922 | 610 | 312 | 51.1 | % | |||||||||||
Regulatory assessments |
645 | 49 | 596 | 1216.3 | % | |||||||||||
Advertising and marketing expenses |
427 | 404 | 23 | 5.7 | % | |||||||||||
Loan operations and other real estate owned expenses |
278 | 1,023 | (745 | ) | (72.8 | )% | ||||||||||
Loss on sale of other real estate owned |
— | 375 | (375 | ) | (100.0 | )% | ||||||||||
Other expenses |
966 | 783 | 183 | 23.4 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total noninterest expense |
$ | 20,181 | $ | 15,518 | $ | 4,663 | 30.0 | % | ||||||||
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
||||||||
(Dollars in thousands) |
2022 |
2021 |
||||||
Income tax expense |
$ | 608 | $ | 1,354 | ||||
Effective tax rate |
22.6 | % | 21.0 | % |
March 31, 2022 |
December 31, 2021 |
|||||||||||||||
(Dollars in thousands) |
Amount |
Percent |
Amount |
Percent |
||||||||||||
Real estate: |
||||||||||||||||
Commercial real estate: |
||||||||||||||||
Non-farm non-residential owner occupied |
$ | 477,573 | 19.5 | % | $ | 383,941 | 18.6 | % | ||||||||
Non-farm non-residential non-owner occupied |
463,618 | 19.0 | % | 445,308 | 21.5 | % | ||||||||||
Residential |
225,649 | 9.2 | % | 213,264 | 10.3 | % | ||||||||||
Construction, development and other |
414,653 | 16.9 | % | 320,335 | 15.5 | % | ||||||||||
Farmland |
13,467 | 0.6 | % | 9,934 | 0.5 | % | ||||||||||
Commercial and industrial |
756,005 | 30.9 | % | 611,348 | 29.5 | % | ||||||||||
Consumer |
3,304 | 0.1 | % | 4,001 | 0.2 | % | ||||||||||
Other |
93,676 | 3.8 | % | 80,593 | 3.9 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total loans |
$ | 2,447,945 | 100.0 | % | $ | 2,068,724 | 100.0 | % | ||||||||
|
|
|
|
|
|
|
|
As of March 31, 2022 |
||||||||||||||||||||
(Dollars in thousands) |
One Year or Less |
One Through Five Years |
Five Years Through Fifteen Years |
After Fifteen Years |
Total |
|||||||||||||||
Real estate: |
||||||||||||||||||||
Commercial real estate: |
||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | 22,320 | $ | 125,510 | $ | 230,699 | $ | 99,044 | $ | 477,573 | ||||||||||
Non-farm non-residential non-owner occupied |
41,477 | 213,842 | 175,329 | 32,970 | 463,618 | |||||||||||||||
Residential |
10,796 | 93,141 | 61,972 | 59,740 | 225,649 | |||||||||||||||
Construction, development and other |
90,875 | 287,323 | 26,301 | 10,154 | 414,653 | |||||||||||||||
Farmland |
2,233 | 4,002 | 5,904 | 1,328 | 13,467 | |||||||||||||||
Commercial and industrial |
317,492 | 335,906 | 96,838 | 5,769 | 756,005 | |||||||||||||||
Consumer |
79 | 2,464 | 761 | — | 3,304 | |||||||||||||||
Other |
43,139 | 49,380 | 1,157 | — | 93,676 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total loans |
$ | 528,411 | $ | 1,111,568 | $ | 598,961 | $ | 209,005 | $ | 2,447,945 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Amounts with fixed rates |
$ | 240,997 | $ | 483,430 | $ | 80,118 | $ | 46,754 | $ | 851,299 | ||||||||||
Amounts with floating rates |
$ | 287,414 | $ | 628,138 | $ | 518,843 | $ | 162,251 | $ | 1,596,646 |
(Dollars in thousands) |
As of March 31, 2022 |
As of December 31, 2021 |
||||||
Nonaccrual loans (1) |
$ | 9,896 | $ | 10,030 | ||||
Loans > 90 days and still accruing |
40 | 278 | ||||||
Restructured loan—accruing |
790 | 5,295 | ||||||
|
|
|
|
|||||
Total nonperforming loans |
$ | 10,726 | $ | 15,603 | ||||
|
|
|
|
|||||
Other real estate owned and repossessed assets |
1,666 | 1,676 | ||||||
|
|
|
|
|||||
Total nonperforming assets |
$ | 12,392 | $ | 17,279 | ||||
|
|
|
|
|||||
Ratio of nonaccrual loans to total loans |
0.40 | % | 0.48 | % | ||||
Ratio of nonperforming loans to total loans |
0.44 | % | 0.75 | % | ||||
Ratio of nonperforming loans to total assets |
0.35 | % | 0.62 | % | ||||
Ratio of nonperforming assets to total assets |
0.41 | % | 0.69 | % | ||||
Ratio of nonperforming loans to total loans plus OREO |
0.44 | % | 0.75 | % | ||||
Ratio of allowance for loan losses to nonaccrual loans |
235.57 | % | 192.37 | % |
(1) | Restructured loans-nonaccrual are included in nonaccrual loans. |
(Dollars in thousands) |
As of March 31, 2022 |
As of December 31, 2021 |
||||||
Nonaccrual loans by category: |
||||||||
Real estate: |
||||||||
Commercial real estate: |
||||||||
Non-farm non-residential owner occupied |
$ | 986 | $ | 1,008 | ||||
Non-farm non-residential non-owner occupied |
334 | 346 | ||||||
Residential |
121 | 127 | ||||||
Construction, development and other |
238 | 244 | ||||||
Farmland |
— | — | ||||||
Commercial and industrial |
8,210 | 8,297 | ||||||
Consumer |
— | — | ||||||
Other |
— | — | ||||||
Purchased credit impaired |
7 | 8 | ||||||
|
|
|
|
|||||
Total nonaccrual loans |
$ | 9,896 | $ | 10,030 | ||||
|
|
|
|
March 31, 2022 |
||||||||||||||||||||||||
(Dollars in thousands) |
Pass |
Special Mention |
Substandard |
Purchased Credit Impaired |
Doubtful |
Total |
||||||||||||||||||
Real estate: |
||||||||||||||||||||||||
Commercial real estate: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | 466,035 | $ | 4,695 | $ | 6,843 | $ | — | $ | — | $ | 477,573 | ||||||||||||
Non-farm non-residential non-owner occupied |
454,476 | — | 8,411 | 731 | — | 463,618 | ||||||||||||||||||
Residential |
224,593 | — | 1,056 | — | — | 225,649 | ||||||||||||||||||
Construction, development and other |
410,319 | — | 238 | 4,096 | — | 414,653 | ||||||||||||||||||
Farmland |
13,467 | — | — | — | — | 13,467 | ||||||||||||||||||
Commercial and industrial |
751,356 | — | 4,588 | 61 | — | 756,005 | ||||||||||||||||||
Consumer |
3,283 | 21 | — | — | — | 3,304 | ||||||||||||||||||
Other |
93,676 | — | — | — | — | 93,676 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Gross loans |
$ | 2,417,205 | $ | 4,716 | $ | 21,136 | $ | 4,888 | $ | — | $ | 2,447,945 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
December 31, 2021 |
||||||||||||||||||||||||
(Dollars in thousands) |
Pass |
Special Mention |
Substandard |
Purchased Credit Impaired |
Doubtful |
Total |
||||||||||||||||||
Real estate: |
||||||||||||||||||||||||
Commercial real estate: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | 370,062 | $ | 6,953 | $ | 6,926 | $ | — | $ | — | $ | 383,941 | ||||||||||||
Non-farm non-residential non-owner occupied |
428,972 | 8,338 | 7,276 | 722 | — | 445,308 | ||||||||||||||||||
Residential |
212,109 | — | 1,069 | 86 | — | 213,264 | ||||||||||||||||||
Construction, development and other |
315,979 | — | 244 | 4,112 | — | 320,335 | ||||||||||||||||||
Farmland |
9,934 | — | — | — | — | 9,934 | ||||||||||||||||||
Commercial and industrial |
605,322 | 1,146 | 4,816 | 64 | — | 611,348 | ||||||||||||||||||
Consumer |
3,979 | 22 | — | — | — | 4,001 | ||||||||||||||||||
Other |
80,593 | — | — | — | — | 80,593 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Gross loans |
$ | 2,026,950 | $ | 16,459 | $ | 20,331 | $ | 4,984 | $ | — | $ | 2,068,724 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended March 31, |
||||||||
(Dollars in thousands) |
2022 |
2021 |
||||||
Allowance for loan loss at beginning of period |
$ | 19,295 | $ | 11,979 | ||||
Provision for loan loss |
4,000 | 1,500 | ||||||
Charge-offs: |
||||||||
Other |
— | (13 | ) | |||||
|
|
|
|
|||||
Total charge-offs |
— | (13 | ) | |||||
|
|
|
|
|||||
Recoveries: |
||||||||
Commercial and industrial |
4 | 3 | ||||||
Consumer |
13 | — | ||||||
Other |
— | 2 | ||||||
|
|
|
|
|||||
Total recoveries |
17 | 5 | ||||||
|
|
|
|
|||||
Net (charge-offs) recoveries |
17 | (8 | ) | |||||
|
|
|
|
|||||
Allowance for loan losses at end of period |
$ | 23,312 | $ | 13,471 | ||||
|
|
|
|
|||||
Ratio of net (charge-offs) recoveries to average loans (1) |
0.00 | % | (0.00 | )% |
(1) | Interim periods annualized. |
March 31, 2022 |
December 31, 2021 |
|||||||||||||||
(Dollars in thousands) |
Amount |
% Loans in Each Category |
Amount |
% Loans in Each Category |
||||||||||||
Real estate: |
||||||||||||||||
Commercial real estate: |
||||||||||||||||
Non-farm non-residential owner occupied |
$ | 4,087 | 19.5 | % | $ | 3,456 | 18.6 | % | ||||||||
Non-farm non-residential non-owner occupied |
5,613 | 19.0 | % | 5,935 | 21.5 | % | ||||||||||
Residential |
766 | 9.2 | % | 957 | 10.3 | % | ||||||||||
Construction, development and other |
2,324 | 16.9 | % | 2,064 | 15.5 | % | ||||||||||
Farmland |
44 | 0.6 | % | 45 | 0.5 | % | ||||||||||
Commercial and industrial |
10,173 | 30.9 | % | 6,500 | 29.5 | % | ||||||||||
Consumer |
5 | 0.1 | % | 6 | 0.2 | % | ||||||||||
Other |
300 | 3.8 | % | 332 | 3.9 | % | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 23,312 | 100.0 | % | $ | 19,295 | 100.00 | % | |||||||||
|
|
|
|
|
|
|
|
March 31, 2022 |
||||||||||||||||
(Dollars in thousands) |
Amortized Cost |
Unrealized Gain |
Unrealized Loss |
Estimated Fair Value |
||||||||||||
Investment securities available for sale: |
||||||||||||||||
State and municipal securities |
$ | 425 | $ | — | $ | 1 | $ | 424 | ||||||||
Mortgage-backed securities |
753 | 12 | 4 | 761 | ||||||||||||
U.S. Treasury bonds |
101,080 | 2 | — | 101,082 | ||||||||||||
Corporate bonds |
23,551 | 477 | 77 | 23,951 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 125,809 | $ | 491 | $ | 82 | $ | 126,218 | |||||||||
|
|
|
|
|
|
|
|
December 31, 2021 |
||||||||||||||||
(Dollars in thousands) |
Amortized Cost |
Unrealized Gain |
Unrealized Loss |
Estimated Fair Value |
||||||||||||
Investment securities available for sale: |
||||||||||||||||
State and municipal securities |
$ | 1,087 | $ | 7 | $ | — | $ | 1,094 | ||||||||
Mortgage-backed securities |
791 | 20 | — | 811 | ||||||||||||
Corporate bonds |
23,556 | 972 | 1 | 24,527 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 25,434 | $ | 999 | $ | 1 | $ | 26,432 | |||||||||
|
|
|
|
|
|
|
|
March 31, 2022 | ||||||||
Amortized Cost |
Estimated Fair Value |
|||||||
Due in one year or less |
$ | — | $ | — | ||||
Due from one year to five years |
101,505 | 101,506 | ||||||
Due from five years to ten years |
23,551 | 23,951 | ||||||
|
|
|
|
|||||
125,056 | 125,457 | |||||||
Mortgage-backed securities |
753 | 761 | ||||||
|
|
|
|
|||||
$ | 125,809 | $ | 126,218 | |||||
|
|
|
|
As of March 31, |
As of December 31, |
|||||||||||||||
2022 |
2021 |
|||||||||||||||
(Dollars in thousands) |
Amount |
Percent |
Amount |
Percent |
||||||||||||
Interest-bearing deposits |
$ | 1,350,837 | 81.6 | % | $ | 1,298,546 | 69.7 | % | ||||||||
Savings |
34,825 | 2.1 | % | 33,539 | 1.7 | % | ||||||||||
Time deposits $100,000 and over |
254,581 | 15.4 | % | 261,856 | 27.3 | % | ||||||||||
Time deposits less than $100,000 |
15,304 | 0.9 | % | 15,857 | 1.3 | % | ||||||||||
|
|
|
|
|||||||||||||
Total interest-bearing deposits |
$ | 1,655,547 | 64.0 | % | $ | 1,609,798 | 75.2 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Noninterest-bearing demand deposits |
$ | 931,622 | 36.0 | % | $ | 531,401 | 24.8 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total deposits |
$ | 2,587,169 | 100.0 | % | $ | 2,141,199 | 100.00 | % | ||||||||
|
|
|
|
|
|
|
|
As of March 31, |
||||
(Dollars in thousands) |
2022 |
|||
Three months or less |
$ | 20,229 | ||
Over three months through six months |
52,770 | |||
Over six months through twelve months |
41,719 | |||
Over twelve months |
2,109 | |||
|
|
|||
Total |
$ | 116,827 | ||
|
|
Three Months Ended March 31, 2022 |
Year Ended December 31, 2021 |
|||||||||||||||
(Dollars in thousands) |
Average Balance |
Average Rate |
Average Balance |
Average Rate |
||||||||||||
Noninterest-bearing deposits |
$ | 620,900 | — | $ | 383,747 | — | ||||||||||
Interest-bearing demand deposits |
$ | 1,328,485 | 0.49 | % | $ | 1,064,737 | 0.62 | % | ||||||||
Savings |
33,607 | 0.28 | % | 27,776 | 0.29 | % | ||||||||||
Time deposits |
278,181 | 0.30 | % | 329,244 | 0.57 | % | ||||||||||
|
|
|
|
|||||||||||||
Total interest-bearing deposits |
$ | 1,640,273 | 0.46 | % | $ | 1,421,757 | 0.60 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total deposits |
$ | 2,261,173 | 0.33 | % | $ | 1,805,504 | 0.47 | % | ||||||||
|
|
|
|
|
|
|
|
(Dollars in thousands) |
As of March 31, 2022 |
As of December 31, 2021 |
||||||
FHLB advances |
$ | 50,000 | $ | 50,000 | ||||
Line of Credit |
1,000 | 1,000 | ||||||
Note Payable—Subordinated Debt |
80,507 | — | ||||||
|
|
|
|
|||||
Total borrowings |
$ | 131,507 | $ | 51,000 | ||||
|
|
|
|
For the Three Months Ended March 31, |
For the Year Ended December 31, |
|||||||
2022 |
2021 |
|||||||
Sources of Funds: |
||||||||
Deposits: |
||||||||
Noninterest-bearing |
23.6 | % | 18.6 | % | ||||
Interest-bearing |
62.4 | % | 68.9 | % | ||||
FHLB advances |
1.9 | % | 2.7 | % | ||||
Notes payable |
0.1 | % | 1.1 | % | ||||
Other liabilities |
0.5 | % | 0.4 | % | ||||
Shareholders’ equity |
11.5 | % | 8.3 | % | ||||
|
|
|
|
|||||
Total |
100.0 | % | 100.0 | % | ||||
|
|
|
|
|||||
Uses of Funds: |
||||||||
Loans, net |
83.3 | % | 79.1 | % | ||||
Securities (available for sale and held to maturity) |
1.1 | % | 1.4 | % | ||||
Federal funds sold and other interest-earning assets |
9.9 | % | 13.0 | % | ||||
Other noninterest-earning assets |
5.7 | % | 6.5 | % | ||||
|
|
|
|
|||||
Total |
100.0 | % | 100.0 | % | ||||
|
|
|
|
|||||
Average noninterest-bearing deposits to average deposits |
27.5 | % | 21.3 | % | ||||
Average total loans to average deposits |
97.7 | % | 91.2 | % |
Actual |
Minimum Capital Requirement |
Minimum Capital Requirement with Capital Buffer |
Minimum To Be Well Capitalized |
|||||||||||||||||
March 31, 2022 |
December 31, 2021 |
|||||||||||||||||||
Third Coast Bank, SSB |
||||||||||||||||||||
Tier 1 leverage capital (to average assets) |
13.7 | % | 12.3 | % | 4.0 | % | 4.0 | % | 5.0 | % | ||||||||||
Common equity tier 1 capital (to risk weighted assets) |
12.4 | % | 12.6 | % | 4.5 | % | 7.0 | % | 6.5 | % | ||||||||||
Tier 1 capital (to risk weighted assets) |
12.4 | % | 12.6 | % | 6.0 | % | 8.5 | % | 8.0 | % | ||||||||||
Total capital (to risk weighted assets) |
13.2 | % | 13.5 | % | 8.0 | % | 10.5 | % | 10.0 | % |
As of March 31, 2022 |
As of December 31, 2021 |
|||||||||||||||
Change in Interest Rates (Basis Points) |
Percent Change in Net Interest Income |
Percent Change in Fair Value of Equity |
Percent Change in Net Interest Income |
Percent Change in Fair Value of Equity |
||||||||||||
+ 300 |
14.35 | % | 17.54 | % | 8.22 | % | 16.74 | % | ||||||||
+ 200 |
9.13 | % | 11.91 | % | 4.80 | % | 11.29 | % | ||||||||
+ 100 |
4.17 | % | 5.96 | % | 1.83 | % | 5.74 | % | ||||||||
Base |
— | — | — | — | ||||||||||||
–100 |
0.00 | % | (3.21 | )% | 2.34 | % | (2.36 | )% |
Name of Executive Officer |
Position |
Age |
||||
Bart O. Caraway |
Chairman, President and Chief Executive Officer of the Company and the Bank | 51 | ||||
R. John McWhorter |
Chief Financial Officer of the Company and Senior Executive Vice President and Chief Financial Officer of the Bank | 57 | ||||
Donald C. Legato |
Senior Executive Vice President and Chief Lending Officer of the Bank | 54 | ||||
Audrey A. Duncan |
Senior Executive Vice President and Chief Credit Officer of the Bank | 57 |
• | Bart O. Caraway |
• | R. John McWhorter |
• | Donald C. Legato |
Name and Principal Position |
Year |
Salary ($) |
Bonus (1) ($) |
Stock Awards (2) ($) |
Option Awards (2) ($) |
All Other Compensation ($) (3)(4) |
Total ($) |
|||||||||||||||||||||
Bart O. Caraway |
2021 | 520,833 | 575,000 | 276,000 | 29,614 | 149,271 | 1,550,718 | |||||||||||||||||||||
Chairman of the Board, President and Chief Executive Officer |
2020 | 469,792 | 575,000 | — | 100,691 | 88,355 | 1,233,838 | |||||||||||||||||||||
R. John McWhorter |
2021 | 297,914 | 150,000 | 162,000 | 2,194 | 161,424 | 773,532 | |||||||||||||||||||||
Chief Financial Officer |
2020 | 275,000 | 150,000 | — | 6,011 | 94,906 | 525,917 | |||||||||||||||||||||
Donald C. Legato |
2021 | 293,327 | 150,000 | 120,000 | 18,154 | 109,133 | 690,614 | |||||||||||||||||||||
Chief Lending Officer |
2020 | 275,000 | 150,000 | — | 30,057 | 65,549 | 520,606 |
(1) | The amounts in this column represent the aggregate amount of annual discretionary cash bonuses earned by our named executive officers for fiscal years 2021 and 2020 performance, respectively. |
(2) | As required by SEC rules, amounts in this column represent the aggregate grant date fair value of stock-based compensation expense as required by FASB ASC Topic 718 Stock Based Compensation and were calculated using the valuation assumptions for restricted stock and nonqualified stock option awards that are |
contained in the notes to the Company’s financial statements under Note 8, “Stock Options and Warrants,” included in Annex B for the year ended December 31, 2021. These amounts are not the actual value that may be realized by our named executive officers. |
(3) | All other compensation for 2021 includes: $11,600 of matching contributions to Mr. Caraway’s 401(k) account, $175 of life insurance premiums for Mr. Caraway, and an accrual of $137,496 in connection with Mr. Caraway’s salary continuation agreement; $11,373 of matching contributions to Mr. McWhorter’s 401(k) account, $283 of life insurance premiums for Mr. McWhorter, and an accrual of $149,768 in connection with Mr. McWhorter’s salary continuation agreement; and $11,600 of matching contributions to Mr. Legato’s 401(k) account, $210 of life insurance premiums for Mr. Legato, and an accrual of $97,323 in connection with Mr. Legato’s salary continuation agreement. |
(4) | All other compensation for 2020 includes: $11,400 of matching contributions to Mr. Caraway’s 401(k) account, $165 of life insurance premiums for Mr. Caraway, and an accrual of $76,790 in connection with Mr. Caraway’s salary continuation agreement; $11,000 of matching contributions to Mr. McWhorter’s 401(k) account, $263 of life insurance premiums for Mr. McWhorter, and an accrual of $83,643 in connection with Mr. McWhorter’s salary continuation agreement; and $11,000 of matching contributions to Mr. Legato’s 401(k) account, $195 of life insurance premiums for Mr. Legato, and an accrual of $54,354 in connection with Mr. Legato’s salary continuation agreement. |
• | all accrued compensation and benefits; |
• | for Mr. Caraway, a payment that totals 150% of his annual base salary; for Mr. McWhorter, a payment that totals 100% of his annual base salary; and for Mr. Legato, a payment that totals 100% of his annual base salary, with each payment payable in substantially equal installments over a period of one year in accordance with the Bank’s normal payroll practices; |
• | for Mr. Caraway, a payment that totals 150% of the average of his annual bonus earned for the three full years preceding the year in which the termination date occurs, or, if less than three years, the greater of (i) the average of his annual bonuses awarded for all full years preceding the year in which the termination date occurs, or (ii) if less than one year, his target annual bonus in effect for the year in which the termination date occurs; and for each of Mr. McWhorter and Mr. Legato, a payment that totals the average of his respective annual bonus earned for the three full years preceding the year in which the termination date occurs, or, if less than three years, the greater of (i) the average of his annual bonuses awarded for all full years preceding the year in which the termination date occurs, or (ii) if less than one year, his target annual bonus in effect for the year in which the termination date occurs, with each payment payable in substantially equal installments over a period of one year in accordance with the Bank’s normal payroll practices; |
• | if timely and properly elected, reimbursement of monthly premiums paid under the Consolidated Omnibus Reconciliation Act of 1985, or COBRA, until the earliest of (i) for Mr. Caraway, 18 months following the termination date, and for each of Mr. McWhorter and Mr. Legato, 12 months following the termination date, (ii) the date the named executive officer is no longer eligible to receive COBRA benefits, and (iii) the date on which the named executive officer either receives or becomes eligible to receive substantially similar coverage from another employer; and |
• | the vesting of any outstanding equity awards held by the named executive officer immediately prior to the termination date accelerated by one year. |
• | all accrued compensation and benefits; |
• | a lump sum payment that totals 100% of the named executive officer’s annual base salary, paid on the date that annual bonuses are paid to similarly situated executives in the current calendar year, but in no event later than March 15 of the year following the end of the calendar year in which the termination date occurs; |
• | a lump sum payment that totals the average of the named executive officer’s annual bonuses earned for the three full years preceding the year in which the termination date occurs, or, if less than three years, the greater of (i) the average of his annual bonuses awarded for all full years preceding the year in which the termination date occurs, or (ii) if less than one year, his target annual bonus in effect for the year in which the termination date occurs, paid on the date that annual bonuses are paid to similarly situated executives in the current calendar year, but in no event later than March 15 of the year following the end of the calendar year in which the termination date occurs; and |
• | the vesting of any outstanding equity awards held by the named executive officer immediately prior to the termination date accelerated by one year. |
• | all accrued compensation and benefits; |
• | a lump sum payment equal to any earned but unpaid annual bonus for the most recently completed calendar year and, in the case of Mr. Caraway 2.99 times, in the case of McWhorter 2.0 times, and in the case of Mr. Legato 1.5 times, the sum of (i) the named executive officer’s annual base salary and (ii) the average of the named executive officer’s annual bonuses earned for the three full years preceding the year in which the termination date occurs, or, if less than three years, the greater of (A) the average of his annual bonuses awarded for all full years preceding the year in which the |
termination date occurs, or (B) if less than one year, his target annual bonus in effect for the year in which the termination date occurs; |
• | if timely and properly elected, reimbursement of monthly COBRA premiums, until the earliest of (i) for each of Mr. Caraway and Mr. McWhorter, 24 months following the termination date, and for Mr. Legato, 12 months following the termination date, (ii) the date the named executive officer is no longer eligible to receive COBRA benefits, and (iii) the date on which the named executive officer either receives or becomes eligible to receive substantially similar coverage from another employer; and |
• | immediate vesting of any outstanding equity awards held by the named executive officer immediately prior to the termination date, in accordance with the terms of the applicable equity plan and award agreements. |
Option Awards |
Stock Awards |
|||||||||||||||||||||||||||
Number of securities underlying unexercised options (#) exercisable |
Number of securities underlying unexercised options (#) unexercisable |
Equity incentive plan awards: number of securities underlying unexercised unearned options (#) |
Option exercise price |
Option expiration date |
Number of Shares or Units of Stock That Have Not Vested (#) |
Market Value of Shares or Units of Stock That Have Not Vested ($) (20) |
||||||||||||||||||||||
Bart O. Caraway |
857 | — | — | $ | 11.00 | 7/1/23 | ||||||||||||||||||||||
93,700 | — | — | $ | 11.00 | 12/31/24 | |||||||||||||||||||||||
11,200 | 2,800 | (1) |
— | $ | 13.00 | 2/23/27 | ||||||||||||||||||||||
80,000 | 20,000 | (2) |
— | $ | 16.30 | 7/19/28 | ||||||||||||||||||||||
6,700 | 26,800 | (3) |
— | $ | 16.78 | 1/1/30 | ||||||||||||||||||||||
— | 13,500 | (4) |
— | $ | 16.43 | 1/1/31 | ||||||||||||||||||||||
11,500 | (17) |
$ | 298,770 | |||||||||||||||||||||||||
R. John McWhorter |
400 | — | — | $ | 13.00 | 11/10/26 | ||||||||||||||||||||||
— | 800 | (5) |
— | $ | 16.00 | 2/1/28 | ||||||||||||||||||||||
— | 12,000 | (6) |
— | $ | 16.30 | 1/1/29 | ||||||||||||||||||||||
— | 1,600 | (7) |
— | $ | 16.78 | 1/1/30 | ||||||||||||||||||||||
— | 1,000 | (8) |
— | $ | 16.43 | 1/1/31 | ||||||||||||||||||||||
6,750 | (18) |
$ | 175,365 | |||||||||||||||||||||||||
Donald C. Legato |
500 | — | (9) |
— | $ | 11.00 | 3/1/22 | |||||||||||||||||||||
2,000 | — | — | $ | 11.00 | 3/31/24 | |||||||||||||||||||||||
500 | — | — | $ | 11.00 | 5/1/24 | |||||||||||||||||||||||
10,000 | — | — | $ | 11.00 | 12/31/24 | |||||||||||||||||||||||
3,200 | 800 | (10) |
— | $ | 13.00 | 1/31/27 | ||||||||||||||||||||||
2,400 | 1,600 | (11) |
— | $ | 16.00 | 4/1/28 | ||||||||||||||||||||||
6,000 | 9,000 | (12) |
— | $ | 16.30 | 1/1/29 | ||||||||||||||||||||||
1,200 | 1,800 | (13) |
— | $ | 16.30 | 1/1/29 | ||||||||||||||||||||||
2,000 | 8,000 | (14) |
— | $ | 16.78 | 1/1/30 | ||||||||||||||||||||||
— | 1,000 | (15) |
$ | 16.43 | 1/1/31 | |||||||||||||||||||||||
— | 6,000 | (16) |
$ | 16.43 | 4/1/31 | |||||||||||||||||||||||
5,000 | (19) |
$ | 129,900 |
(1) | Stock options to acquire 2,800 shares vested on February 23, 2022. |
(2) | Stock options to acquire 20,000 shares vested on January 1, 2022. |
(3) | Stock options to acquire 6,700 shares vested on January 1, 2022 and stock options to acquire 6,700 shares will vest on January 1, 2023, 2024 and 2025. |
(4) | Stock options to acquire 2,700 shares vested on January 1, 2022 and stock options to acquire 2,700 shares will vest on January 1, 2023, 2024, 2025 and 2026. |
(5) | Stock options to acquire 400 shares vested on February 1, 2022 and stock options to acquire 400 shares will vest on January 1, 2023. |
(6) | Stock options to acquire 4,000 shares vested on January 1, 2022 and stock options to acquire 4,000 shares will vest on January 1, 2023 and 2024. |
(7) | Stock options to acquire 400 shares vested on January 1, 2022 and stock options to acquire 400 shares will vest on January 1, 2023, 2024 and 2025. |
(8) | Stock options to acquire 200 shares vested on January 1, 2022 and stock options to acquire 200 shares will vest on January 1, 2023, 2024, 2025 and 2026. |
(9) | Stock options to acquire 500 shares were exercised on February 24, 2022. |
(10) | Stock options to acquire 800 shares vested on January 31, 2022. |
(11) | Stock options to acquire 800 shares vested on April 1, 2022 and stock options to acquire 800 shares will vest on April 1, 2023. |
(12) | Stock options to acquire 3,000 shares vested on January 1, 2022 and stock options to acquire 3,000 shares will vest on January 1, 2023 and 2024. |
(13) | Stock options to acquire 600 shares vested on January 1, 2022 and stock options to acquire 600 shares will vest on January 1, 2023 and 2024. |
(14) | Stock options to acquire 2,000 shares vested on January 1, 2022 and stock options to acquire 2,000 shares will vest on January 1, 2023, 2024 and 2025. |
(15) | Stock options to acquire 200 shares vested on January 1, 2022 and stock options to acquire 200 shares will vest on January 1, 2023, 2024, 2025 and 2026. |
(16) | Stock options to acquire 1,200 shares vested on April 1, 2022 and stock options to acquire 1,200 shares will vest on April 1, 2023, 2024, 2025 and 2026. |
(17) | Restricted stock that will vest in equal increments on an annual basis over a three-year period beginning on November 8, 2022. |
(18) | Restricted stock that will vest in equal increments on an annual basis over a three-year period beginning on November 8, 2022. |
(19) | Restricted stock that will vest in equal increments on an annual basis over a three-year period beginning on November 8, 2022. |
(20) | Market value of shares of restricted stock that have not vested is calculated by multiplying the number of shares of stock that have not vested by the closing market price of our common stock on December 31, 2021, which was $25.98. |
Fee Per Meeting Attended ($) |
Chairperson’s Quarterly Stipend ($) |
|||||||
Executive Committee |
— | — | ||||||
Directors’ Loan Committee |
300 | 875 | ||||||
Audit Committee |
400 | 1,250 | ||||||
ALCO |
300 | 812.50 | ||||||
Compensation Committee |
250 | 625 | ||||||
Director Information Technology Committee |
300 | 625 | ||||||
Corporate Governance and Nominating Committee |
300 | 1,250 |
Director fees earned or paid in cash ($) |
All other compensation ($) (1) |
Total ($) |
||||||||||
Carolyn Bailey |
38,838 | — | 38,838 | |||||||||
Dr. Martin Basaldua |
27,138 | 1,017 | 28,155 | |||||||||
Dennis Bonnen |
31,338 | 333,333 | 364,671 | |||||||||
W. Donald Brunson |
39,288 | — | 39,288 | |||||||||
Norma J. Galloway |
38,038 | 91,182 | 129,220 | |||||||||
Troy A. Glander |
26,513 | 190 | 26,703 | |||||||||
Shelton J. McDonald |
36,438 | — | 36,438 | |||||||||
Joseph L. Stunja |
34,238 | 900 | 35,138 | |||||||||
Reagan Swinbank |
29,338 | — | 29,338 |
(1) | All other compensation for 2021 includes: $1,017 of life insurance premiums for Dr. Basaldua; $333,333 paid to Mr. Bonnen pursuant to his separation agreement with Heritage; $89,400 of consulting fees and $1,782 of phone fees paid to Ms. Galloway; $190 of life insurance premiums for Mr. Glander; and $900 of life insurance premiums for Mr. Stunja. |
Plan Category |
Number of Shares to be Issued Upon Exercise of Outstanding Options, Warrants and Rights |
Weighted Average Exercise Price of Outstanding Options, Warrants and Rights |
Number of Shares Remaining available for Future Issuance Under Equity Compensation Plans (excluding column (a)) |
|||||||||
(a) |
(b) |
(c) |
||||||||||
Equity compensation plans approved by shareholders (1) |
1,274,463 | $ | 18.05 | 209,023 | ||||||||
Equity compensation plans not approved by shareholders |
— | — | — | |||||||||
|
|
|
|
|
|
|||||||
Total |
1,274,463 | $ | 18.05 | 209,023 | ||||||||
|
|
|
|
|
|
(1) | The number of shares available for future issuance includes 8,000 shares available under the 2017 Plan (which allows for the issuance of options, as well as various other stock-based awards) and 201,023 shares available under the 2019 Plan. |
Name of Beneficial Owner |
Number of Shares Beneficially Owned |
Percentage Beneficially Owned (14) |
||||||
Directors and Named Executive Officers: |
||||||||
Carolyn Bailey (1) |
7,600 | * | ||||||
Dr. Martin Basaldua (2) |
95,090 | * | ||||||
Dennis Bonnen (3) |
143,503 | 1.1 | % | |||||
W. Donald Brunson (4) |
50,792 | * | ||||||
Bart O. Caraway (5) |
271,369 | 2.0 | % | |||||
Norma J. Galloway (6) |
7,000 | * | ||||||
Troy A. Glander (7) |
38,813 | * | ||||||
Donald C. Legato (8) |
58,362 | * | ||||||
Shelton J. McDonald (9) |
5,000 | * | ||||||
R. John McWhorter (10) |
222,963 | 1.7 | % | |||||
Joseph L. Stunja (11) |
146,774 | 1.1 | % | |||||
Reagan Swinbank (12) |
60,914 | * | ||||||
Directors and Executive Officers as a group (13 persons) (13) |
1,133,771 | 8.2 | % |
* | Represents beneficial ownership of less than 1%. |
(1) | Includes (i) 1,000 shares held by Ms. Bailey individually, (ii) 1,600 shares held by Ms. Bailey’s individual retirement account, (iii) options to purchase 3,000 shares of common stock, and (iv) 2,000 shares of restricted stock held by Ms. Bailey individually, which will vest in equal increments on an annual basis over a two-year period beginning on November 8, 2022. |
(2) | Includes (i) 36,248 shares held by Pinnacle Executive Services LLC over which Dr. Basaldua has shared voting and investment control and may be deemed beneficially owned by Dr. Basaldua, (ii) 2,710 shares held by Dr. Basaldua individually, (iii) 37,525 shares held by Dr. Basaldua’s individual retirement account, (iv) options to purchase 15,750 shares of common stock, (v) organizer warrants to purchase 857 shares of common stock, and (vi) 2,000 shares of restricted stock held by Dr. Basaldua individually, which will vest in equal increments on an annual basis over a two-year period beginning on November 8, 2022. |
(3) | Includes (i) 128,283 shares held by Mr. Bonnen individually, (ii) 5,675 shares held by Mr. Bonnen’s individual retirement account, (iii) 4,545 shares held by the individual retirement account of Mr. Bonnen’s spouse, (iv) options to purchase 3,000 shares of common stock, and (v) 2,000 shares of restricted stock held by Mr. Bonnen individually, which will vest in equal increments on an annual basis over a two-year period beginning on November 8, 2022. |
(4) | Includes (i) 33,292 shares held by Mr. Brunson individually, (ii) 12,500 shares held by Mr. Brunson’s individual retirement account, (iii) options to purchase 3,000 shares of common stock, and (iv) 2,000 shares of restricted stock held by Mr. Brunson individually, which will vest in equal increments on an annual basis over a two-year period beginning November 8, 2022. |
(5) | Includes (i) 19,850 shares held by Mr. Caraway individually, (ii) 2,746 shares held by Mr. Caraway’s individual retirement account, (iii) options to purchase 223,800 shares of common stock, (iv) organizer warrants to purchase 857 shares of common stock, (v) 11,500 shares of restricted stock held by |
Mr. Caraway individually, which will vest in equal increments on an annual basis over a three-year period beginning on November 8, 2022, (vi) 10,000 shares of restricted stock held by Mr. Caraway individually, which will vest in equal increments on an annual basis over a four-year period beginning on February 1, 2023, and (vii) 2,616 shares held by the Company’s ESOP and allocated to Mr. Caraway’s account. Mr. Caraway has the right to direct the ESOP trustee to vote the shares held by the Company’s ESOP and allocated to his account on all matters requiring the vote of our shareholders and as a ESOP participant, Mr. Caraway may be deemed the beneficial owner of such shares. |
(6) | Includes (i) 2,000 shares held by Ms. Galloway individually, (ii) options to purchase 3,000 shares of common stock, and (iii) 2,000 shares of restricted stock held by Ms. Galloway individually, which will vest in equal increments on an annual basis over a two-year period beginning on November 8, 2022. |
(7) | Includes (i) 20,206 shares held by Mr. Glander individually, (ii) options to purchase 15,750 shares of common stock, (iii) organizer warrants to purchase 857 shares of common stock, and (iv) 2,000 shares of restricted stock held by Mr. Glander individually, which will vest in equal increments on an annual basis over a two-year period beginning on November 8, 2022. |
(8) | Includes (i) 500 shares held by Mr. Legato individually, (ii) 12,500 shares held by Mr. Legato’s individual retirement account, (iii) options to purchase 35,900 shares of common stock, (iv) 5,000 shares of restricted stock held by Mr. Legato individually, which will vest in equal increments on an annual basis over a three-year period beginning on November 8, 2022, (v) 2,000 shares of restricted stock held by Mr. Legato individually, which will vest in equal increments on an annual basis over a four-year period beginning on February 1, 2023, and (vi) 2,462 shares held by the Company’s ESOP and allocated to Mr. Legato’s account. Mr. Legato has the right to direct the ESOP trustee to vote the shares owned by the Company’s ESOP and allocated to his account on all matters requiring the vote of our shareholders and as a ESOP participant, Mr. Legato may be deemed the beneficial owner of such shares. |
(9) | Includes (i) options to purchase 3,000 shares of common stock, and (ii) 2,000 shares of restricted stock held by Mr. McDonald individually, which will vest in equal increments on an annual basis over a two-year period beginning November 8, 2022. |
(10) | Includes (i) 87,547 shares held by Mr. McWhorter individually, (ii) 55,538 shares held by Mr. McWhorter’s individual retirement account, (iii) 61,343 shares held by Richard and Amy McWhorter Management Trust of which Mr. McWhorter serves as the trustee, (iv) options to purchase 5,400 shares of common stock, (v) 2,385 shares held by the Company’s ESOP and allocated to Mr. McWhorter’s account, (vi) 6,750 shares of restricted stock held by Mr. McWhorter individually, which will vest in equal increments on an annual basis over a three-year period beginning on November 8, 2022, and (v) 4,000 shares of restricted stock held by Mr. McWhorter individually, which will vest in equal increments on an annual basis over a four-year period beginning February 1, 2023. Mr. McWhorter has the right to direct the ESOP trustee to vote the shares owned by the Company’s ESOP and allocated to his account on all matters requiring the vote of our shareholders and as a ESOP participant, Mr. McWhorter may be deemed the beneficial owner of such shares. |
(11) | Includes (i) 128,167 shares of common stock held by The Stunja Family Trust of which Mr. Stunja serves as the trustee, (ii) organizer warrants to purchase 857 shares of common stock held by The Stunja Family Trust of which Mr. Stunja serves as the trustee, (iii) options to purchase 15,750 shares of common stock, and (iv) 2,000 shares of restricted stock held by Mr. Stunja directly, which will vest in equal increments on an annual basis over a two-year period beginning on November 8, 2022. |
(12) | Includes (i) 35,081 shares held by Mr. Swinbank individually, (ii) 20,833 shares held by RTS Family LP of which Mr. Swinbank is a partner, (iii) options to purchase 3,000 shares of common stock, and (iv) 2,000 shares of restricted stock held by Mr. Swinbank individually, which will vest in equal increments on an annual basis over a two-year period beginning on November 8, 2022. |
(13) | Includes (i) options held by a director or executive officer to purchase 345,550 shares of common stock, and (ii) warrants held by a director, executive officer, or entity in which a director is a principal to purchase 3,428 shares of common stock. Shares beneficially owned also include 9,354 shares held by the Company’s ESOP and allocated to our directors’ and executive officers’ accounts. Each ESOP participant has the right to direct the ESOP trustee to vote the shares allocated to his or her account on all matters requiring the vote of our shareholders and as a ESOP participant, our directors and executive officers may be deemed the |
beneficial owner of such shares. Shares beneficially owned also include 45,750 shares of restricted stock, which were granted to our directors and executive officers in connection with the completion of our initial public offering in November of 2021. The shares of restricted stock awarded to our executive officers will vest in equal increments on an annual basis over a three-year period beginning on November 8, 2022. The shares of restricted stock awarded to our directors, other than Mr. Caraway, will vest in equal increments on an annual basis over a two-year period beginning on November 8, 2022. Shares beneficially owned also include 18,000 shares of restricted stock, which will vest in equal increments on an annual basis over a four-year period beginning February 1, 2023. |
(14) | Percentages are based on 13,445,782 shares of common stock issued and outstanding at March 28, 2022. For purposes of computing the percentage of outstanding shares of common stock held by any individual listed in this table, any shares of common stock that such person has the right to acquire pursuant to the exercise of a stock option that are exercisable or will vest within 60 days of March 28, 2022 are deemed to be outstanding, but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other person. |
Page |
||||
B-2 | ||||
B-3 | ||||
B-4 | ||||
B-5 | ||||
B-6 | ||||
B-8 | ||||
B-50 | ||||
B-51 | ||||
B-52 | ||||
B-53 | ||||
B-54 | ||||
B-55 | ||||
B-57 | ||||
|
(Dollars in thousands, except share and per share data) |
March 31, 2022 |
December 31, 2021 |
||||||
ASSETS |
(unaudited) |
|||||||
Cash and cash equivalents: |
||||||||
Cash and due from banks |
$ |
$ | ||||||
Federal funds sold |
||||||||
|
|
|
|
|||||
Total cash and cash equivalents |
||||||||
Interest bearing time deposits in other banks |
||||||||
Investment securities available for sale |
||||||||
Loans, net of allowance for loan loss of $ |
||||||||
Accrued interest receivable |
||||||||
Premises and equipment, net |
||||||||
Other real estate owned |
||||||||
Bank-owned life insurance |
||||||||
Non-marketable equity securities, at cost |
||||||||
Deferred tax asset, net |
||||||||
Core Deposit Intangible, net |
||||||||
Goodwill |
||||||||
Other assets |
||||||||
|
|
|
|
|||||
Total assets |
$ |
$ | ||||||
|
|
|
|
|||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||||
Deposits: |
||||||||
Noninterest bearing |
$ |
$ | ||||||
Interest bearing |
||||||||
|
|
|
|
|||||
Total deposits |
||||||||
Accrued interest payable |
||||||||
Other liabilities |
||||||||
FHLB advances |
||||||||
Line of credit—Senior Debt |
||||||||
Note payable—Subordinated Debt, net |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
Shareholders’ equity: |
||||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Retained earnings |
||||||||
Accumulated other comprehensive income |
||||||||
Treasury stock: at cost; |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Total shareholders’ equity |
||||||||
|
|
|
|
|||||
Total liabilities & shareholders’ equity |
$ |
$ | ||||||
|
|
|
|
For the Three Months Ended March 31, |
||||||||
(Dollars in thousands, except share and per share data) |
2022 |
2021 | ||||||
Interest income: |
||||||||
Loans, including fees |
$ |
$ | ||||||
Investment securities available-for-sale |
||||||||
Federal funds sold and deposits in other banks |
||||||||
|
|
|
|
|||||
Total interest income |
||||||||
Interest expense: |
||||||||
Deposit accounts |
||||||||
FHLB advances and notes payable |
||||||||
|
|
|
|
|||||
Total interest expense |
||||||||
|
|
|
|
|||||
Net interest income |
||||||||
Provision for loan losses |
||||||||
|
|
|
|
|||||
Net interest income after provision for loan losses |
||||||||
Noninterest income: |
||||||||
Services charges and fees |
||||||||
Other |
||||||||
|
|
|
|
|||||
Total noninterest income |
||||||||
Noninterest expense: |
||||||||
Salaries and employee benefits |
||||||||
Data processing and network expense |
||||||||
Occupancy and equipment expense |
||||||||
Legal and professional |
||||||||
Loan operations and other real estate owned expense |
||||||||
Advertising and marketing |
||||||||
Telephone and communications |
||||||||
Software purchases and maintenance |
||||||||
Regulatory assessments |
||||||||
Loss on sale of other real estate owned |
||||||||
Other |
||||||||
|
|
|
|
|||||
Total noninterest expense |
||||||||
|
|
|
|
|||||
Net income before income tax expense |
||||||||
Income tax expense |
||||||||
|
|
|
|
|||||
Net income |
$ |
$ | ||||||
|
|
|
|
|||||
Earnings per common share: |
||||||||
Basic earnings per share |
$ |
$ | ||||||
|
|
|
|
|||||
Diluted earnings per share |
$ |
$ | ||||||
|
|
|
|
For the Three Months Ended March 31, |
||||||||
(Dollars in thousands) |
2022 |
2021 | ||||||
Net Income |
$ |
$ | ||||||
Other comprehensive income: |
||||||||
Unrealized gain on securities: |
||||||||
Unrealized holding loss arising during the period |
( |
) |
( |
) | ||||
Income tax benefit |
||||||||
|
|
|
|
|||||
Other comprehensive loss on securities |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Unrealized gain (loss) on derivatives: |
||||||||
Unrealized holding loss arising during the period |
( |
) | ||||||
Unrealized gain on termination fee from derivatives |
||||||||
Reclassification adjustment for accretion recorded in interest expense during the period |
( |
) |
( |
) | ||||
Income tax benefit (expense) |
( |
) | ||||||
|
|
|
|
|||||
Other comprehensive (loss) income on derivatives |
( |
) |
||||||
|
|
|
|
|||||
Total other comprehensive (loss) income |
( |
) | ||||||
|
|
|
|
|||||
Total comprehensive income |
$ |
$ | ||||||
|
|
|
|
(Dollars in thousands) |
Common Stock |
Additional Paid in Capital |
Retained Earnings |
Accumulated Other Comprehensive Income (Loss) |
Treasury Stock |
Less: ESOP- Owned Shares |
Total |
|||||||||||||||||||||
Balance, December 31, 2020 |
$ | $ | $ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Share-based compensation |
— | — | — | — | — | |||||||||||||||||||||||
Stock options exercised |
— | — | — | — | ||||||||||||||||||||||||
Issuance of common stock to ESOP |
— | — | — | ( |
) | — | ||||||||||||||||||||||
Net change in fair value of ESOP shares |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Other comprehensive income, net of tax |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance, March 31, 2021 |
$ | $ | $ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
(Dollars in thousands) |
||||||||||||||||||||||||||||
Balance, December 31, 2021 |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
— |
$ |
||||||||||||||||||
Net income |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Share-based compensation |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Stock options exercised |
— |
— |
— |
— |
||||||||||||||||||||||||
Issuance of common stock to ESOP |
— |
— |
— |
— |
||||||||||||||||||||||||
Restricted stock grants |
( |
) |
— |
— |
— |
— |
— |
|||||||||||||||||||||
Other comprehensive loss, net of tax |
— |
— |
— |
( |
) |
— |
— |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance, March 31, 2022 |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
— |
$ |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended March 31, |
||||||||
(Dollars in thousands) |
2022 |
2021 | ||||||
Cash flows from operating activities: |
||||||||
Net income |
$ |
$ | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Provision for loan losses |
||||||||
Share based compensation expense |
||||||||
Loss on sale of other real estate owned |
— |
|||||||
Amortization of premium on securities, net |
||||||||
Accretion of fees on derivative instruments |
( |
) |
( |
) | ||||
Accretion of SBA Paycheck Protection Program Fees |
( |
) |
( |
) | ||||
Depreciation, amortization and accretion |
( |
) |
||||||
Earnings on bank-owned life insurance |
( |
) |
( |
) | ||||
Changes in operating assets and liabilities: |
||||||||
Proceeds from sale of loans held for sale |
— |
|||||||
Accrued interest receivable and other assets |
( |
) |
||||||
Accrued interest payable and other liabilities |
||||||||
Net cash provided by operating activities |
||||||||
Cash flows from investing activities: |
||||||||
Net increase in interest bearing deposits in other banks |
— |
( |
) | |||||
Increase in non-marketable equity securities |
( |
) |
( |
) | ||||
Investment securities available-for-sale |
||||||||
Purchases |
( |
) |
— | |||||
Maturities, calls and principal paydowns |
||||||||
Termination fee proceeds from derivative instruments |
— |
|||||||
Net originations on loans held for investment |
( |
) |
( |
) | ||||
Net additions to bank premises and equipment |
( |
) |
( |
) | ||||
Deposit proceeds from pending sales of foreclosed assets |
— | |||||||
Proceeds from sales of foreclosed assets |
— |
|||||||
Net cash used in investing activities |
( |
) |
( |
) | ||||
Cash flows from financing activities: |
||||||||
Net increase in deposits |
||||||||
Net repayment of FHLB Advances |
— |
( |
) | |||||
Proceeds from subordinated debt offering |
— | |||||||
Repayment of notes payable |
— |
( |
) | |||||
Proceeds from issuance of common stock—ESOP Contributions |
||||||||
Proceeds from stock options exercised |
||||||||
Net cash provided by financing activities |
||||||||
Increase in cash and cash equivalents |
||||||||
Cash and cash equivalents at beginning of period |
||||||||
Cash and cash equivalents at end of period |
$ |
$ | ||||||
For the Three Months Ended March 31, |
||||||||
(Dollars in thousands) |
2022 |
2021 | ||||||
Supplemental Disclosures of Cash Flow Information: |
||||||||
Cash paid for interest |
$ |
$ | ||||||
Cash paid for income taxes |
$ |
— |
$ | |||||
Supplemental Disclosure of Noncash Investing and Financing Activities: |
||||||||
Initial recognition of lease liability |
$ |
$ | — | |||||
Net increase in fair value of ESOP-owned shares |
$ |
— |
$ | ( |
) |
1. |
Nature of Operations and Summary of Significant Accounting Policies |
2. |
Investment Securities Available for Sale |
March 31, 2022 |
||||||||||||||||
(Dollars in thousands) |
Amortized Cost |
Gross Unrealized Gains |
Gross Unrealized Losses |
Estimated Fair Value |
||||||||||||
Securities available-for-sale: |
||||||||||||||||
State and municipal securities |
$ |
$ |
— |
$ |
$ |
|||||||||||
Mortgage-backed securities |
||||||||||||||||
U.S. Treasury bonds |
— |
|||||||||||||||
Corporate bonds |
||||||||||||||||
$ |
$ |
$ |
$ |
|||||||||||||
December 31, 2021 | ||||||||||||||||
(Dollars in thousands) |
Amortized Cost |
Gross Unrealized Gains |
Gross Unrealized Losses |
Estimated Fair Value |
||||||||||||
Securities Available-for-sale: |
||||||||||||||||
State and municipal securities |
$ | $ | $ | — | $ | |||||||||||
Mortgage-backed securities |
— | |||||||||||||||
Corporate bonds |
||||||||||||||||
$ | $ | $ | $ | |||||||||||||
March 31, 2022 |
||||||||
Securities Available for Sale |
||||||||
(Dollars in thousands) |
Amortized Cost |
Estimated Fair Value |
||||||
Due in one year or less |
$ |
$ |
||||||
Due from one year to five years |
||||||||
Due from five to ten years |
||||||||
Mortgage-backed securities |
||||||||
$ |
$ |
|||||||
March 31, 2022 |
||||||||||||||||
(Dollars in thousands) |
Less Than 12 Months in a Loss Position |
Greater Than 12 Months in a Loss Position |
Total Unrealized Loss |
Estimated Fair Value |
||||||||||||
Securities available-for-sale: |
||||||||||||||||
State and municipal securities |
$ |
$ |
— |
$ |
$ |
|||||||||||
Mortgage-backed securities |
— |
|||||||||||||||
Corporate bonds |
— |
|||||||||||||||
$ |
$ |
— |
$ |
$ |
||||||||||||
December 31, 2021 | ||||||||||||||||
(Dollars in thousands) |
Less Than 12 Months in a Loss Position |
Greater Than 12 Months in a Loss Position |
Total Unrealized Loss |
Estimated Fair Value |
||||||||||||
Securities available-for-sale: |
||||||||||||||||
Corporate bonds |
$ | — | $ | $ | $ | |||||||||||
$ | — | $ | $ | $ | ||||||||||||
3. |
Loans and Allowance for Loan Losses |
March 31, |
December 31, | |||||||
(Dollars in thousands) |
2022 |
2021 | ||||||
Real estate loans: |
||||||||
Non-farm non-residential owner occupied |
$ |
$ | ||||||
Non-farm non-residential non-owner occupied |
||||||||
Residential |
||||||||
Construction, development & other |
||||||||
Farmland |
||||||||
Commercial & industrial |
||||||||
Consumer |
||||||||
Other |
||||||||
Allowance for loan losses |
( |
) |
( |
) | ||||
Loans, net |
$ |
$ | ||||||
March 31, |
December 31, | |||||||||||||||
2022 |
2021 | |||||||||||||||
(Dollars in thousands) |
Non-accrual |
Accruing loans past due more than 90 days |
Non-accrual |
Accruing loans past due more than 90 days |
||||||||||||
Real estate loans: |
||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
— |
$ | $ | — | ||||||||||
Non-farm non-residential non-owner occupied |
— |
— | ||||||||||||||
Residential |
— |
— | ||||||||||||||
Construction, development & other |
— |
— | ||||||||||||||
Farmland |
— |
— |
— | — | ||||||||||||
Commercial & industrial |
||||||||||||||||
Consumer |
— |
— |
— | — | ||||||||||||
Other |
— |
— |
— | — | ||||||||||||
Purchased credit impaired |
— |
— | ||||||||||||||
$ |
$ |
$ | $ | |||||||||||||
March 31, 2022 |
||||||||||||||||||||||||
(Dollars in thousands) |
30-59 days |
60-89 days |
Over 90 days |
Total past due |
Total current |
Total loans |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
Non-farm non-residential non-owner occupied |
||||||||||||||||||||||||
Residential |
— |
|||||||||||||||||||||||
Construction, development & other |
— |
|||||||||||||||||||||||
Farmland |
— |
— |
— |
— |
||||||||||||||||||||
Commercial & industrial |
||||||||||||||||||||||||
Consumer |
— |
— |
||||||||||||||||||||||
Other |
— |
— |
||||||||||||||||||||||
Purchased credit impaired |
— |
— |
||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||
December 31, 2021 | ||||||||||||||||||||||||
(Dollars in thousands) |
30-59 days |
60-89 days |
Over 90 days |
Total past due |
Total current |
Total loans |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | — | $ | $ | $ | $ | |||||||||||||||||
Non-farm non-residential non-owner occupied |
— | |||||||||||||||||||||||
Residential |
— | |||||||||||||||||||||||
Construction, development & other |
— | |||||||||||||||||||||||
Farmland |
— | — | — | — | ||||||||||||||||||||
Commercial & industrial |
||||||||||||||||||||||||
Consumer |
— | — | ||||||||||||||||||||||
Other |
— | |||||||||||||||||||||||
Purchased credit impaired |
— | — | ||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | |||||||||||||||||||
March 31, 2022 |
||||||||||||||||||||||||
(Dollars in thousands) |
Unpaid contractual principal balance |
Recorded investment with no allowance |
Recorded investment with allowance |
Total recorded investment |
Related allowance |
Average recorded investment during period |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
$ |
— |
$ |
$ |
— |
$ |
||||||||||||||||
Non-farm non-residential non-owner occupied |
— |
— |
||||||||||||||||||||||
Residential |
— |
— |
||||||||||||||||||||||
Construction, development & other |
— |
— |
||||||||||||||||||||||
Farmland |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Commercial & industrial |
||||||||||||||||||||||||
Consumer |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Other |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Purchased credit impaired |
— |
|||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||
December 31, 2021 | ||||||||||||||||||||||||
(Dollars in thousands) |
Unpaid contractual principal balance |
Recorded investment with no allowance |
Recorded investment with allowance |
Total recorded investment |
Related allowance |
Average recorded investment during year |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | $ | — | $ | $ | — | $ | ||||||||||||||||
Non-farm non-residential non-owner occupied |
— | — | ||||||||||||||||||||||
Residential |
— | — | ||||||||||||||||||||||
Construction, development & other |
— | — | ||||||||||||||||||||||
Farmland |
— | — | — | — | — | — | ||||||||||||||||||
Commercial & industrial |
||||||||||||||||||||||||
Consumer |
— | — | — | — | — | — | ||||||||||||||||||
Other |
— | — | — | — | — | — | ||||||||||||||||||
Purchased credit impaired |
— | |||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | |||||||||||||||||||
March 31, 2022 |
||||||||||||||||||||||||
Loan modifications |
||||||||||||||||||||||||
(Dollars in thousands) |
Number of loans |
Pre- restructuring recorded investment |
Post- restructuring recorded investment |
Adjusted interest rate |
Payment deferral |
Combined rate and payment deferral |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
$ |
— |
$ |
$ |
— |
|||||||||||||||||
Non-farm non-residential non-owner occupied |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Residential |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Construction, development & other |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Farmland |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Commercial & industrial |
— |
— |
||||||||||||||||||||||
Consumer |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Other |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
$ |
$ |
$ |
— |
$ |
$ |
— |
||||||||||||||||||
December 31, 2021 | ||||||||||||||||||||||||
Loan modifications | ||||||||||||||||||||||||
(Dollars in thousands) |
Number of loans |
Pre- restructuring recorded investment |
Post- restructuring recorded investment |
Adjusted interest rate |
Payment deferral |
Combined rate and payment deferral |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | $ | — | $ | $ | — | |||||||||||||||||
Non-farm non-residential non-owner occupied |
— | — | — | — | — | — | ||||||||||||||||||
Residential |
— | — | — | — | — | — | ||||||||||||||||||
Construction, development & other |
— | — | — | — | — | — | ||||||||||||||||||
Farmland |
— | — | — | — | — | — | ||||||||||||||||||
Commercial & industrial |
— | — | ||||||||||||||||||||||
Consumer |
— | — | — | — | — | — | ||||||||||||||||||
Other |
— | — | — | — | — | — | ||||||||||||||||||
$ | $ | $ | — | $ | $ | — | ||||||||||||||||||
March 31, 2022 |
||||||||||||||||||||||||
(Dollars in thousands) |
Pass |
Special Mention |
Substandard |
Purchased Credit Impaired |
Doubtful |
Total |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
$ |
$ |
— |
$ |
— |
$ |
||||||||||||||||
Non-farm non-residential non-owner occupied |
— |
— |
||||||||||||||||||||||
Residential |
— |
— |
— |
|||||||||||||||||||||
Construction, development & other |
— |
— |
||||||||||||||||||||||
Farmland |
— |
— |
— |
— |
||||||||||||||||||||
Commercial & industrial |
— |
— |
||||||||||||||||||||||
Consumer |
— |
— |
— |
|||||||||||||||||||||
Other |
— |
— |
— |
|||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
— |
$ |
||||||||||||||||||
December 31, 2021 | ||||||||||||||||||||||||
(Dollars in thousands) |
Pass | Special Mention |
Substandard | Purchased Credit Impaired |
Doubtful | Total | ||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | $ | $ | — | $ | — | $ | ||||||||||||||||
Non-farm non-residential non-owner occupied |
— | |||||||||||||||||||||||
Residential |
— | — | ||||||||||||||||||||||
Construction, development & other |
— | — | ||||||||||||||||||||||
Farmland |
— | — | — | — | ||||||||||||||||||||
Commercial & industrial |
— | |||||||||||||||||||||||
Consumer |
— | — | — | |||||||||||||||||||||
Other |
— | — | — | — | ||||||||||||||||||||
$ | $ | $ | $ | $ | — | $ | ||||||||||||||||||
For the Three Months Ended March 31, 2022 |
||||||||||||||||||||
(Dollars in thousands) |
Beginning balance |
Provision for loan losses |
Charge- offs |
Recoveries |
Ending balance |
|||||||||||||||
Real estate loans: |
||||||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
$ |
— |
$ |
— |
$ |
|||||||||||||
Non-farm non-residential non-owner occupied |
( |
) |
— |
— |
||||||||||||||||
Residential |
( |
) |
— |
— |
||||||||||||||||
Construction, development & other |
— |
— |
||||||||||||||||||
Farmland |
( |
) |
— |
— |
||||||||||||||||
Commercial & industrial |
— |
|||||||||||||||||||
Consumer |
( |
) |
— |
|||||||||||||||||
Other |
( |
) |
— |
— |
||||||||||||||||
$ |
$ |
$ |
— |
$ |
$ |
|||||||||||||||
For the Three Months Ended March 31, 2021 | ||||||||||||||||||||
(Dollars in thousands) |
Beginning balance |
Provision for loan losses |
Charge- offs |
Recoveries | Ending balance |
|||||||||||||||
Real estate loans: |
||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | $ | — | $ | — | $ | |||||||||||||
Non-farm non-residential non-owner occupied |
— | — | ||||||||||||||||||
Residential |
( |
) | — | — | ||||||||||||||||
Construction, development & other |
( |
) | — | — | ||||||||||||||||
Farmland |
— | — | — | |||||||||||||||||
Commercial & industrial |
( |
) | — | |||||||||||||||||
Consumer |
( |
) | — | — | ||||||||||||||||
Other |
( |
) | ||||||||||||||||||
$ | $ | $ | ( |
) | $ | $ | ||||||||||||||
March 31, 2022 |
||||||||||||||||
Period end amounts of ALLL allocated to loans evaluated for impairment: |
||||||||||||||||
(Dollars in thousands) |
Individually |
Collectively |
PCI |
Total |
||||||||||||
Real estate loans: |
||||||||||||||||
Non-farm non-residential owner occupied |
$ |
— |
$ |
$ |
— |
$ |
||||||||||
Non-farm non-residential non-owner occupied |
— |
— |
||||||||||||||
Residential |
— |
— |
||||||||||||||
Construction, development & other |
— |
— |
||||||||||||||
Farmland |
— |
— |
||||||||||||||
Commercial & industrial |
||||||||||||||||
Consumer |
— |
— |
||||||||||||||
Other |
— |
— |
||||||||||||||
$ |
$ |
$ |
$ |
|||||||||||||
December 31, 2021 | ||||||||||||||||
Period end amounts of ALLL allocated to loans evaluated for impairment: |
||||||||||||||||
(Dollars in thousands) |
Individually | Collectively | PCI | Total | ||||||||||||
Real estate loans: |
||||||||||||||||
Non-farm non-residential owner occupied |
$ | — | $ | $ | — | $ | ||||||||||
Non-farm non-residential non-owner occupied |
— | — | ||||||||||||||
Residential |
— | — | ||||||||||||||
Construction, development & other |
— | — | ||||||||||||||
Farmland |
— | — | ||||||||||||||
Commercial & industrial |
||||||||||||||||
Consumer |
— | — | ||||||||||||||
Other |
— | — | ||||||||||||||
$ | $ | $ | $ | |||||||||||||
March 31, 2022 |
||||||||||||||||
Loans evaluated for impairment: |
||||||||||||||||
(Dollars in thousands) |
Individually |
Collectively |
PCI |
Total |
||||||||||||
Real estate loans: |
||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
$ |
— |
$ |
|||||||||||
Non-farm non-residential non-owner occupied |
— |
|||||||||||||||
Residential |
— |
|||||||||||||||
Construction, development & other |
— |
|||||||||||||||
Farmland |
— |
— |
||||||||||||||
Commercial & industrial |
||||||||||||||||
Consumer |
— |
— |
||||||||||||||
Other |
— |
— |
||||||||||||||
$ |
$ |
$ |
$ |
|||||||||||||
December 31, 2021 | ||||||||||||||||
Loans evaluated for impairment: |
||||||||||||||||
(Dollars in thousands) |
Individually | Collectively | PCI | Total | ||||||||||||
Real estate loans: |
||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | — | $ | ||||||||||||
Non-farm non-residential non-owner occupied |
— | |||||||||||||||
Residential |
— | |||||||||||||||
Construction, development & other |
— | |||||||||||||||
Farmland |
— | — | ||||||||||||||
Commercial & industrial |
||||||||||||||||
Consumer |
— | — | ||||||||||||||
Other |
— | — | ||||||||||||||
$ | $ | $ | $ | |||||||||||||
Contractual required payments |
$ | |||
Non-accretable difference (expected loss) |
||||
|
|
|||
Cash flows expected to be collected at acquisition |
||||
Accretable yield |
||||
|
|
|||
Basis in acquired Heritage PCI loans |
$ | |||
|
|
(Dollars in thousands) |
March 31, 2022 |
December 31, 2021 |
||||||
Real estate loans: |
||||||||
Non-farm non-residential owner occupied |
$ |
— |
$ | — | ||||
Non-farm non-residential non-owner occupied |
||||||||
Residential |
||||||||
Construction, development & other |
||||||||
Farmland |
— |
— | ||||||
Commercial & industrial |
||||||||
Consumer |
— |
— | ||||||
Other |
— |
— | ||||||
|
|
|
|
|||||
Total outstanding balances |
$ |
$ | ||||||
|
|
|
|
|||||
Carrying amount |
$ |
$ | ||||||
|
|
|
|
(Dollars in thousands) |
March 31, 2022 |
December 31, 2021 |
||||||
Balance at beginning of year |
$ |
$ | ||||||
Accretion of income |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Balance at end of period |
$ |
$ | ||||||
|
|
|
|
4. |
Premises and Equipment |
(Dollars in thousands) |
Estimated Useful Life |
March 31, 2022 |
December 31, 2021 |
|||||||||
Building and building improvements |
|
$ |
$ | |||||||||
Land |
||||||||||||
Equipment |
||||||||||||
Leasehold improvements |
||||||||||||
Furniture and fixtures |
||||||||||||
Construction in process |
||||||||||||
|
|
|
|
|||||||||
Accumulated depreciation |
( |
) |
( |
) | ||||||||
|
|
|
|
|||||||||
$ |
$ | |||||||||||
|
|
|
|
5. |
Deposits |
(Dollars in thousands) |
March 31, 2022 |
December 31, 2021 |
||||||
Transaction accounts: |
||||||||
Noninterest bearing demand accounts |
$ |
$ | ||||||
Interest bearing demand accounts |
||||||||
Savings |
||||||||
|
|
|
|
|||||
Total transaction accounts |
||||||||
Time deposits |
||||||||
|
|
|
|
|||||
Total deposits |
$ |
$ | ||||||
|
|
|
|
2022 (nine months remaining) |
$ | |||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
2027 and thereafter |
||||
$ | ||||
6. |
Income Taxes |
7. |
FHLB Advances and Other Borrowings |
(Dollars in thousands) |
FHLB Advances |
Other Borrowings |
||||||
2022 (nine months remaining) |
$ | — | $ | |||||
2023 |
— | — | ||||||
2024 |
— | — | ||||||
2025 |
— | — | ||||||
2026 |
— | — | ||||||
2027 and thereafter |
||||||||
$ | $ | |||||||
8. |
Stock Options and Warrants |
March 31, 2022 |
December 31, 2021 | |||||||||||||||
(Dollars in thousands, except share and per share data) |
Shares Underlying Options |
Weighted Average Exercise Price |
Shares Underlying Options |
Weighted Average Exercise Price |
||||||||||||
Outstanding at beginning of period |
$ |
$ | ||||||||||||||
Granted during the period |
||||||||||||||||
Forfeited during the period |
( |
) |
( |
) | ||||||||||||
Exercised during the period |
( |
) |
( |
) | ||||||||||||
Outstanding at the end of period |
$ |
$ | ||||||||||||||
Options exercisable at end of period |
$ |
$ | ||||||||||||||
Weighted-average grant date fair value of options granted during the period |
$ |
$ |
(Dollars in thousands, except share and per share data) |
March 31, 2022 |
December 31, 2021 | ||||||||||||||||||||||
Exercise Price |
Options Outstanding |
Weighted Average Remaining Life (years) |
Options Exercisable |
Options Outstanding |
Weighted Average Remaining Life (years) |
Options Exercisable |
||||||||||||||||||
$ |
||||||||||||||||||||||||
$ |
||||||||||||||||||||||||
$ |
||||||||||||||||||||||||
March 31, 2022 |
December 31, 2021 | |||||||||||||||
(Dollars in thousands, except share and per share data) |
Shares |
Weighted Average Grant Date Fair Value |
Shares | Weighted Average Grant Date Fair Value |
||||||||||||
Nonvested at January 1, |
$ |
$ | ||||||||||||||
Granted during the period |
||||||||||||||||
Vested during the period |
( |
) |
( |
) | ||||||||||||
Forfeited during the period |
( |
) |
( |
) | ||||||||||||
Nonvested at end of period |
$ |
$ | ||||||||||||||
March 31, 2022 |
December 31, 2021 | |||||||||||||||
(Dollars in thousands, except share and per share data) |
Shares Underlying Warrants |
Weighted- Average Exercise Price |
Shares Underlying Warrants |
Weighted- Average Exercise Price |
||||||||||||
Outstanding at beginning of period |
$ |
$ | ||||||||||||||
Granted |
||||||||||||||||
Exercised |
( |
) | ||||||||||||||
Expired or forfeited |
— |
— | ||||||||||||||
Outstanding at end of period |
$ |
$ | ||||||||||||||
Exercisable at end of period |
$ |
$ | ||||||||||||||
March 31, 2022 |
December 31, 2021 | |||||||||||||||
(Dollars in thousands, except share and per share data) |
Shares |
Weighted Average Grant Date Fair Value |
Shares | Weighted Average Grant Date Fair Value |
||||||||||||
Nonvested at beginning of period |
$ |
$ | ||||||||||||||
Granted during the period |
||||||||||||||||
Vested during the period |
||||||||||||||||
Forfeited during the period |
||||||||||||||||
Nonvested at the end of period |
$ |
$ | ||||||||||||||
9. |
Leases |
(Dollars in thousands) |
March 31, 2022 |
|||
Operating lease cost |
$ | |||
Short-term lease cost |
||||
Total lease cost |
$ | |||
(Dollars in thousands) |
March 31, 2022 |
|||
2022 (nine months remaining) |
$ | |||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
2027 and thereafter |
||||
Total undiscounted lease liability |
||||
Less: |
||||
Discount on cash flows |
( |
) | ||
Lease signed, but not yet commenced |
( |
) | ||
Total operating lease liability |
$ | |||
10. |
Financial Instruments with Off-Balance Sheet Risk |
(Dollars in thousands) |
March 31, 2022 |
December 31, 2021 |
||||||
Commitments to extend credit |
$ |
$ | ||||||
Standby letters of credit |
||||||||
Total |
$ |
$ | ||||||
11. |
Fair Value Measurements |
• | Level 1 Inputs – |
• | Level 2 Inputs |
active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (for example, interest rates, volatilities, prepayment speeds, loss severities, credit risks and default rates) or inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 2 investments consist primarily of obligations of U.S. government sponsored enterprises and agencies, obligations of state and municipal subdivisions, corporate bonds and mortgage backed securities. |
• | Level 3 Inputs |
Fair Value Measurements Using |
||||||||||||||||
(Dollars in thousands) |
Level 1 Inputs |
Level 2 Inputs |
Level 3 Inputs |
Total Fair Value |
||||||||||||
At March 31, 2022: |
||||||||||||||||
Securities available for sale: |
||||||||||||||||
State and municipal securities |
$ |
— |
$ |
$ |
— |
$ |
||||||||||
Mortgage-backed securities |
— |
— |
||||||||||||||
U.S. Treasury bonds |
— |
— |
||||||||||||||
Corporate bonds |
— |
— |
||||||||||||||
Total investment securities available for sale |
$ |
— |
$ |
$ |
— |
$ |
||||||||||
Asset derivatives: |
||||||||||||||||
Interest rate swaps |
$ |
— |
$ |
$ |
— |
$ |
||||||||||
Risk participation agreements |
— |
— |
||||||||||||||
Total asset derivatives |
$ |
— |
$ |
$ |
— |
$ |
||||||||||
Liability derivatives: |
||||||||||||||||
Interest rate swaps |
$ |
— |
$ |
$ |
— |
$ |
||||||||||
Risk participation agreements |
— |
— |
||||||||||||||
Total liability derivatives |
$ |
— |
$ |
$ |
— |
$ |
||||||||||
Fair Value Measurements Using |
||||||||||||||||
(Dollars in thousands) |
Level 1 Inputs |
Level 2 Inputs |
Level 3 Inputs |
Total Fair Value |
||||||||||||
At December 31, 2021: |
||||||||||||||||
Securities available for sale: |
||||||||||||||||
State and municipal securities |
$ | — | $ | $ | — | $ | ||||||||||
Mortgage-backed securities |
— | — | ||||||||||||||
Corporate bonds |
— | — | ||||||||||||||
Total investment securities available for sale |
$ | — | $ | $ | — | $ | ||||||||||
Loans held for sale: |
$ | — | $ | — | $ | $ | ||||||||||
Asset derivatives: |
||||||||||||||||
Interest rate swaps |
$ | — | $ | $ | — | $ | ||||||||||
Total asset derivatives |
$ | — | $ | $ | — | $ | ||||||||||
Liability derivatives: |
||||||||||||||||
Interest rate swaps |
$ | — | $ | $ | — | $ | ||||||||||
Total liability derivatives |
$ | — | $ | $ | — | $ | ||||||||||
(Dollars in thousands) |
March 31, 2022 |
December 31, 2021 |
||||||
Foreclosed assets remeasured subsequent to initial recognition: |
||||||||
Carrying value of foreclosed assets prior to remeasurement |
$ |
$ | ||||||
Write downs included in other non-interest expense |
— |
— | ||||||
Fair value of foreclosed assets remeasured subsequent to initial recognition |
$ |
$ | ||||||
March 31, 2022 |
December 31, 2021 | |||||||||||||||
(Dollars in thousands) |
Carrying Value |
Estimated Fair Value |
Carrying Value |
Estimated Fair Value |
||||||||||||
Financial assets |
||||||||||||||||
Level 2 inputs |
||||||||||||||||
Cash and cash equivalents |
$ |
$ |
$ | $ | ||||||||||||
Interest bearing time deposits in other banks |
||||||||||||||||
Investment securities available for sale |
||||||||||||||||
Non-marketable securities |
||||||||||||||||
Accrued interest receivable |
||||||||||||||||
Bank-owned life insurance |
||||||||||||||||
Derivative instruments assets |
||||||||||||||||
$ |
$ |
$ | $ | |||||||||||||
Level 3 inputs |
||||||||||||||||
Loans, including held for sale, net |
$ |
$ |
$ | $ | ||||||||||||
Financial liabilities |
||||||||||||||||
Level 2 inputs |
||||||||||||||||
Deposits |
$ |
$ |
$ | $ | ||||||||||||
Accrued interest payable |
||||||||||||||||
FHLB advances |
||||||||||||||||
Notes payable |
||||||||||||||||
Derivative instrument liabilities |
||||||||||||||||
$ |
$ |
$ | $ |
12. |
Significant Group Concentrations of Credit Risk |
13. |
Employee Benefit Plans |
14. |
Related Party Transactions |
15. |
Shareholders’ Equity and Regulatory Matters |
Actual |
|
For Capital Adequacy Purposes Basel III Fully Phased-In (2) |
To Be Well Capitalized Under Prompt Corrective Action Provisions |
|||||||||||||||||||||||||||||||||||||
Amount |
Ratio |
Amount |
Ratio |
Amount |
Ratio |
|||||||||||||||||||||||||||||||||||
As of March 31, 2022: |
||||||||||||||||||||||||||||||||||||||||
Total capital (to risk weighted assets) |
$ |
% |
≥ | $ |
≥ | % |
≥ | $ |
≥ | % | ||||||||||||||||||||||||||||||
Tier I capital (to risk weighted assets) |
$ |
% |
≥ | $ |
≥ | % |
≥ | $ |
≥ | % | ||||||||||||||||||||||||||||||
Tier I capital (to average assets) (1) |
$ |
% |
≥ | $ |
≥ | % |
≥ | $ |
≥ | % | ||||||||||||||||||||||||||||||
Common equity tier 1 (to risk weighted assets) |
$ |
% |
≥ | $ |
≥ | % |
≥ | $ |
≥ | % | ||||||||||||||||||||||||||||||
As of December 31, 2021: |
||||||||||||||||||||||||||||||||||||||||
Total capital (to risk weighted assets) |
$ | % | ≥ | $ | ≥ | % | ≥ | $ | ≥ | % | ||||||||||||||||||||||||||||||
Tier I capital (to risk weighted assets) |
$ | % | ≥ | $ | ≥ | % | ≥ | $ | ≥ | % | ||||||||||||||||||||||||||||||
Tier I capital (to average assets) (1) |
$ | % | ≥ | $ | ≥ | % | ≥ | $ | ≥ | % | ||||||||||||||||||||||||||||||
Common equity tier 1 (to risk weighted assets) |
$ | % | ≥ | $ | ≥ | % | ≥ | $ | ≥ | % |
(1) | The Tier 1 capital ratio (to average assets) is not impacted by the Basel III Capital Rules; however, the Federal Reserve and the FDIC may require the Bank to maintain a Tier 1 capital ratio (to average assets) above the minimum required. |
(2) | Percentages represent the minimum capital ratios plus, as applicable, the fully phased-in |
16. |
Earnings Per Common Share |
For the Three Months Ended March 31, |
||||||||
(Dollars in thousands, except share and per share data) |
2022 |
2021 | ||||||
Net income available to common shareholders |
$ |
$ | ||||||
|
|
|
|
|||||
Weighted-average shares outstanding for basic earnings per common share |
||||||||
Dilutive effect of stock compensation |
||||||||
|
|
|
|
|||||
Weighted-average shares outstanding for diluted earnings per common share |
||||||||
|
|
|
|
17. |
Derivative Financial Instruments |
(Dollars in thousands) |
Outstanding Notional Balance |
Asset Derivative Fair Value |
Liability Derivative Fair Value |
Pay Rate (1) |
Receive Rate (1) |
Remaining Term (2) |
||||||||||||||||||
March 31, 2022 |
||||||||||||||||||||||||
Pay-fixed interest rate swap (*) |
$ |
— |
$ |
— |
$ |
— |
% |
Funds-H.15 |
||||||||||||||||
Risk participation agreements purchased |
— |
— |
— |
|||||||||||||||||||||
Risk participation agreements sold |
— |
— |
— |
|||||||||||||||||||||
Commercial loan interest rate swaps: |
||||||||||||||||||||||||
Loan customer counterparty |
— |
— |
% |
|||||||||||||||||||||
Financial institution counterparty |
— |
% |
— |
|||||||||||||||||||||
$ |
$ |
$ |
||||||||||||||||||||||
(Dollars in thousands) |
Outstanding Notional Balance |
Asset Derivative Fair Value |
Liability Derivative Fair Value |
Pay Rate (1) |
Receive Rate (1) |
Remaining Term (2) |
||||||||||||||||||
December 31, 2021 |
||||||||||||||||||||||||
Pay-fixed interest rate swap (*) |
$ | — | $ | — | $ | — | % | |
Funds-H.15 |
|||||||||||||||
Commercial loan interest rate swaps: |
||||||||||||||||||||||||
Loan customer counterparty |
— | % | ||||||||||||||||||||||
Financial institution counterparty |
— | % | ||||||||||||||||||||||
$ | $ | $ | ||||||||||||||||||||||
(*) | Facility terminated on February 18, 2021 (see disclosure narrative on cash flow hedge above). |
(1) | Weighted average rate. |
(2) | Weighted average life (in years). |
18. |
Goodwill and Core Deposit Intangible, Net |
(Dollars in thousands) |
CDI Amortization |
|||
2022 (nine months remaining) |
$ |
|||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
2027 and thereafter |
||||
$ |
||||
December 31, |
||||||||
(Dollars in thousands, except share and per share data) |
2021 |
2020 | ||||||
ASSETS |
||||||||
Cash and cash equivalents: |
||||||||
Cash and due from banks |
$ |
$ | ||||||
Federal funds sold |
||||||||
|
|
|
|
|||||
Total cash and cash equivalents |
||||||||
Interest bearing time deposits in other banks |
||||||||
Investment securities available for sale |
||||||||
Loans held for sale |
— |
|||||||
Loans, net of allowance for loan loss of $ |
||||||||
Accrued interest receivable |
||||||||
Premises and equipment, net |
||||||||
Other real estate owned |
||||||||
Bank-owned life insurance |
||||||||
Non-marketable equity securities, at cost |
||||||||
Deferred tax asset, net |
||||||||
Core Deposit Intangible, net |
||||||||
Goodwill |
||||||||
Other assets |
||||||||
|
|
|
|
|||||
Total assets |
$ |
$ | ||||||
|
|
|
|
|||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||||
Deposits: |
||||||||
Noninterest bearing |
$ |
$ | ||||||
Interest bearing |
||||||||
|
|
|
|
|||||
Total deposits |
||||||||
Accrued interest payable |
||||||||
Other liabilities |
||||||||
FHLB advances |
||||||||
Line of credit - Senior Debt |
— | |||||||
Note payable - Senior Debt |
— |
|||||||
Note payable - Subordinated Debt |
— |
|||||||
|
|
|
|
|||||
Total liabilities |
||||||||
Commitments and contingencies - ESOP-owned shares |
— |
|||||||
Shareholders’ equity: |
||||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Retained earnings |
||||||||
Accumulated other comprehensive income |
||||||||
Treasury stock: at cost; |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Less: ESOP-owned shares |
— |
|||||||
|
|
|
|
|||||
Total shareholders’ equity |
||||||||
|
|
|
|
|||||
Total liabilities & shareholders’ equity |
$ |
$ | ||||||
|
|
|
|
For the Years Ended December 31, |
||||||||||||
(Dollars in thousands, except share and per share data) |
2021 |
2020 | 2019 | |||||||||
Interest income: |
||||||||||||
Loans, including fees |
$ |
$ | $ | |||||||||
Investment securities available-for-sale |
||||||||||||
Federal funds sold and other |
||||||||||||
|
|
|
|
|
|
|||||||
Total interest income |
||||||||||||
Interest expense: |
||||||||||||
Deposit accounts |
||||||||||||
FHLB advances and notes payable |
||||||||||||
|
|
|
|
|
|
|||||||
Total interest expense |
||||||||||||
|
|
|
|
|
|
|||||||
Net interest income |
||||||||||||
Provision for loan losses |
||||||||||||
|
|
|
|
|
|
|||||||
Net interest income after provision for loan losses |
||||||||||||
Noninterest income: |
||||||||||||
Services charges and fees |
||||||||||||
Gain on sales of SBA loans |
— | |||||||||||
Other |
||||||||||||
|
|
|
|
|
|
|||||||
Total noninterest income |
||||||||||||
Noninterest expense: |
||||||||||||
Salaries and employee benefits |
||||||||||||
Data processing and network expense |
||||||||||||
Occupancy and equipment expense |
||||||||||||
Legal and professional |
||||||||||||
Loan operations and other real estate owned expense |
||||||||||||
Advertising and marketing |
||||||||||||
Telephone and communications |
||||||||||||
Software purchases and maintenance |
||||||||||||
Regulatory assessments |
||||||||||||
Loss on sale of other real estate owned |
— | |||||||||||
Other |
||||||||||||
|
|
|
|
|
|
|||||||
Total noninterest expense |
||||||||||||
|
|
|
|
|
|
|||||||
Net income before income tax expense |
||||||||||||
Income tax expense |
||||||||||||
|
|
|
|
|
|
|||||||
Net income |
$ |
$ | $ | |||||||||
|
|
|
|
|
|
|||||||
Earnings per common share: |
||||||||||||
Basic earnings per share |
$ |
$ | $ | |||||||||
|
|
|
|
|
|
|||||||
Diluted earnings per share |
$ |
$ | $ | |||||||||
|
|
|
|
|
|
For the Years Ended December 31, |
||||||||||||
(Dollars in thousands) |
2021 |
2020 | 2019 | |||||||||
Net income |
$ |
$ | $ | |||||||||
Other comprehensive income: |
||||||||||||
Unrealized gain on securities: |
||||||||||||
Unrealized holding gains arising during the period |
||||||||||||
Income tax expense |
( |
) |
( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Other comprehensive income on securities |
||||||||||||
|
|
|
|
|
|
|||||||
Unrealized gain on derivatives: |
||||||||||||
Unrealized holding gains (losses) arising during the period |
( |
) |
— | |||||||||
Unrealized gain on termination fee from derivatives |
— | — | ||||||||||
Reclassification adjustment for accretion recorded in interest expense during the period |
( |
) |
— | — | ||||||||
Income tax expense |
( |
) |
( |
) | — | |||||||
|
|
|
|
|
|
|||||||
Other comprehensive income on derivatives |
— | |||||||||||
|
|
|
|
|
|
|||||||
Total other comprehensive income |
||||||||||||
|
|
|
|
|
|
|||||||
Total comprehensive income |
$ |
$ | $ | |||||||||
|
|
|
|
|
|
(Dollars in thousands) |
Common Stock |
Additional Paid in Capital |
Retained Earnings |
Accumulated Other Comprehensive Income (Loss) |
Treasury Stock |
Less: ESOP- Owned Shares |
Total |
|||||||||||||||||||||
Balance, December 31, 2018 |
$ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | |||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Share-based compensation |
— | — | — | — | — | |||||||||||||||||||||||
Stock options exercised |
— | — | — | — | ||||||||||||||||||||||||
Issuance of common stock to ESOP |
— | — | — | ( |
) | — | ||||||||||||||||||||||
Net change in fair value of ESOP shares |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Net redemption of treasury stock |
— | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
Other comprehensive income, net of tax |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance, December 31, 2019 |
$ | $ | $ | $ | — | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
(Dollars in thousands) |
||||||||||||||||||||||||||||
Balance, December 31, 2019 |
$ | $ | $ | $ | — | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Share-based compensation |
— | — | — | — | — | |||||||||||||||||||||||
Stock options exercised |
— | — | — | — | ||||||||||||||||||||||||
Common stock issued for acquisition of Heritage Bancorp, Inc. |
— | — | — | — | ||||||||||||||||||||||||
Issuance of common stock to ESOP |
— | — | — | ( |
) | ( |
) | |||||||||||||||||||||
Net change in fair value of ESOP shares |
— | — | — | — | — | |||||||||||||||||||||||
Net redemption of treasury stock |
— | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
Other comprehensive income, net of tax |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance, December 31, 2020 |
$ | $ | $ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
(Dollars in thousands) |
||||||||||||||||||||||||||||
Balance, December 31, 2020 |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||||||
Net income |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Share-based compensation |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Warrants exercised |
— |
— |
— |
— |
||||||||||||||||||||||||
Stock options exercised |
— |
— |
— |
— |
||||||||||||||||||||||||
Common stock issued from initial public offering |
— |
— |
— |
— |
||||||||||||||||||||||||
Common stock issued from private placement offering |
— |
— |
— |
— |
||||||||||||||||||||||||
Issuance of common stock to ESOP |
— |
— |
— |
( |
) |
— |
||||||||||||||||||||||
Terminated ESOP put option |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Restricted stock grants |
( |
) |
— |
— |
— |
— |
— |
|||||||||||||||||||||
Net change in fair value of ESOP shares |
— |
— |
— |
— |
— |
( |
) |
( |
) | |||||||||||||||||||
Net redemption of treasury stock |
— |
— |
— |
— |
( |
) |
— |
( |
) | |||||||||||||||||||
Other comprehensive income, net of tax |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance, December 31, 2021 |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
— |
$ |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31, |
||||||||||||
(Dollars in thousands) |
2021 |
2020 | 2019 | |||||||||
Cash flows from operating activities: |
||||||||||||
Net income |
$ |
$ | $ | |||||||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
||||||||||||
Provision for loan losses |
||||||||||||
Changes in deferred tax asset, net |
( |
) |
( |
) | ( |
) | ||||||
Share based compensation expense |
||||||||||||
Gain on sale of SBA loans |
( |
) |
( |
) | — | |||||||
Writedown of other real estate owned |
— |
— | ||||||||||
Loss on sale of other real estate owned |
— | |||||||||||
Loss on disposal of fixed assets |
— |
— | ||||||||||
Amortization of premium on securities, net |
||||||||||||
Accretion of fees on derivative instruments |
( |
) |
— | — | ||||||||
Accretion of SBA Paycheck Protection Program fees |
( |
) |
( |
) | — | |||||||
Depreciation, amortization and accretion |
( |
) |
||||||||||
Earnings on bank-owned life insurance |
( |
) |
( |
) | ( |
) | ||||||
Changes in operating assets and liabilities: |
||||||||||||
Originations of loans held for sale |
— |
( |
) | — | ||||||||
Proceeds from sale of loans held for sale |
— | |||||||||||
Accrued interest receivable and other assets |
( |
) | ( |
) | ||||||||
Accrued interest payable and other liabilities |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net cash provided by (used in) operating activities |
( |
) | ||||||||||
Cash flows from investing activities: |
||||||||||||
Net increase in interest bearing deposits in other banks |
( |
) |
— | ( |
) | |||||||
(Increase) decrease in non-marketable equity securities |
( |
) |
( |
) | ||||||||
Investment securities available-for-sale |
||||||||||||
Purchases |
( |
) |
( |
) | ( |
) | ||||||
Maturities, calls and principal paydowns |
||||||||||||
Termination fee proceeds from derivative instruments |
— | — | ||||||||||
Net originations on loans held for investment |
( |
) |
( |
) | ( |
) | ||||||
Net additions to bank premises and equipment |
( |
) |
( |
) | ( |
) | ||||||
Proceeds from disposal of fixed assets |
— |
— | ||||||||||
Construction additions on foreclosed assets |
— |
( |
) | ( |
) | |||||||
Proceeds from sales of foreclosed assets |
— | |||||||||||
Purchase of bank owned life insurance |
— |
( |
) | — | ||||||||
Net cash acquired from acquisition of Heritage Bancorp, Inc. |
— |
— | ||||||||||
|
|
|
|
|
|
|||||||
Net cash used in investing activities |
( |
) |
( |
) | ( |
) | ||||||
Cash flows from financing activities: |
||||||||||||
Net increase in deposits |
||||||||||||
Net (repayment) proceeds from issuance of FHLB Advances |
( |
) |
— | |||||||||
Proceeds from issuance of notes payable |
— |
|||||||||||
Repayment of notes payable |
( |
) |
( |
) | ( |
) | ||||||
Proceeds from issuance of common stock - private placement offering |
— | — | ||||||||||
Proceeds from issuance of common stock - initial public offering |
— | — | ||||||||||
Proceeds from issuance of common stock - ESOP Contributions |
||||||||||||
Proceeds from stock warrants exercised |
— | — | ||||||||||
Proceeds from stock options exercised |
||||||||||||
Net redemption of treasury stock |
( |
) |
( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Net cash provided by financing activities |
||||||||||||
|
|
|
|
|
|
|||||||
Increase in cash and cash equivalents |
( |
) | ||||||||||
Cash and cash equivalents at beginning of period |
||||||||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents at end of period |
$ |
$ | $ | |||||||||
|
|
|
|
|
|
For the Years Ended December 31, |
||||||||||||
(Dollars in thousands) |
2021 |
2020 |
2019 |
|||||||||
Supplemental Disclosures of Cash Flow Information: |
||||||||||||
Cash paid for interest |
$ |
$ | $ | |||||||||
Cash paid for income taxes, net of $ |
$ |
$ | $ | |||||||||
Supplemental Disclosure of Noncash Investing and Financing Activities: |
||||||||||||
Loans transferred to other real estate owned, net |
$ |
— |
$ | $ | ||||||||
Net (increase) decrease in fair value of ESOP-owned shares |
$ |
( |
) |
$ | $ | ( |
) | |||||
Common stock issued for acquisition of Heritage Bancorp, Inc. |
$ |
— |
$ | $ | — | |||||||
Terminated ESOP put option |
$ |
$ | — | $ | — | |||||||
1. |
Nature of Operations and Summary of Significant Accounting Policies |
2. |
Investment Securities Available for Sale |
December 31, 2021 |
||||||||||||||||
(Dollars in thousands) |
Amortized Cost |
Gross Unrealized Gains |
Gross Unrealized Losses |
Estimated Fair Value |
||||||||||||
Securities available-for-sale: |
||||||||||||||||
State and municipal securities |
$ |
$ |
$ |
— |
$ |
|||||||||||
Mortgage-backed securities |
— |
|||||||||||||||
Corporate bonds |
||||||||||||||||
$ |
$ |
$ |
$ |
|||||||||||||
December 31, 2020 | ||||||||||||||||
(Dollars in thousands) |
Amortized Cost |
Gross Unrealized Gains |
Gross Unrealized Losses |
Estimated Fair Value |
||||||||||||
Securities Available-for-sale: |
||||||||||||||||
State and municipal securities |
$ | $ | $ | $ | ||||||||||||
Mortgage-backed securities |
— | |||||||||||||||
Corporate bonds |
||||||||||||||||
$ | $ | $ | $ | |||||||||||||
December 31, 2021 |
||||||||
Securities Available for Sale |
||||||||
(Dollars in thousands) |
Amortized Cost |
Estimated Fair Value |
||||||
Due in one year or less |
$ |
$ |
||||||
Due from one year to five years |
||||||||
Due from five to ten years |
||||||||
Mortgage-backed securities |
||||||||
$ |
$ |
|||||||
December 31, 2021 |
||||||||||||||||
(Dollars in thousands) |
Less Than 12 Months in a Loss Position |
Greater Than 12 Months in a Loss Position |
Total Unrealized Loss |
Estimated Fair Value |
||||||||||||
Securities available-for-sale: |
||||||||||||||||
Corporate bonds |
$ | — | $ | $ | $ | |||||||||||
$ | — | $ | $ | $ | ||||||||||||
December 31, 2020 | ||||||||||||||||
(Dollars in thousands) |
Less Than 12 Months in a Loss Position |
Greater Than 12 Months in a Loss Position |
Total Unrealized Loss |
Estimated Fair Value |
||||||||||||
Securities available-for-sale: |
||||||||||||||||
State and municipal securities |
$ | $ | — | $ | $ | |||||||||||
Corporate bonds |
— | |||||||||||||||
$ | $ | — | $ | $ | ||||||||||||
3. |
Loans and Allowance for Loan Losses |
December 31, |
||||||||
(Dollars in thousands) |
2021 |
2020 | ||||||
Real estate loans: |
||||||||
Non-farm non-residential owner occupied |
$ |
$ | ||||||
Non-farm non-residential non-owner occupied |
||||||||
Residential |
||||||||
Construction, development & other |
||||||||
Farmland |
||||||||
Commercial & industrial |
||||||||
Consumer |
||||||||
Other |
||||||||
Allowance for loan losses |
( |
) |
( |
) | ||||
Loans, net |
$ |
$ | ||||||
December 31, |
||||||||||||||||
2021 |
2020 | |||||||||||||||
(Dollars in thousands) |
Non-accrual |
Accruing loans past due more than 90 days |
Non-accrual |
Accruing loans past due more than 90 days |
||||||||||||
Real estate loans: |
||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
— |
$ | $ | |||||||||||
Non-farm non-residential non-owner occupied |
— |
— | ||||||||||||||
Residential |
— |
|||||||||||||||
Construction, development & other |
— |
— | ||||||||||||||
Farmland |
— |
— |
— | — | ||||||||||||
Commercial & industrial |
— | |||||||||||||||
Consumer |
— |
— |
— | — | ||||||||||||
Other |
— |
— |
— | — | ||||||||||||
Purchased credit impaired |
— |
— | ||||||||||||||
$ |
$ |
$ | $ | |||||||||||||
December 31, 2021 |
||||||||||||||||||||||||
(Dollars in thousands) |
30-59 days |
60-89 days |
Over 90 days |
Total past due |
Total current |
Total loans |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
— |
$ |
$ |
$ |
$ |
|||||||||||||||||
Non-farm non-residential non-owner occupied |
— |
|||||||||||||||||||||||
Residential |
— |
|||||||||||||||||||||||
Construction, development & other |
— |
|||||||||||||||||||||||
Farmland |
— |
— |
— |
|||||||||||||||||||||
Commercial & industrial |
||||||||||||||||||||||||
Consumer |
— |
— |
||||||||||||||||||||||
Other |
— |
|||||||||||||||||||||||
Purchased credit impaired |
— |
— |
||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||
December 31, 2020 | ||||||||||||||||||||||||
(Dollars in thousands) |
30-59 days |
60-89 days |
Over 90 days |
Total past due |
Total current |
Total loans |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | — | $ | $ | $ | $ | |||||||||||||||||
Non-farm non-residential non-owner occupied |
— | |||||||||||||||||||||||
Residential |
— | |||||||||||||||||||||||
Construction, development & other |
— | — | ||||||||||||||||||||||
Farmland |
— | — | — | — | ||||||||||||||||||||
Commercial & industrial |
||||||||||||||||||||||||
Consumer |
— | — | ||||||||||||||||||||||
Other |
— | — | ||||||||||||||||||||||
Purchased credit impaired |
— | — | ||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | |||||||||||||||||||
December 31, 2021 |
||||||||||||||||||||||||
(Dollars in thousands) |
Unpaid contractual principal balance |
Recorded investment with no allowance |
Recorded investment with allowance |
Total recorded investment |
Related allowance |
Average recorded investment during year |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
$ |
— |
$ |
$ |
— |
$ |
||||||||||||||||
Non-farm non-residential non-owner occupied |
— |
— |
||||||||||||||||||||||
Residential |
— |
— |
||||||||||||||||||||||
Construction, development & other |
— |
— |
||||||||||||||||||||||
Farmland |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Commercial & industrial |
||||||||||||||||||||||||
Consumer |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Other |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Purchased credit impaired |
— |
|||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||
December 31, 2020 | ||||||||||||||||||||||||
(Dollars in thousands) |
Unpaid contractual principal balance |
Recorded investment with no allowance |
Recorded investment with allowance |
Total recorded investment |
Related allowance |
Average recorded investment during year |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | $ | — | $ | $ | — | $ | ||||||||||||||||
Non-farm non-residential non-owner occupied |
— | — | ||||||||||||||||||||||
Residential |
— | — | ||||||||||||||||||||||
Construction, development & other |
— | — | ||||||||||||||||||||||
Farmland |
— | — | — | — | — | — | ||||||||||||||||||
Commercial & industrial |
||||||||||||||||||||||||
Consumer |
— | — | — | — | — | — | ||||||||||||||||||
Other |
— | — | — | — | — | — | ||||||||||||||||||
Purchased credit impaired |
— | — | — | — | — | — | ||||||||||||||||||
$ | $ | $ | $ | $ | $ | |||||||||||||||||||
December 31, 2019 | ||||||||||||||||||||||||
(Dollars in thousands) |
Unpaid contractual principal balance |
Recorded investment with no allowance |
Recorded investment with allowance |
Total recorded investment |
Related allowance |
Average recorded investment during year |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | $ | — | $ | $ | — | $ | ||||||||||||||||
Non-farm non-residential non-owner occupied |
— | — | — | — | — | — | ||||||||||||||||||
Residential |
— | — | ||||||||||||||||||||||
Construction, development & other |
— | — | — | — | — | — | ||||||||||||||||||
Farmland |
— | — | — | — | — | — | ||||||||||||||||||
Commercial & industrial |
||||||||||||||||||||||||
Consumer |
— | — | ||||||||||||||||||||||
Other |
— | |||||||||||||||||||||||
Purchased credit impaired |
— | — | ||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | |||||||||||||||||||
December 31, 2021 |
||||||||||||||||||||||||
Loan modifications |
||||||||||||||||||||||||
(Dollars in thousands) |
Number of loans |
Pre- restructuring recorded investment |
Post- restructuring recorded investment |
Adjusted interest rate |
Payment deferral |
Combined rate and payment deferral |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
$ |
— |
$ |
$ |
— |
|||||||||||||||||
Non-farm non-residential non-owner occupied |
— |
— |
||||||||||||||||||||||
Residential |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Construction, development & other |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Farmland |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Commercial & industrial |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Consumer |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
Other |
— |
— |
— |
— |
— |
— |
||||||||||||||||||
$ |
$ |
$ |
— |
$ |
$ |
— |
||||||||||||||||||
December 31, 2020 | ||||||||||||||||||||||||
Loan modifications | ||||||||||||||||||||||||
(Dollars in thousands) |
Number of loans |
Pre- restructuring recorded investment |
Post- restructuring recorded investment |
Adjusted interest rate |
Payment deferral |
Combined rate and payment deferral |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | $ | — | $ | $ | — | |||||||||||||||||
Non-farm non-residential non-owner occupied |
— | — | — | — | — | — | ||||||||||||||||||
Residential |
— | — | — | — | — | — | ||||||||||||||||||
Construction, development & other |
— | — | — | — | — | — | ||||||||||||||||||
Farmland |
— | — | — | — | — | — | ||||||||||||||||||
Commercial & industrial |
— | — | ||||||||||||||||||||||
Consumer |
— | — | — | — | — | — | ||||||||||||||||||
Other |
— | — | — | — | — | — | ||||||||||||||||||
$ | $ | $ | — | $ | $ | — | ||||||||||||||||||
December 31, 2021 |
||||||||||||||||||||||||
(Dollars in thousands) |
Pass |
Special Mention |
Substandard |
Purchased Credit Impaired |
Doubtful |
Total |
||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
$ |
$ |
— |
$ |
— |
$ |
||||||||||||||||
Non-farm non-residential non-owner occupied |
— |
|||||||||||||||||||||||
Residential |
— |
— |
||||||||||||||||||||||
Construction, development & other |
— |
— |
||||||||||||||||||||||
Farmland |
— |
— |
— |
— |
||||||||||||||||||||
Commercial & industrial |
— |
|||||||||||||||||||||||
Consumer |
— |
— |
— |
|||||||||||||||||||||
Other |
— |
— |
— |
— |
||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
— |
$ |
||||||||||||||||||
December 31, 2020 | ||||||||||||||||||||||||
(Dollars in thousands) |
Pass | Special Mention |
Substandard | Purchased Credit Impaired |
Doubtful | Total | ||||||||||||||||||
Real estate loans: |
||||||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | $ | $ | — | $ | — | $ | ||||||||||||||||
Non-farm non-residential non-owner occupied |
— | |||||||||||||||||||||||
Residential |
— | — | ||||||||||||||||||||||
Construction, development & other |
— | — | ||||||||||||||||||||||
Farmland |
— | — | — | — | ||||||||||||||||||||
Commercial & industrial |
||||||||||||||||||||||||
Consumer |
— | — | — | — | ||||||||||||||||||||
Other |
— | — | — | — | ||||||||||||||||||||
$ | $ | $ | $ | $ | $ | |||||||||||||||||||
For the Year Ended December 31, 2021 |
||||||||||||||||||||
(Dollars in thousands) |
Beginning balance |
Provision for loan losses |
Charge- offs |
Recoveries |
Ending balance |
|||||||||||||||
Real estate loans: |
||||||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
$ |
— |
$ |
— |
$ |
|||||||||||||
Non-farm non-residential non-owner occupied |
— |
— |
||||||||||||||||||
Residential |
( |
) |
— |
— |
||||||||||||||||
Construction, development & other |
— |
— |
||||||||||||||||||
Farmland |
— |
— |
||||||||||||||||||
Commercial & industrial |
( |
) |
||||||||||||||||||
Consumer |
( |
) |
— |
|||||||||||||||||
Other |
( |
) |
||||||||||||||||||
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||
For the Year Ended December 31, 2020 | ||||||||||||||||||||
(Dollars in thousands) |
Beginning balance |
Provision for loan losses |
Charge- offs |
Recoveries | Ending balance |
|||||||||||||||
Real estate loans: |
||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | $ | — | $ | — | $ | |||||||||||||
Non-farm non-residential non-owner occupied |
( |
) | — | |||||||||||||||||
Residential |
— | — | ||||||||||||||||||
Construction, development & other |
— | — | ||||||||||||||||||
Farmland |
— | |||||||||||||||||||
Commercial & industrial |
( |
) | ||||||||||||||||||
Consumer |
( |
) | ||||||||||||||||||
Other |
— | — | ||||||||||||||||||
$ | $ | $ | ( |
) | $ | $ | ||||||||||||||
For the Year Ended December 31, 2019 | ||||||||||||||||||||
(Dollars in thousands) |
Beginning balance |
Provision for loan losses |
Charge- offs |
Recoveries | Ending balance |
|||||||||||||||
Real estate loans: |
||||||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | $ | — | $ | $ | ||||||||||||||
Non-farm non-residential non-owner occupied |
( |
) | — | — | ||||||||||||||||
Residential |
— | — | ||||||||||||||||||
Construction, development & other |
— | — | ||||||||||||||||||
Farmland |
— | — | — | |||||||||||||||||
Commercial & industrial |
( |
) | ||||||||||||||||||
Consumer |
4 | ( |
) | — | ||||||||||||||||
Other |
— | — | ||||||||||||||||||
$ | $ | $ | ( |
) | $ | $ | ||||||||||||||
December 31, 2021 |
||||||||||||||||
Period end amounts of ALLL allocated to loans evaluated for impairment: |
||||||||||||||||
(Dollars in thousands) |
Individually |
Collectively |
PCI |
Total |
||||||||||||
Real estate loans: |
||||||||||||||||
Non-farm non-residential owner occupied |
$ |
— |
$ |
$ |
— |
$ |
||||||||||
Non-farm non-residential non-owner occupied |
— |
— |
||||||||||||||
Residential |
— |
— |
||||||||||||||
Construction, development & other |
— |
— |
||||||||||||||
Farmland |
— |
— |
||||||||||||||
Commercial & industrial |
||||||||||||||||
Consumer |
— |
— |
||||||||||||||
Other |
— |
— |
||||||||||||||
$ |
$ |
$ |
$ |
|||||||||||||
December 31, 2020 | ||||||||||||||||
Period end amounts of ALLL allocated to loans evaluated for impairment: |
||||||||||||||||
(Dollars in thousands) |
Individually | Collectively | PCI | Total | ||||||||||||
Real estate loans: |
||||||||||||||||
Non-farm non-residential owner occupied |
$ | — | $ | $ | — | $ | ||||||||||
Non-farm non-residential non-owner occupied |
— | — | ||||||||||||||
Residential |
— | — | ||||||||||||||
Construction, development & other |
— | — | ||||||||||||||
Farmland |
— | — | ||||||||||||||
Commercial & industrial |
— | |||||||||||||||
Consumer |
— | — | ||||||||||||||
Other |
— | — | ||||||||||||||
$ | $ | $ | — | $ | ||||||||||||
December 31, 2021 |
||||||||||||||||
Loans evaluated for impairment: |
||||||||||||||||
(Dollars in thousands) |
Individually |
Collectively |
PCI |
Total |
||||||||||||
Real estate loans: |
||||||||||||||||
Non-farm non-residential owner occupied |
$ |
$ |
$ |
— |
$ |
|||||||||||
Non-farm non-residential non-owner occupied |
— |
|||||||||||||||
Residential |
— |
|||||||||||||||
Construction, development & other |
— |
|||||||||||||||
Farmland |
— |
— |
||||||||||||||
Commercial & industrial |
||||||||||||||||
Consumer |
— |
— |
||||||||||||||
Other |
— |
— |
||||||||||||||
$ |
$ |
$ |
$ |
|||||||||||||
December 31, 2020 | ||||||||||||||||
Loans evaluated for impairment: |
||||||||||||||||
(Dollars in thousands) |
Individually | Collectively | PCI | Total | ||||||||||||
Real estate loans: |
||||||||||||||||
Non-farm non-residential owner occupied |
$ | $ | — | $ | ||||||||||||
Non-farm non-residential non-owner occupied |
||||||||||||||||
Residential |
||||||||||||||||
Construction, development & other |
||||||||||||||||
Farmland |
— | — | ||||||||||||||
Commercial & industrial |
||||||||||||||||
Consumer |
— | — | ||||||||||||||
Other |
— | — | ||||||||||||||
$ | $ | $ | $ | |||||||||||||
(Dollars in thousands) |
||||
Contractual required payments |
$ | |||
Non-accretable difference (expected loss) |
||||
Cash flows expected to be collected at acquisition |
||||
Accretable yield |
||||
Basis in acquired Heritage PCI loans |
$ | |||
December 31, |
||||||||
(Dollars in thousands) |
2021 |
2020 | ||||||
Real estate loans: |
||||||||
Non-farm non-residential owner occupied |
$ |
— |
$ | — | ||||
Non-farm non-residential non-owner occupied |
||||||||
Residential |
||||||||
Construction, development & other |
||||||||
Farmland |
— |
— | ||||||
Commercial & industrial |
||||||||
Consumer |
— |
— | ||||||
Other |
— |
— | ||||||
Total outstanding balances |
$ |
$ | ||||||
Carrying amount |
$ |
$ | ||||||
December 31, |
||||||||||||
(Dollars in thousands) |
2021 |
2020 | 2019 | |||||||||
Balance at beginning of year |
$ |
$ | $ | |||||||||
New loans acquired from Heritage acquisition |
— |
— | ||||||||||
Accretion of income |
( |
) |
( |
) | — | |||||||
Reclassifications from non-accretable difference |
— |
— | ||||||||||
Disposals |
— |
— | — | |||||||||
Balance at end of year |
$ |
$ | $ | |||||||||
4. |
Premises and Equipment |
Estimated Useful Life |
December 31, |
|||||||||||
(Dollars in thousands) |
2021 |
2020 | ||||||||||
Building |
$ |
$ | ||||||||||
Building improvements |
||||||||||||
Land |
||||||||||||
Equipment |
||||||||||||
Leasehold improvements |
||||||||||||
Furniture and fixtures |
5 years |
|||||||||||
Construction in process |
||||||||||||
Accumulated depreciation |
( |
) |
( |
) | ||||||||
$ |
$ | |||||||||||
5. |
Deposits |
December 31, |
||||||||
(Dollars in thousands) |
2021 |
2020 | ||||||
Transaction accounts: |
||||||||
Noninterest bearing demand accounts |
$ |
$ | ||||||
Interest bearing demand accounts |
||||||||
Savings |
||||||||
Total transaction accounts |
||||||||
Time deposits |
||||||||
Total deposits |
$ |
$ | ||||||
2022 |
$ | |||
2023 |
||||
2024 |
||||
2025 |
||||
2026 and thereafter |
||||
$ | ||||
6. |
Income Taxes |
December 31, |
||||||||
(Dollars in thousands) |
2021 |
2020 | ||||||
Current income tax expense |
$ |
$ | ||||||
Deferred income tax benefit |
( |
) |
( |
) | ||||
Income tax expense as reported |
$ |
$ | ||||||
December 31, |
||||||||
(Dollars in thousands) |
2021 |
2020 | ||||||
Income tax expense computed at statutory rate |
$ |
$ | ||||||
Stock-based compensation |
||||||||
Bank-owned life insurance |
( |
) |
( |
) | ||||
Non-deductible meals, entertainment, and dues |
||||||||
Tax-exempt income |
( |
) |
( |
) | ||||
Non-deductible capital offering expenses |
— |
|||||||
Non-deductible merger costs |
||||||||
Other, net |
( |
) |
( |
) | ||||
Income tax expense as reported |
$ |
$ | ||||||
December 31, |
||||||||
(Dollars in thousands) |
2021 |
2020 | ||||||
Deferred tax assets: |
||||||||
Allowance for loan losses |
$ |
$ | ||||||
Organizational and start-up costs |
||||||||
Accrued expenses |
||||||||
Stock options |
||||||||
Loan purchase mark-to-mark |
||||||||
Deposit purchase premium |
||||||||
Deferred loan origination fees |
||||||||
Other |
||||||||
Total deferred tax assets |
||||||||
Deferred tax liabilities: |
||||||||
Premises and equipment |
||||||||
Goodwill and core deposit intangibles |
||||||||
Investments |
||||||||
Net unrealized gain on securities available for sale |
||||||||
Unrealized gain on derivatives |
||||||||
Prepaid expenses and other |
||||||||
Total deferred tax liabilities |
||||||||
Net deferred tax asset |
$ |
$ | ||||||
7. |
FHLB Advances and Other Borrowings |
(Dollars in thousands) |
FHLB Advances |
Other Borrowings |
||||||
2022 |
$ | — | $ | |||||
2023 |
— | — | ||||||
2024 |
— | — | ||||||
2025 |
— | — | ||||||
2026 and thereafter |
— | |||||||
$ | $ | |||||||
December 31, |
||||||||||||||||
2021 |
2020 | |||||||||||||||
(Dollars in thousands, except share and per share data) |
Shares Underlying Options |
Weighted Average Exercise Price |
Shares Underlying Options |
Weighted Average Exercise Price |
||||||||||||
Outstanding at beginning of period |
$ |
$ | ||||||||||||||
Granted during the period |
||||||||||||||||
Acquired and converted options from acquisition |
— |
— |
||||||||||||||
Forfeited during the period |
( |
) |
( |
) | ||||||||||||
Exercised during the period |
( |
) |
( |
) | ||||||||||||
|
|
|
|
|||||||||||||
Outstanding at the end of period |
$ |
$ | ||||||||||||||
|
|
|
|
|||||||||||||
Options exercisable at end of period |
$ |
$ | ||||||||||||||
|
|
|
|
|||||||||||||
Weighted-average grant date fair value of options granted during the period |
$ |
$ |
December 31, |
||||||||||||||||||||||||
(Dollars in thousands, except share and per share data) |
2021 |
2020 | ||||||||||||||||||||||
Exercise Price |
Options Outstanding |
Weighted Average Remaining Life (years) |
Options Exercisable |
Options Outstanding |
Weighted Average Remaining Life (years) |
Options Exercisable |
||||||||||||||||||
$ |
||||||||||||||||||||||||
$ |
||||||||||||||||||||||||
$ |
— |
— | — | — | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
December 31, |
||||||||||||||||
2021 |
2020 | |||||||||||||||
(Dollars in thousands, except share and per share data) |
Shares |
Weighted Average Grant Date Fair Value |
Shares | Weighted Average Grant Date Fair Value |
||||||||||||
Nonvested at January 1, |
$ |
$ | ||||||||||||||
Granted during the period |
||||||||||||||||
Acquired and converted options from acquisition |
— |
— |
||||||||||||||
Vested during the period |
( |
) |
( |
) | ||||||||||||
Forfeited during the period |
( |
) |
( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Nonvested at end of period |
$ |
$ | ||||||||||||||
|
|
|
|
|
|
|
|
December 31, |
||||||||||||||||
2021 |
2020 | |||||||||||||||
(Dollars in thousands, except share and per share data) |
Shares Underlying Warrants |
Weighted Average Exercise Price |
Shares Underlying Warrants |
Weighted Average Exercise Price |
||||||||||||
Outstanding at beginning of period |
$ |
$ | ||||||||||||||
Granted |
— |
— |
— | — | ||||||||||||
Exercised |
( |
) |
||||||||||||||
Expired or forfeited |
— |
— |
— | — | ||||||||||||
Outstanding at end of period |
$ |
$ | ||||||||||||||
Exercisable at end of period |
$ |
$ | ||||||||||||||
December 31, |
||||||||||||||||||||||||
2021 |
2020 | 2019 | ||||||||||||||||||||||
(Dollars in thousands, except share and per share data) |
Shares |
Weighted Average Grant Date Fair Value |
Shares | Weighted Average Grant Date Fair Value |
Shares | Weighted Average Grant Date Fair Value |
||||||||||||||||||
Nonvested at beginning of period |
$ |
$ | $ | |||||||||||||||||||||
Granted during the period |
||||||||||||||||||||||||
Vested during the period |
— |
— |
||||||||||||||||||||||
Forfeited during the period |
— |
— |
— | — | — | — | ||||||||||||||||||
Nonvested at the end of period |
$ |
$ | $ | |||||||||||||||||||||
(Dollars in thousands) |
||||
2022 |
$ | |||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
2027 and thereafter |
||||
$ | ||||
December 31, |
||||||||
(Dollars in thousands) |
2021 |
2020 | ||||||
Commitments to extend credit |
$ |
$ | ||||||
Standby letters of credit |
||||||||
Total |
$ |
$ | ||||||
• | Level 1 Inputs – |
• | Level 2 Inputs |
active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (for example, interest rates, volatilities, prepayment speeds, loss severities, credit risks and default rates) or inputs that are derived principally from or corroborated by observable market data by correlation or other means. |
• | Level 3 Inputs |
Fair Value Measurements Using |
Total Fair Value |
|||||||||||||||
(Dollars in thousands) |
Level 1 Inputs |
Level 2 Inputs |
Level 3 Inputs |
|||||||||||||
At December 31, 2021: |
||||||||||||||||
Securities available for sale: |
||||||||||||||||
State and municipal securities |
$ |
— |
$ |
$ |
— |
$ |
||||||||||
Mortgage-backed securities |
— |
— |
||||||||||||||
Corporate bonds |
— |
— |
||||||||||||||
Total investment securities available for sale |
$ |
— |
$ |
$ |
— |
$ |
||||||||||
Asset derivatives: |
||||||||||||||||
Interest rate swaps |
$ |
— |
$ |
$ |
— |
$ |
||||||||||
Liability derivatives: |
||||||||||||||||
Interest rate swaps |
$ |
— |
$ |
$ |
— |
$ |
||||||||||
Fair Value Measurements Using | Total Fair Value |
|||||||||||||||
(Dollars in thousands) |
Level 1 Inputs |
Level 2 Inputs |
Level 3 Inputs |
|||||||||||||
At December 31, 2020: |
||||||||||||||||
Securities available for sale: |
||||||||||||||||
State and municipal securities |
$ | — | $ | $ | — | $ | ||||||||||
Mortgage-backed securities |
— | — | ||||||||||||||
Corporate bonds |
— | — | ||||||||||||||
Total investment securities available for sale |
$ | — | $ | $ | — | $ | ||||||||||
Loans held for sale: |
$ | — | $ | — | $ | $ | ||||||||||
Asset derivatives: |
||||||||||||||||
Interest rate swaps |
$ | — | $ | $ | — | $ | ||||||||||
Pay-fixed interest rate swaps |
— | — | ||||||||||||||
$ | — | $ | $ | — | $ | |||||||||||
Liability derivatives: |
||||||||||||||||
Interest rate swaps |
$ | — | $ | $ | — | $ | ||||||||||
Pay-fixed interest rate swaps |
— | — | ||||||||||||||
$ | — | $ | $ | — | $ | |||||||||||
December 31, |
||||||||
(Dollars in thousands) |
2021 |
2020 | ||||||
Foreclosed assets remeasured at initial recognition: |
||||||||
Carrying value of foreclosed assets prior to remeasurement |
$ |
— |
$ | |||||
Charge-offs recognized in the allowance for loan losses |
— |
|||||||
Fair value of foreclosed assets remeasured at initial recognition |
$ |
— |
$ | |||||
Foreclosed assets remeasured subsequent to initial recognition: |
||||||||
Carrying value of foreclosed assets prior to remeasurement |
$ |
$ | ||||||
Write downs included in other non-interest expense |
— |
|||||||
Fair value of foreclosed assets remeasured subsequent to initial recognition |
$ |
$ | ||||||
December 31, 2021 |
December 31, 2020 | |||||||||||||||
(Dollars in thousands) |
Carrying Value |
Estimated Fair Value |
Carrying Value |
Estimated Fair Value |
||||||||||||
Financial assets |
||||||||||||||||
Level 2 inputs |
||||||||||||||||
Cash and cash equivalents |
$ |
$ |
$ | $ | ||||||||||||
Interest bearing time deposits in other banks |
||||||||||||||||
Investment securities available for sale |
||||||||||||||||
Non-marketable securities |
||||||||||||||||
Accrued interest receivable |
||||||||||||||||
Bank-owned life insurance |
||||||||||||||||
Derivative instruments assets |
||||||||||||||||
$ |
$ |
$ | $ | |||||||||||||
Level 3 inputs |
||||||||||||||||
Loans, including held for sale, net |
$ |
$ |
$ | $ | ||||||||||||
Financial liabilities |
||||||||||||||||
Level 2 inputs |
||||||||||||||||
Deposits |
$ |
$ |
$ | $ | ||||||||||||
Accrued interest payable |
||||||||||||||||
FHLB advances |
||||||||||||||||
Notes payable |
||||||||||||||||
Derivative instrument liabilities |
||||||||||||||||
$ |
$ |
$ | $ | |||||||||||||
12. |
Significant Group Concentrations of Credit Risk |
Actual |
|
For Capital Adequacy Purposes Basel III Fully Phased-In (2) |
To Be Well Capitalized Under Prompt Corrective Action Provisions |
|||||||||||||||||||||||||||||||||||||
(Dollars in thousands) |
Amount |
Ratio |
Amount |
Ratio |
Amount |
Ratio |
||||||||||||||||||||||||||||||||||
As of December 31, 2021: |
||||||||||||||||||||||||||||||||||||||||
Total capital (to risk weighted assets) |
$ |
% |
≥ | $ |
≥ | % |
≥ | $ |
≥ | % | ||||||||||||||||||||||||||||||
Tier I capital (to risk weighted assets) |
$ |
% |
≥ | $ |
≥ | % |
≥ | $ |
≥ | % | ||||||||||||||||||||||||||||||
Tier I capital (to average assets) (1) |
$ |
% |
≥ | $ |
≥ | % |
≥ | $ |
≥ | % | ||||||||||||||||||||||||||||||
Common equity tier 1 (to risk weighted assets) |
$ |
% |
≥ | $ |
≥ | % |
≥ | $ |
≥ | % | ||||||||||||||||||||||||||||||
As of December 31, 2020: |
||||||||||||||||||||||||||||||||||||||||
Total capital (to risk weighted assets) |
$ | % | ≥ | $ | ≥ | % | ≥ | $ | ≥ | % | ||||||||||||||||||||||||||||||
Tier I capital (to risk weighted assets) |
$ | % | ≥ | $ | ≥ | % | ≥ | $ | ≥ | % | ||||||||||||||||||||||||||||||
Tier I capital (to average assets) (1) |
$ | % | ≥ | $ | ≥ | % | ≥ | $ | ≥ | % | ||||||||||||||||||||||||||||||
Common equity tier 1 (to risk weighted assets) |
$ | % | ≥ | $ | ≥ | % | ≥ | $ | ≥ | % |
(1) | The Tier 1 capital ratio (to average assets) is not impacted by the Basel III Capital Rules; however, the Federal Reserve and the FDIC may require the Bank to maintain a Tier 1 capital ratio (to average assets) above the minimum required. |
(2) | Percentages represent the minimum capital ratios plus, as applicable, the fully phased-in |
For the Years Ended December 31, |
||||||||||||
(Dollars in thousands, except share and per share data) |
2021 |
2020 | 2019 | |||||||||
Net income available to common shareholders |
$ |
$ | $ | |||||||||
|
|
|
|
|
|
|||||||
Weighted-average shares outstanding for basic earnings per common share |
||||||||||||
Dilutive effect of stock compensation |
||||||||||||
|
|
|
|
|
|
|||||||
Weighted-average shares outstanding for diluted earnings per common share |
||||||||||||
|
|
|
|
|
|
(Dollars in thousands) |
Outstanding Notional Balance |
Asset Derivative Fair Value |
Liability Derivative Fair Value |
Pay Rate (1) |
Receive Rate (1) |
Remaining Term (2) |
||||||||||||||||||
December 31, 2021 |
||||||||||||||||||||||||
Pay-fixed interest rate swap (*) |
$ |
— |
$ |
— |
$ |
— |
% |
Funds-H.15 |
||||||||||||||||
Commercial loan interest rate swaps: |
||||||||||||||||||||||||
Loan customer counterparty |
— |
% |
||||||||||||||||||||||
Financial institution counterparty |
— |
% |
||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
$ |
$ |
$ |
||||||||||||||||||||||
|
|
|
|
|
|
(*) | Facility terminated on February 18, 2021 (see disclosure narrative on cash flow hedge above). |
(1) | Weighted average rate. |
(2) | Weighted average life (in years). |
(Dollars in thousands) |
Outstanding Notional Balance |
Asset Derivative Fair Value |
Liability Derivative Fair Value |
Pay Rate (1) |
Receive Rate (1) |
Remaining Term (2) |
||||||||||||||||||
December 31, 2020 |
||||||||||||||||||||||||
Pay-fixed interest rate swap (*) |
$ | $ | $ | % | |
Funds-H.15 |
||||||||||||||||||
Commercial loan interest rate swaps: |
||||||||||||||||||||||||
Loan customer counterparty |
— | % | ||||||||||||||||||||||
Financial institution counterparty |
— | % | ||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
$ | $ | $ | ||||||||||||||||||||||
|
|
|
|
|
|
(*) | Facility terminated on February 18, 2021 (see disclosure narrative on cash flow hedge above). |
(1) | Weighted average rate. |
(2) | Weighted average life (in years). |
(Dollars in thousands) |
CDI Amortization |
|||
2022 |
$ |
|||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
2027 and thereafter |
||||
|
|
|||
$ |
||||
|
|
(Dollars in thousands) |
||||
Assets of acquired bank: |
||||
Cash and cash equivalents |
$ | |||
Securities available for sale |
||||
Loans |
||||
Premises and equipment |
||||
Goodwill |
||||
Core deposit intangible |
||||
Bank owned life insurance |
||||
Federal Home Loan Bank stock |
||||
Other assets |
||||
|
|
|||
Total assets acquired |
$ | |||
|
|
|||
Liabilities of acquired bank: |
||||
Deposits |
$ | |||
Other liabilities |
||||
|
|
|||
Total liabilities assumed |
$ | |||
|
|
|||
Common stock issued @ $ |
$ | |||
|
|
|||
Cash paid |
$ | |||
|
|
(Dollars in thousands) |
December 31, |
|||||||
ASSETS |
2021 |
2020 | ||||||
Cash and cash equivalents |
$ |
$ | ||||||
Investment in subsidiary |
||||||||
Other assets |
||||||||
|
|
|
|
|||||
Total assets |
$ |
$ | ||||||
|
|
|
|
|||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||||
Other borrowings |
$ |
$ | ||||||
Other liabilities |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
Commitments and contingencies—ESOP-owned shares |
— |
|||||||
Shareholders’ equity: |
||||||||
Common stock |
||||||||
Additional paid-in capital |
||||||||
Retained earnings |
||||||||
Accumulated other comprehensive income |
||||||||
Treasury stock: at cost |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Less: ESOP-owned shares |
— |
|||||||
|
|
|
|
|||||
Total shareholders’ equity |
||||||||
|
|
|
|
|||||
Total liabilities & shareholders’ equity |
$ |
$ | ||||||
|
|
|
|
For the Years Ended December 31, |
||||||||||||
(Dollars in thousands) |
2021 |
2020 | 2019 | |||||||||
Interest expense: |
||||||||||||
Interest on notes payable |
$ |
$ | $ | |||||||||
|
|
|
|
|
|
|||||||
Total interest expense |
||||||||||||
|
|
|
|
|
|
|||||||
Noninterest expense: |
||||||||||||
Legal and professional |
||||||||||||
Other |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Total noninterest expense |
||||||||||||
|
|
|
|
|
|
|||||||
Loss before income tax expense and equity in undistributed earnings of subsidiaries |
( |
) |
( |
) | ( |
) | ||||||
Income tax benefit |
||||||||||||
|
|
|
|
|
|
|||||||
Loss before equity in undistributed earnings of subsidiaries |
( |
) |
( |
) | ( |
) | ||||||
Equity in undistributed earnings of subsidiaries |
||||||||||||
|
|
|
|
|
|
|||||||
Net income |
$ |
$ | $ | |||||||||
|
|
|
|
|
|
|||||||
Comprehensive income |
$ |
$ | $ | |||||||||
|
|
|
|
|
|
For the Years Ended December 31, |
||||||||||||
(Dollars in thousands) |
2021 |
2020 | 2019 | |||||||||
Cash flows from operating activities: |
||||||||||||
Net income |
$ |
$ | $ | |||||||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||||||
Equity in undistributed net income of subsidiaries |
( |
) |
( |
) | ( |
) | ||||||
Net change in other assets |
( |
) |
( |
) | ||||||||
Net change in other liabilities |
( |
) |
( |
) | ||||||||
|
|
|
|
|
|
|||||||
Net cash used in operating activities |
( |
) |
( |
) | ( |
) | ||||||
Cash flows from investing activities: |
||||||||||||
Capital investment in subsidiaries |
( |
) |
— | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Net cash used in investing activities |
( |
) |
— | ( |
) | |||||||
Cash flows from financing activities: |
||||||||||||
Proceeds from other borrowings |
— |
|||||||||||
Repayment of notes payable |
( |
) |
( |
) | ( |
) | ||||||
Proceeds from issuance of common stock |
||||||||||||
Proceeds from stock warrants exercised |
— | — | ||||||||||
Proceeds from stock options exercised |
||||||||||||
Net redemption of treasury stock |
( |
) |
( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Net cash provided by financing activities |
||||||||||||
|
|
|
|
|
|
|||||||
Increase in cash and cash equivalents |
||||||||||||
Cash and cash equivalents at beginning of period |
||||||||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents at end of period |
$ |
$ | $ | |||||||||
|
|
|
|
|
|
For the Quarters Ended December 31, 2021 |
||||||||||||||||
(Dollars in thousands) |
Q4 |
Q3 |
Q2 |
Q1 |
||||||||||||
Selected income statement data: |
||||||||||||||||
Interest income |
$ |
$ |
$ |
$ |
||||||||||||
Interest expense |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net interest income |
||||||||||||||||
Provision for loan losses |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net interest income after provision for loan losses |
||||||||||||||||
Noninterest income |
||||||||||||||||
Noninterest expense |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income before income tax expense |
||||||||||||||||
Income tax expense |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income |
$ |
$ |
$ |
$ |
||||||||||||
|
|
|
|
|
|
|
|
For the Quarters Ended December 31, 2020 | ||||||||||||||||
(Dollars in thousands) |
Q4 | Q3 | Q2 | Q1 | ||||||||||||
Selected income statement data: |
||||||||||||||||
Interest income |
$ | $ | $ | $ | ||||||||||||
Interest expense |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net interest income |
||||||||||||||||
Provision for loan losses |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net interest income after provision for loan losses |
||||||||||||||||
Noninterest income |
||||||||||||||||
Noninterest expense |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income before income tax expense |
||||||||||||||||
Income tax expense |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
* | Filed herewith. |
(a) | The undersigned registrant hereby undertakes: |
(1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
(i) | To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; |
(ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in the volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and |
(iii) | To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement. |
(2) | That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(3) | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
(4) | That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a |
document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. |
(5) | That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: |
(i) | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
(ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
(iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and |
(iv) | Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
(b) | The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(c) | Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. |
(d) | The undersigned registrant hereby undertakes to respond to requests for information that is incorporated by reference into the prospectus pursuant to Items 4, 10(b), 11 or 13 of this Form, within one (1) business day of receipt of such request, and to send the incorporated documents by first class mail or other equally prompt means. This includes information contained in documents filed subsequent to the effective date of the registration statement through the date of responding to the request. |
(e) | The undersigned registrant hereby undertakes to supply by means of a post-effective amendment all information concerning a transaction, and the company being acquired involved therein, that was not the subject of and included in this registration statement when it became effective. |
THIRD COAST BANCSHARES, INC. | ||
By: | /s/ Bart O. Caraway | |
Bart O. Caraway Chairman, President and Chief Executive Officer |
Signature |
Title |
Date | ||
/s/ Bart O. Caraway Bart O. Caraway |
Chairman, President and Chief Executive Officer (Principal Executive Officer) |
May 26, 2022 | ||
/s/ R. John McWhorter R. John McWhorter |
Chief Financial Officer (Principal Financial Officer and Accounting Officer) |
May 26, 2022 | ||
/s/ Carolyn Bailey Carolyn Bailey |
Director | May 26, 2022 | ||
/s/ Martin Basaldua Martin Basaldua |
Director | May 26, 2022 | ||
/s/ Dennis Bonnen Dennis Bonnen |
Director | May 26, 2022 | ||
/s/ W. Donald Brunson W. Donald Brunson |
Director | May 26, 2022 |
Signature |
Title |
Date | ||
/s/ Norma J. Galloway Norma J. Galloway |
Director | May 26, 2022 | ||
/s/ Troy A. Glander Troy A. Glander |
Director | May 26, 2022 | ||
/s/ Shelton J. McDonald Shelton J. McDonald |
Director | May 26, 2022 | ||
/s/ Joseph L. Stunja Joseph L. Stunja |
Director | May 26, 2022 | ||
/s/ Reagan Swinbank Reagan Swinbank |
Director | May 26, 2022 |